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1 
I  Abstract 
With the advances in genome-wide screening arrays and sequencing techniques scientists 
were enabled to examine genetic variations and their effects on behavioral phenotypes. 
While single nucleotide polymorphisms (SNPs) are the most widely studied form of 
genomic variations to date, another type of variants has become increasingly important in 
recent research, the copy number variants (CNVs). These large segments of DNA that can 
comprise up to several megabasepairs and differ in copy number with respect to a 
reference genome have been associated with several disorders and behavioral 
phenotypes before. 
This study investigated the influence of CNVs on anxiety-related behavior. The detection 
of these variants turned out to be a major challenge since all methods available are 
biased by limitations of the design of the approach and the subsequent computational 
analyses. Therefore, three different techniques (next-generation sequencing and two 
distinct whole-genome genotyping arrays) were employed to identify CNVs in a 
CD-1-derived mouse model consisting of two mouse strains showing high (HAB) and low 
(LAB) anxiety-related behavior, respectively. By comparing CNVs in HAB vs. LAB mice with 
expression data of four distinct brain regions of high relevance to the limbic system 
(central and basolateral amygdala, cingulate cortex and the hypothalamic paraventricular 
nucleus), it was shown that CNVs can influence the expression of protein coding genes by 
the alteration of the genes’ copy number per se. Therefore, the genes mapping into 
regions where CNVs were detected in HAB vs. LAB mice (by all three detection methods) 
were suggested to be possible effectors of anxiety-related behavior. Amongst these 
candidate genes those were considered to be the most interesting ones that were 
additionally found to map into regions of CNVs associated with anxiety-related behavior 
in CD-1 mice. CNVs in these mice were detected by means of a whole-genome genotyping 
array and subsequent processing of the raw data with a novel computational approach 
that was adapted from existing analysis methods. 
Furthermore, to test the effect of a specific CNV on anxiety-related behavior in vivo, a 
breeding approach was used to generate animals with a full genetic background of HAB 
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mice except for one LAB-derived locus harboring a CNV that included the Glo1 gene. No 
direct effect on the phenotype could be observed, however, the respective CNV might be 
involved in the manipulation of anxiety-related behavior taken into account the 
interaction with other factors. 
Taken together, this study provides not only a comprehensive catalogue of CNVs in 
HAB/LAB mice but also the evidence that these variants can influence anxiety-related 
behavior. Furthermore, it gives a first insight into the functionality of CNVs with respect 
to anxiety-related behavior. Therefore, this thesis provides a profound basis for multiple 
advanced studies. 
 
3 
II  Introduction 
1  The definition of anxiety 
When talking about anxiety, it is inevitable to address the term of fear since both are 
often conflated in the literature (Sylvers et al., 2011). The relationship between fear and 
anxiety has been described controversially. Beck and Emery (2005) assessed fear as the 
cognitive response to threat whereas anxiety is the emotional response to that fear, while 
Sylvers and colleagues (Sylvers et al., 2011) postulated that anxiety and fear encompass 
distinct emotional states and are largely unrelated. However, there is consensus in the 
definition of fear being an emotion that triggers adaptation mechanisms in response to 
the exposure to a distinct threat (Belzung and Philippot, 2007; Sylvers et al., 2011), while 
anxiety is considered to be a future-oriented (emotional) state that does not require the 
presence of an acute stressor (Barlow, 2000; Belzung and Philippot, 2007; Sylvers et al., 
2011). Both anxiety and fear could be differentiated in either a state emotion that affects 
adaptations to specific situations, or a trait emotion that refers to affective characteristics 
of an individual across time and situation (Sylvers et al., 2011). Hence, state anxiety is a 
type of anxiety that occurs at a particular moment in time when an individual approaches 
an ambiguous and uncertain threat. In contrast, trait anxiety is a persistent feature of an 
organism leading to a persistent hypervigilance for potential threats (Clement et al., 2007; 
Sylvers et al., 2011). However, since in most publications on anxiety the authors refrained 
from discriminating these two subtypes of anxiety, this distinction was also not made in 
this thesis. It could be kept in mind, though, that behavioral tests like the elevated 
plus-maze and open field test are considered to assess state anxiety, while trait anxiety 
would reflect a consistent characteristic (Belzung and Griebel, 2001; Clement et al., 2007). 
The complex phenomena of anxiety and fear are accompanied by specific responses 
including a behavioral (e.g., flight), physiological (e.g., increase in hart rate) and 
expressive (e.g., vocalization) component (Belzung and Philippot, 2007; Gross and Hen, 
2004). Each of these components evolved to protect the individual from danger. 
However, in a pathological form of anxiety, they can severely lower the quality of life. In 
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humans six major anxiety disorders have been classified: generalized anxiety disorder, 
social and simple phobia, panic disorder, post-traumatic stress disorder and 
obsessive-compulsive disorder (American Psychiatric Association, 1994; Gross and Hen, 
2004). The 1-year and lifetime prevalence rate of anxiety disorders in adults have been 
estimated to be higher than 10% and 16%, respectively, though these numbers vary 
greatly between published reports (Sommers, 2006). This huge number of affected 
people turns the elucidation of molecular and genetic causes of anxiety into an important 
field of current clinical and basic research. 
2  The comorbidity of anxiety and depression 
The relationship between anxiety and depression has been in the focus of interest since 
the 1980s (Mineka et al., 1998). Although anxiety disorders have been classified distinct 
from mood disorders, like the major depressive disorder, there is evidence of an existing 
complex comorbidity (American Psychiatric Association, 1994; Hettema et al., 2003; 
Kessler et al., 2005; Mineka et al., 1998; Stein and Heimberg, 2004; Yerevanian et al., 
2001). This comorbidity was shown on a diagnostic as well as molecular level. Thus, for 
example, it was reported that 40% of patients suffering from anxiety disorders also were 
afflicted with depression and, the other way round, that 67% of patients affected by 
depression had experienced any anxiety disorder (Hranov, 2007). Furthermore, a 
dysfunctional hypothalamic-pituitary-adrenal (HPA) axis, a system, which is involved in 
stress response, was connected with both types of disease (Cowen, 2009; Faravelli et al., 
2012; Hettema et al., 2006; Kallen et al., 2008). The involvement of the stress hormone 
system in anxiety and depression was further shown in clinical studies, which found 
elevated serum glucocorticoid concentrations in depressive patients, and animal studies, 
which revealed a correlation of increased corticosterone levels and measures of risk 
assessment (Finn et al., 2003; Krishnan and Nestler, 2008). Other studies have focused on 
the genetic level of comorbidity (e.g., Lawford et al., 2006; Molina et al., 2011; van Veen 
et al., 2012), leading to the assumption that the underlying genetics of anxiety and 
depression are nearly identical (Kendler and Prescott, 2006). 
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It therefore seems that both anxiety and depression may be triggered by a complex 
system of different molecular mechanisms, of which some are unique to a respective type 
of disorder and others are shared. Although the relationship between anxiety and 
depression is not yet fully understood, the comorbidity cannot be denied. On this 
account, even though the focus of this thesis was on the analysis of anxiety, tests for 
depression-like behavior and stress-reactivity (stress-reactivity test and tail suspension 
test) were performed to provide the basis for future examinations on this topic. 
3  Can human anxiety be modeled in animals? 
Believing in the theory of evolution, each complex phenotype is supposed to have its 
roots in more simple behavioral and molecular patterns. The investigation of a behavioral 
phenotype requires not only to question the underlying molecular characteristics, but 
also to consider how and why these behavioral and molecular patterns could have 
evolved. Especially for the study of complex traits like emotions (e.g., fear and anxiety) 
the knowledge of the traits’ origin is important to comprehend the complex interactions 
of molecular processes involved. It has been postulated that a steadily changing 
environment could have led to the evolution of emotions to coordinate the activity of 
multiple body systems to meet the new challenges (Andrews et al., 2002; Andrews and 
Thomson, 2009; Tooby and Cosmides, 1990). This coordination is likely to have evolved in 
a step-wise manner following the construction of new systems. Therefore, a gain in 
complexity of emotional processes and their related logistical systems should be apparent 
over evolutionary time (Andrews and Thomson, 2009; Belzung and Philippot, 2007). 
Indeed, such a trend was observed in a study investigating human anxiety from a 
phylogenetic perspective (Belzung and Philippot, 2007). For example, triggered by fear, 
biogenic amines like adrenaline, noradrenaline and dopamine have been shown to be 
released in humans. With some variations, these amines have been described in all 
vertebrates, and some of them were also found to be increased under stressful situations 
in invertebrates (Belzung and Philippot, 2007; Lacoste et al., 2001; Weiger, 1997). 
Furthermore, stress hormones linked to human anxiety like the corticotropic-releasing 
hormone (CRH) are highly conserved across species. CRH has been found in vertebrates 
(e.g., mammals, birds and amphibians) but also as CRH-like molecules in some 
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invertebrates, for example annelids, insects and mollusks (Belzung and Philippot, 2007; 
Deussing and Wurst, 2005; Merali et al., 2004; Ottaviani and Franceschi, 1996). There is 
further evidence that most animals share expressive components of fear and anxiety. 
Vocalizations to threat can be observed all across the phylum, from insects (e.g., crickets 
emit ultrasonic signals specific to the danger they are exposed to) to higher mammals 
(e.g., vervet monkeys have alarm calls specific to different predators) (Belzung and 
Philippot, 2007; Seyfarth et al., 1980; Wyttenbach et al., 1996). Moreover, chemical cues 
are known in this context. Social hymenoptera for instance use pheromones as alarm 
calls, thereby triggering fight or flight reactions in conspecifics (Maschwitz, 1966). The 
excretion of odors when experiencing fear or anxiety has also been shown in rodents, 
primates, and humans (Belzung and Philippot, 2007; Chen et al., 2006; Haegler et al., 
2010; Kiyokawa et al., 2006).  
Besides, there are components of anxiety that seem to be unique to higher mammals and 
humans. The most important is certainly the subjective feeling state, thus the awareness 
of the emotion, which might appear at different levels (Belzung and Philippot, 2007; Lane 
et al., 1998). It has been controversially discussed if animals, and primates in particular, 
are able to mentally experience past events or to imagine how a future might look like or 
what future experiences might feel like (Roberts and Feeney, 2009; Sajithlal et al., 2002; 
Suddendorf and Corballis, 2007; Wheeler et al., 1997). Such ability would imply a kind of 
self-consciousness, also called autonoetic consciousness (Chiong, 2011; Tulving, 1985). It 
is subject of discussion whether it exists in non-humans, and which level is required to 
experience anxiety. While the debate on this topic is still going on, it has be shown that 
human anxiety can be discriminated from anxiety of lower animals by the brain regions 
engaged (insofar as these even exist in animals). Thus, the involvement of the 
hypothalamus, hippocampus and amygdala in emotional response has been proven for 
many mammals and animals even lower in the phylogenetic tree. In contrast, there seem 
to be aspects of anxiety that are unique to great apes and humans since they engage the 
insular and cingulate cortex in these species solely (Belzung and Philippot, 2007). 
In conclusion, human anxiety comprises facets that could be observed already in insects, 
but also others that seem to be unique to humans and maybe hominids (Belzung and 
Philippot, 2007). Therefore, it is likely that critical aspects of anxiety are regulated in a 
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similar way in humans and animals. To understand the complexity of molecular 
interactions triggering and triggered by anxiety in humans, it is inevitable to reveal the 
distinct systems involved in these complex patterns. These systems can be best examined 
in animals showing a rudimentary form of the respective behavior and molecular 
mechanisms. Additionally, specific genomic and physiological manipulations are required 
to investigate the underlying mechanisms, which are not feasible in humans. Hence, 
although not every aspect of anxiety can be modeled in animals, model organisms are an 
important and indispensable tool in science and in anxiety research in particular. 
The use of the mouse as model organism in neuropsychiatric and other preclinical 
research has rapidly escalated in the last decades (Cryan and Holmes, 2005). There are 
different reasons for this trend. First, due to their high reproduction rate and their 
relatively small size, mice are easy to host and breed in a quick and cost effective manner. 
Furthermore, and even more important, there is evidence of a large genetic homology 
between mice and men. About 99% mouse orthologs were reported to be found in 
human genes and vice versa (Tecott, 2003). Therefore, genes influencing anxiety-related 
behavior in mice could be regarded as excellent candidate genes for human anxiety 
disorders. Besides the genetic there is also an extensive neuroanatomical homology 
between mice and men and, finally, mice show a similar response to specific drugs that 
are used to treat human disease (Blanchard et al., 2003; Hovatta and Barlow, 2008; 
Tecott, 2003). 
To date, several mouse models of anxiety and depression have been developed based on 
genetic engineering or inbreeding approaches (Cryan and Holmes, 2005; El Yacoubi and 
Vaugeois, 2007). A genetically homogeneous population resulting from sufficient 
inbreeding is beneficial for the investigation of genetic influences on specific traits since it 
reduces genomic variability. The individuals of that population are genetically almost 
identical and thus highly suitable for long-term investigations (Tecott, 2003). Following a 
breeding strategy of selecting mice showing extremes for a specific trait like anxiety, one 
can enhance the genetic features associated with the respective trait. Thereby, the mice’s 
phenotype is shifted bidirectionally from the mean behavior of the original population, 
finally resulting in two distinct mouse lines (Krömer et al., 2005). These two lines provide 
a powerful tool to investigate genetic underpinnings of the respective trait. As described 
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below, such a selective and bidirectional breeding approach was applied to generate the 
mouse model that was used in the context of this study. 
4  The HAB/LAB mouse model 
Following bidirectional selective breeding protocols, which were successfully applied in 
rats before (Landgraf et al., 2007; Landgraf and Wigger, 2002; Liebsch et al., 1998), a 
mouse model of two lines reflecting extremes in anxiety-related behavior was generated. 
The crucial breeding parameter, for which the animals were tested, was the time they 
spent on the open arms of the elevated plus-maze (EPM). The procedure of this test, a 
standard test to determine anxiety-related behavior in rodents (Pellow et al., 1985), is 
described in chapter III-2.1. Depending on their performance on the EPM, the individuals 
of a founder population of more than 250 animals from over 25 litters of outbred Swiss 
CD-1 mice were used to form the basis for either the HAB (high anxiety-related behavior) 
or LAB (low anxiety-related behavior) mouse line. For nine generations outbreeding 
across families but within behavioral restrictions was performed. Afterwards, a strict 
inbreeding protocol (brother-sister mating) was followed (Krömer et al., 2005). As 
illustrated in Figure II-1 the two mouse lines show a stable anxiety-related phenotype 
over generations of inbreeding, with HAB mice spending about 10% of the test time on 
the open arm of the EPM while LAB mice stay there for about 50% of the time. 23 
generations after establishing the HAB/LAB mouse model the breeding of a control line 
(NAB; normal anxiety-related behavior) was initiated. The individuals of this line show an 
intermediate anxiety-related behavior, which is similar to the mean behavior shown by 
CD-1 mice, as depicted in Figure II-1. 
To this day more than 40 generations of HAB/LAB mice have served as a basis for multiple 
studies with genetic, proteomic, cognitive, developmental and brain physiological 
background (e.g., Czibere et al., 2011; Ditzen et al., 2009; Hambsch et al., 2010; Ionescu 
et al., 2012; Krömer et al., 2005; Sah et al., 2012; Sotnikov et al., 2011; Yen et al., 2012). 
In the field of genetics several experiments have been performed to test the effect of, for 
instance, single nucleotide polymorphisms (SNPs) (e.g., Kessler et al., 2007) or epigenetic 
factors (studies are still ongoing) in the HAB/LAB mouse model. So far, however, no 
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studies have been performed to investigate the influence of another type of genetic 
variance, the so called copy number variants (CNVs). This is at the central focus of the 
present study. 
 
Figure II-1: Development of anxiety-related behavior in the HAB/LAB mouse model 
over 45 generations. The crucial parameter for the breeding was the time the animals 
spent on the open arm of the EPM, which is plotted on the y-axis. The x-axis shows the 
respective generation. The behavior of HAB animals is indicated by red lines, of LAB by 
blue lines, of NAB by green lines and of CD-1 mice by a thick green line. Dashed lines 
represent females, solid males. 
5  Definition and forming mechanisms of CNVs and SVs 
Lupski and colleagues (Lupski et al., 1991) were the first to report that large genomic 
rearrangements and gene dosage effects, and not small alterations of the coding DNA, 
were causing an autosomal dominant neurodegenerative disorder (Canales and Walz, 
2011). Since 1991, not least thanks to the development of advanced genotyping and 
sequencing techniques, many more examples of diseases caused by these so called copy 
number variants (CNVs) have been found. However, the understanding of the extent and 
influence of this type of genetic variations is still in its infancy (Canales and Walz, 2011). 
Based on a widely accepted definition, CNVs are considered as large regions of duplicated 
or deleted DNA regions that vary in copy number with respect to a reference genome, 
and range in size from 1 kilobasepair (bp) to several megabasepairs (Kim et al., 2008). 
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However, taken into account recent findings, it seems like the definition of the lower 
bound needs to be eased as it relies on an operational definition and approved detection 
methods enable the revelation of even smaller variants. For example, based on the 
application of new techniques, CNVs were found with a lower bound of merely 50 bp (Arlt 
et al., 2012). 
Reading the literature, caution needs to be exercised with respect to a term often 
mentioned in the context of CNVs, the so called segmental duplications (SDs). SDs, also 
called low-copy repeats (LCRs) were defined as duplicated regions, not necessarily 
adjacent to each other, larger than 1 kbp with over 90% sequence identity among the 
duplicates (Bailey et al., 2004; Gu et al., 2008; Kim et al., 2008). In some publications no 
clear distinction between the two terms was drawn and the reader has to take care not to 
be confused. Furthermore, especially for CNVs detected by array-based methods, the 
sequence similarity between the copies of a specific region cannot be determined and 
thus duplications that should strictly be termed SDs are specified as CNVs. To prevent 
confusion, in the present study no classification of CNVs and SDs was established and the 
definition of detected CNVs did not comprise any lower limit. However, another term was 
used in this study, namely structural variations (SVs), which are genomic rearrangements 
that could be of complex nature like inversions or be simple insertions or deletions 
(Malhotra and Sebat, 2012). 
Three major mechanisms, as outlined below, have been proposed to form CNVs and SVs: 
nonallelic homologues recombination (NAHR), nonhomologous end-joining (NHEJ), and 
fork stalling and template switching (FoSTeS) (Gu et al., 2008). 
Most of the recurrent CNVs, i.e. CNVs of the same genomic sequence that have been 
observed in different individuals, are caused by NAHR (Stankiewicz and Lupski, 2002). This 
mechanism is mediated by LCRs (also called SDs) at non-allelic loci during meiosis and, at 
lower frequency, during mitosis (Lam and Jeffreys, 2006; Malhotra and Sebat, 2012; 
Turner et al., 2008). Due to the high sequence similarity between the LCRs, misalignments 
can occur, not only on an interchromosomal but also an inter- and intrachromatid level 
(Figure II-2), leading to subsequent crossing over and thus rearrangement of the genomic 
region. The intrachromatid rearrangements can only lead to deletions (Figure II-2, right), 
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while the others could induce both deletions and duplications (Figure II-2, left and 
middle). Therefore, at least theoretically, a heightened occurrence of deletions would be 
expected (Gu et al., 2008; Stankiewicz and Lupski, 2002; Turner et al., 2008). It has been 
shown that for NAHR to take place specific “hotspots” are required, that is segments of a 
minimal length inside the LCRs sharing identity or at least extremely high similarity 
between the aligned LCRs. Small changes in the sequence of these “hotspots” could lead 
to a reduced recombination frequency. Furthermore, there is evidence that the distance 
between two LCRs is influencing the efficiency of NAHR (Rubnitz and Subramani, 1984; 
Sharp et al., 2005; Waldman and Liskay, 1988). 
 
Figure II-2: Mechanism of NAHR (adapted from Gu et al., 2008). Interchromosomal (left) 
and interchromatid (middle) misalignment could result in the formation of deletions and 
duplications. The misalignment on an intrachromatid (right) level leads to deletions solely. 
The mechanism of NHEJ is known to be one of the two major mechanisms to repair 
double-strand breaks (Gu et al., 2008; Lieber et al., 2003). NHEJ is mediated by the 
activity of different enzymes that first detect the broken DNA ends and then modify the 
ends to make them compatible for the final ligation step (Weterings and van Gent, 2004). 
Thereby, small deletions or insertions could easily be formed (Figure II-3). If combined 
with a preceding step at which one of the broken ends invades and copies from the sister 
chromatid, NHEJ could also be used to explain the synthesis of duplications, thus CNVs 
(Woodward et al., 2005). Although NHEJ-mediated CNVs often fall within repetitive 
elements such as long terminal repeats (LTRs), long interspersed nuclear elements 
(LINEs), mammalian interspersed repeats (MIRs), and short interspersed repeat elements 
(SINEs), sequences of extended homology are not necessarily required (Gu et al., 2008; 
Malhotra and Sebat, 2012; Zhang et al., 2009).  
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Figure II-3: Mechanism of NHEJ (adapted from Malhotra and Sebat, 2012). The classical 
mechanism could contribute to the formation of small SVs by errors occurring during process 
of strand break repair. If one of the broken ends invades and copies from the sister 
chromatid (not depicted here) duplications, thus CNVs, can be formed as well. 
Especially large genomic tandem duplications of several megabases might be explained 
best by the mechanism of FoSTeS (Lee et al., 2007), which was further generalized to the 
microhomology-mediated break-induced replication (MMBIR) model (Hastings et al., 
2009). According to this model errors during the DNA replication process, provoked by 
stalling of the DNA replication fork and further annealing and restart of the DNA synthesis 
at another replication site, lead to the formation of complex genomic rearrangements (Gu 
et al., 2008; Zhang et al., 2009). A simplified illustration of this mechanism is depicted in 
Figure II-4.  
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Figure II-4: Mechanism of FoSTeS (adapted from Malhotra and Sebat, 2012). Here a simple 
model of FoSTeS is depicted resulting in either a duplication or deletion. MH = regions of 
microhomology. 
The extent to which the different mechanisms contribute to the formation of SVs and 
CNVs is not yet clear however a recent study (Mills et al., 2011) on that topic suggested 
NAHR to generate most of the large deletions or duplications and FoSTeS/MMBIR to be 
responsible for the occurrence of most tandem duplications (Malhotra and Sebat, 2012). 
6  How CNVs mediate their effect on gene expression 
CNVs are supposed to affect phenotypes by the alteration of expression. Genes and 
putative regulatory elements found in regions of CNVs have been shown to play a 
significant role in gene expression in mice and humans (Gamazon et al., 2011; Orozco et 
al., 2009). A weak positive correlation between the CNV status of genes and their relative 
expression levels has been found (Henrichsen et al., 2009b). There are several 
explanations why an enhancement of gene dosage does not necessarily result in a 
significant increase of expression products (Figure II-5A+B) or vice versa, as might be 
expected (Henrichsen et al., 2009a). First, an increase of the gene product could activate 
a negative feedback loop that prevents further expression of the respective gene 
(Figure II-5C). Second, if the enhancer of the gene is not included in the copied locus, the 
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influence of the single enhancer might be too weak to trigger a huge increase in 
expression (Figure II-5D). Further, if the copies of the gene map to different chromosomes 
and thus chromatin environments, they might be regulated differentially (Figure II-5E). An 
initial level of gene products proportional to the copy number might induce the 
expression of a repressor, which reduces or abolishes further expression of the gene 
(Figure II-5F). Finally, according to another hypothesis, steric hinderance resulting from 
the gene duplication impairs the access of transcription factors (Sexton et al., 2007) 
(Figure II-5G). 
 
Figure II-5: Gene dosage alterations and their influence on gene expression (adapted 
from Henrichsen et al., 2009a). (A) Relative amount of transcription products (blue wiggly 
lines) of a single gene copy (blue box) is mediated by the gene promoter (red arrow) and its 
enhancer (green arrow). (B) A complete tandem duplication of the locus. (C) Negative 
feedback loop activated by complete tandem duplication of the locus. (D) Tandem 
duplication excluding the enhancer region. (E) Complete non-tandem duplication on 
another chromosome, where a different chromatin context, e.g., insulators (yellow 
ellipses) modifies expression levels. (F) Complete tandem duplication results in increase of 
the gene product (blue hexagons), which induces a repressor (light green box), the product 
of which blocks the expression of the gene. (G) The access of transcription factors is 
physically impaired as a result of tandem duplication (2). 
For genes located in the vicinity of CNVs, alterations of expression have been shown as 
well (Chaignat et al., 2011; Henrichsen et al., 2009b). Here, the effects might be mediated 
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by enhancers, repressors or other transcription regulators that are copied and thus 
increase the transcription of their original target gene or other genes at greater distance 
(Chaignat et al., 2011; Ricard et al., 2010). Another mechanism conceivable in this context 
is a physical dissociation of the transcription unit from its cis-acting regulators or 
modifications of the chromatin structure, leading to silencing of a gene outside the copied 
region (Reymond et al., 2007).  
Furthermore, CNVs could act through effects of transvection. These effects enable the 
communication between homologues chromosomes and were first described in 
Drosophila (Lewis, 1954; Wu and Morris, 1999) and later also in humans (Liu et al., 2008) 
and mice (Rassoulzadegan et al., 2002; Sandhu et al., 2009). CNVs might interrupt that 
communication, which was shown to occur on allelic and nonallelic level (Duncan, 2002; 
Kennison and Southworth, 2002; Sandhu et al., 2009), by disrupting or fully deleting a 
coding sequence or a regulatory element. 
7  The impact of CNVs on human diseases and anxiety phenotypes 
The authors of a study published some years ago concluded that common CNVs are 
unlikely to have a major role in the genetic basis of human diseases (Wellcome Trust Case 
Control Consortium, 2010). This conclusion was drawn from a genome wide association 
study (GWAS). However, the use of GWAS in the context of complex diseases and CNVs 
has been criticized in a more recent review (Lee et al., 2012). In contrast, current findings 
indicate that it would be premature to neglect CNVs as contributors to complex 
phenotypes (Gamazon et al., 2011) and, indeed, many diseases have been linked to CNVs 
based on GWAS but also other studies (Girirajan et al., 2011; Klopocki and Mundlos, 2011; 
Malhotra and Sebat, 2012).  
Besides common disorders like asthma (Brasch-Andersen et al., 2004), metabolic diseases 
like type 2 diabetes and obesity (Bochukova et al., 2010; Jeon et al., 2010), cancer (Shlien 
and Malkin, 2009), and other diseases, CNVs have been reported to affect the disease 
susceptibility of neurological disorders like Parkinson’s disease (Singleton et al., 2003), 
Alzheimer’s disease (Rovelet-Lecrux et al., 2006), Autism (Levy et al., 2011), Schizophrenia 
(Vrijenhoek et al., 2008), bipolar disorders (Lachman et al., 2007; Malhotra et al., 2011) 
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and anxiety disorders. Not many of the studies published to date focused on the 
correlation between anxiety (pathological or non-pathological) and CNVs. In its 
pathological form, anxiety was shown to be associated with CNVs in a study of panic 
disorder in a Japanese population (Kawamura et al., 2011). Non-pathological anxiety with 
respect to CNV-related changes in behavior has been addressed by animal studies. As an 
example, an increased maternal separation-induced anxiety was shown in mouse pups 
harboring an extra copy of a specific (Gtf2i) gene (Mervis et al., 2012). Furthermore, a 
positive relationship between the duplication of the genomic region harboring the 
glyoxalase1 (Glo1) locus and the Glo1 gene expression was reported in the HAB/LAB and 
other mouse lines (Hambsch et al., 2010; Williams et al., 2009). The Glo1 gene has been 
shown to be related to anxiety, however published studies disagree about whether Glo1 
expression is negatively or positively correlated with anxiety-related behavior (Ditzen et 
al., 2006; Hambsch et al., 2010; Hovatta et al., 2005; Krömer et al., 2005; Landgraf et al., 
2007; Thornalley, 2006). 
In conclusion, the general impact of CNVs (as well as SVs) on anxiety and other 
phenotypes is not yet clear. However, there is evidence from many distinct studies that 
CNVs are indeed involved in phenotypic expressions and, considering the mechanisms by 
which they might act on gene expression (see chapter 6) and their large extend over the 
genome, their contribution might be important (Feuk et al., 2006). A recent review 
claimed that the conduction of several large-scale correlation studies should be 
performed, not only with single CNVs but also a combination of other genetic and 
environmental factors, before a general conclusion on the implication of CNVs on health 
could be drawn (Almal and Padh, 2012). 
8  Aim of the study 
The main aim of this study was to generate the first comprehensive catalogue of CNVs in 
the HAB/LAB mouse model and thereby lay the foundation for future investigations on 
the complex interactions of multiple genetic factors (e.g., SNPs, epigenetic factors or 
other SVs) influencing anxiety-related behavior.  
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Although there is evidence from previous studies that CNVs contribute to the phenotypic 
expression of complex behavior, the impact of the variants on anxiety-related behavior 
had to be proven for the HAB/LAB mouse model, which was a second goal of this thesis. 
Finally, if an effect of CNVs on the HAB/LAB phenotype could be shown, then a first 
insight into CNV-based candidate genes potentially influencing the phenotypic 
characteristics of anxiety, not only in HAB/LAB but also CD-1 mice, should be delivered.  
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III  Materials and Methods 
1  Equipment, chemicals and remarks 
Unless otherwise specified, all chemicals mentioned were purchased at Sigma-Aldrich 
(Taufkirchen, Germany).  
The agarose gels for gel electrophoreses were prepared using TBE buffer and UltraPure 
agarose (Invitrogen, LifeTechnologies, Darmstadt, Germany) in the respectively required 
concentration, mixed with 0.5 µl/ml ethidiumbromide (Roth, Karlsruhe, Germany). The 
TBE buffer was prepared at 5-fold concentration with 54 g Tris (Roth), 27.5 g boric acid 
and 20 ml of 0.5 M EDTA (pH 8.0) in a total volume of one liter distilled and autoclaved 
water. After the electrophoresis performance, the signals were visualized under UV light 
using the GelDoc 2000 UV-Transilluminator and the Quantity One software (BioRad, 
Munich, Germany). 
Volumes of up to 1 ml have been transferred with pipettes model Pipetman ClassicTM P2, 
P20, P100, P200 and P1000, respectively (Gilson, Middleton, WI, USA). Larger volumes 
were handled with serological pipettes. Those, as well as the normal and filtered pipette 
tips, were supplied by Sarstedt (Nürmbrecht, Germany).  
All centrifugation steps were done in a Hermle Z216 MK centrifuge (Hermle Labortechnik, 
Wehingen, Germany), shaking and heating steps in the PHMT SC-20 Thermo-shaker 
(Grant Instruments, Cambridge, UK).  
DNA and RNA concentrations were measured on an Implen NanoPhotometer (Implen, 
Munich, Germany). Depending on the amount of DNA/RNA in the respective sample, 
lidfactor 10 or 50 was chosen. The ratio of absorption at 260 nm and at 280 nm, which 
was calculated by the photometer automatically, served as a parameter for quality 
control. Values of around 1.8 for DNA and around 2.0 for RNA were considered to show 
satisfactory quality. 
A thermocycler of type Primus 96 advanced (PeqLab, Erlangen, Germany) was used for 
the reverse transcription of RNA into cDNA. 
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All information on the genomic position of genes and probes mentioned in this thesis 
refer to UCSC genome browser version mm9 (Kent et al., 2002) and NCBI build m37, 
respectively.  
Here, non-human proteins’ abbreviations were written lower-case with a capital as first 
letter. The same applies to non-human genes except that they were italicized. Human 
proteins were written in upper case as well as human proteins, while the latter were 
additionally italicized. 
If not indicated otherwise, all computational analyses were done using R software (R 
Development Core Team, 2010). 
2  Housing and testing conditions of animals 
All animals used for data generation of this thesis were housed in the animal facility of 
the Max Planck Institute of Psychiatry under standard conditions, thus, a temperature of 
23 ± 2 °C, a relative air humidity of 60 ± 5 % and a 12/12-hour light-dark cycle with 
beginning of the light phase at 8 a.m. Animals of the same sex were kept in groups of up 
to four animals per type II standard cage with nesting and bedding material, having access 
to food pellets (Altromin GmbH, Lage) and tap water ad libitum.  
All behavioral experiments were carried out with the sanction of the local authorities in 
accordance with the German law and the Council of the European Communities’ 
“directive of 24 november 1986 on the approximation of laws, regulations and 
administrative provisions of the Member States regarding the protection of animals used 
for experimental and other scientific purposes (86/609/EEC)”. All tests were conducted 
between 9 a.m. and 1 p.m. under standard housing conditions regarding temperature and 
humidity. 
2.1  Elevated plus-maze (EPM) test 
The elevated plus-maze, which consists of an elevated plus-shaped platform with two 
open and two closed arms, was developed as a test for anxiety-related behavior in rats 
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(Pellow et al., 1985). Nowadays it is used as a commonly accepted standard trial for rats 
and mice, since animals were shown to spend more time in the aversive environment of 
the open arm after treatment with clinical effective anxiolytics (Hogg, 1996; Lister, 1987; 
Pellow et al., 1985). The EPM used here (Figure III-1) was made of polyvinylchloride (PVC), 
elevated by four 40 cm-long legs and consisted of two open arms (30 x 5 cm), two closed 
arms (30 x 5 x 15 cm), and an inner zone (5 x 5 cm) in between. To reinforce the 
protective nature of the closed arms they were with 10 lx less brightly illuminated than 
the open arms with 300 lx. 
In each trial one mouse was placed into the inner zone facing one of the closed arms. The 
animal’s behavior was recorded for 5 min and analyzed afterwards using the tracking 
software Any-maze version 4.72 (Stoelting, West Lane, IL, USA). Before the next trial 
started, the apparatus was cleaned with 70% ethanol and soap water. 
 
Figure III-1: Schematic drawing of EPM test. A mouse 
is sitting on one of the open arms. Closed arms are 
surrounded by walls. Illumination is brighter on the 
open arms. 
2.2  Open field (OF) test 
The open field test could not only be used to test for anxiety-related behavior, but also as 
a test for locomotion and exploratory behavior (Prut and Belzung, 2003; Walsh and 
Cummins, 1976). Independent of the approach, there are always two parts to be 
discriminated, an inner zone with brighter illumination and a darker outer zone. The 
brighter the illumination the more aversive appears the zone to the animals. Here, the OF 
was applied to test rather for locomotion than anxiety-related behavior, hence the light 
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intensity was adjusted to differ only about 15 lx between the central part and the 
periphery of the OF. The apparatus itself consisted of a round PVC wall of 40 cm height 
framing a field of 60 cm in diameter (Figure III-2). 
Similar to the EPM test procedure, the animals were placed in the inner zone and tested 
for 5 min. The tracking and analysis was done using Any-maze software. At the end of 
each trial, the apparatus was washed with 70% ethanol and soap water. 
 
Figure III-2: Bird’s eye view of the open field. A mouse is 
placed into a field, surrounded by cylindrical wall. The middle 
of field is brighter illuminated (in current study around 15 lx 
brighter) than the outside. Here the field diameter was 
around 60 cm, the height of walls about 40 cm. 
2.3  Forced swim test (FST) 
Originally, the FST was designed to test animals for depression-like behavior (Porsolt et 
al., 1977, 1978). Even if the FST is still used as the most common test for screening 
antidepressants, considering the discussion about the assumption of psychological states 
that probably not exist in mice, it might be more precise to talk about an alternative 
active and passive reactivity to stress instead of depression-like behavior (El Yacoubi and 
Vaugeois, 2007; Holmes, 2003). 
The animal’s behavior was recorded with a video camera for 5 min. At the beginning of 
the test, the mouse was placed into a 2 l glass beaker filled with 1.75 l of 23 °C warm tap 
water (Figure III-3). Before putting it back into its home cage the mouse was dried with a 
towel. The data were analyzed later on using a custom Eventlog program, differentiating 
between four kinds of behavior: freezing, floating, struggling and swimming. The latter 
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was defined as movements of all four paws underneath the water surface, whereas 
struggling meant extensive paddling and breaking through the surface with at least the 
two fore limbs. The animal was evaluated as floating if it did not show any movements 
except very slight balancing movements. In contrast, when no movements at all could be 
observed and the mouse showed some kind of rigor, the behavior was referred to as 
freezing.  
 
Figure III-3: Drawing of FST. A mouse is 
placed into a 2 l glass beaker filled with warm 
tap water (blue). 
2.4  Stress reactivity test (SRT) 
The stress reactivity of mice was tested via the increase of corticosterone (Cort) in the 
blood after suffering restraint stress (Touma et al., 2008).  
For that purpose an initial blood sample was collected from the tail vessel directly after 
taking the animal out of its home cage, using Micro haematocrit tubes that then were 
sealed with a Haematocrit sealing compound (both from Brand, Wertheim, Germany). 
Afterwards, the mouse was placed into a 50 ml Falcon tube (Sarstedt, Nürmbrecht, 
Germany) for 15 min. The ventilation was assured by a hole at the tip of the tube 
(Figure III-4). Before the animal could recover in its home cage a reaction blood sample 
was collected as described above. The approximately 50 µl blood of each sample were 
centrifuged for 5 min at 14,800 g to separate cellular components and plasma. The latter 
was collected and stored at -20°C until the Cort concentration was measured by 
radioimmunoassay. Finally, the Cort increase was defined by comparing Cort 
concentrations of the initial and reaction blood sample. 
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Figure III-4: Mouse in SRT. The falcon tube has a hole in the 
tip to ensure air flow and another one to lead the tail to the 
outside of the tube. 
2.5  Tail suspension test (TST) 
In the TST the mouse was suspended from a metal frame by fixing its tail tip with a tape. 
Typically in TST, mice immediately behaved in escape-oriented manner, followed by 
periods of immobility and movement. Hence the immobility time could be reduced by a 
variety of antidepressants the TST is commonly used to test for depression-like behavior 
(Cryan and Holmes, 2005; Steru et al., 1987; Steru et al., 1985). Again, referring to the 
description of the FST in chapter 2.3, one might rather talk about an alternative coping 
style in adapting to stress. 
Here, an apparatus was used enabling to test four animals simultaneously (Figure III-5). 
After fixing all four mice, they were recorded with a video camera for 6 min. The video 
tapes were analyzed using a custom Eventlog program. Two different kinds of behavior 
were distinguished: mobility, when the animal showed movements with the head, the 
limbs or the head and immobility, when the animal was not moving at all. 
 
Figure III-5: Experimental set-up of TST. Four mice in a row are 
fixed on metal hooks with glue tape. There are no dividing walls 
between the mice. 
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3  Analysis of CNVs in the HAB/LAB mouse model 
3.1  Detection of CNVs by genome-wide oligonucleotide array-based 
comparative genomic hybridization (aCGH) 
3.1.1  DNA extraction 
Genomic DNA was extracted from tail tips of two 16-week-old HAB and LAB mouse males, 
respectively (both generation 35), as well as from brain tissue of only one pair of these 
mice, using the NucleoSpin® Tissue kit (Macherey Nagel, Düren, Germany). Following the 
manufacturer’s instruction, about 0.5 cm tail or 25 mg brain tissue were incubated and 
gently shaken over night at 56 °C in 180 µl buffer T1 and 10 µl proteinase K. After addition 
of 200 µl lysis buffer B3 and an incubation time of 10 min at 70 °C DNA was precipitated 
by adding 210 µl 99% pure ethanol. The sample was transferred to a spin column 
provided in the kit. During a 1-minute-centrifugation step at 11,000 g the DNA was bound 
to the silica membrane, where it was washed with 500 µl buffer BW first and 600 µl 
buffer B5 thereafter, each time followed by the centrifugation step described above. The 
DNA was dried by repeating the centrifugation twice, discarding the flow-through in 
between. Finally, DNA was eluted in 100 µl elution buffer BE, pre-warmed at 70 °C.  
The DNA concentration was measured on an Implen NanoPhotometer and quality control 
was performed by gel electrophoresis. Therefore, diluted DNA (150 ng in 12 µl) combined 
with an appropriate amount of 6x DNA loading dye (Fermentas, St. Leon-Rot, Germany) 
was loaded onto a 1% agarose gel (see chapter 1 for details). The ZipRulerTM Express DNA 
ladder 2 (Fermentas) was added as DNA standard ladder. The gel ran for 50 min at 90 V. 
3.1.2  Processing of the samples in aCGH 
The extracted DNA of the samples was screened for CNVs on the Mouse CGH 3x720 K 
Whole-Genome Tiling Array. Therefore, the DNA was sent to Roche NimbleGen (Madison, 
WI, USA) to access NimbleGen’s full CGH microarray service. Besides the manufacture of 
the array, the service involved the complete process of hybridization and data analyses. 
Briefly described, the DNA was labeled with fluorescent dyes Cy3 and Cy5, respectively 
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and co-hybridized to the array that includes about 720,000 probes of length 50-75mer 
(based on NCBI build m37, UCSC genome browser mm9), resulting in a median probe 
spacing of 3,537 bp. A microarray scanner was used to scan the fluorescent signal 
intensities, which were then extracted from the scanned images using NimbleGen 
NimbleScan software. After correction and normalization steps, the segMNT algorithm 
was applied to the data to define genomic segments that differ in signal intensity 
between HAB and LAB samples. Both the final results and the Roche NimbleGen 
SignalMap software to review those were provided on a DVD. 
3.1.3  Interpretation and further analysis of aCGH data 
In the provided analyzed data, differences in probe signal with higher signal intensity in 
HAB were indicated by a positive log2 ratio, those with higher signal intensity in LAB by a 
negative one. In a first step, plots showing the log2 ratio for all probes were reviewed 
visually. As a consequence, the background noise was estimated to be in the range of -0.5 
to +0.5 (values of single probes). In a second step, a visual assessment of the mean 
log2 ratios of segments determined by the segMNT algorithm, defined only segments with 
a log2 ratio < -0.09 and > +0.09 (values of segments) to be potential CNVs. 
Since only CNVs consistent in different HAB/LAB individuals and tissues were of interest 
for further studies, the data of the three arrays had to be combined. Therefore, files of all 
three arrays that list the log2 ratio of all probes and the corresponding genomic position 
were combined using Microsoft Excel. Before the resulting tables were merged with data 
of files that list the predicted segments, all probes with a log2 ratio between -0.5 and +0.5 
(values of single probes) were discarded. Next, only those probes were considered that 
show a mean log2 ratio < -0.09 or > +0.09 (values of segments) for the corresponding 
segment in all three arrays, with no contradictions in algebraic sign allowed. In a final 
step, breakpoints of CNVs were defined after careful consideration of segment data in the 
remaining probe table. 
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3.2  Detection of CNVs by the Jax Mouse Diversity Genotyping Array (Jax 
MDGA) 
3.2.1  Performance of the assay 
The Jax Mouse Diversity Genotyping Array, applied here to screen for CNVs, was designed 
by The Jackson Laboratory (Bar Harbor, ME, USA). It is a high-density array containing not 
only 623,124 probes to detect SNPs but also 916,269 invariant genomic probes (IGPs), 
capturing 93.4% of the exons defined in Ensembl (version 49) by three probes each, tiling 
238 of 481 ultraconserved elements (UCEs) identified between human and mouse, and 
covering 950 100-kbp intervals with fewer than 10 of the previously described probes, 
most of which were known to contain segmental duplications (Yang et al., 2009). 
Tail tips of one HAB and one LAB mouse male were sent to The Jackson Laboratory for 
accessing the basic service including the extraction of high-molecular weight DNA, the 
sample preparation, the array hybridizations, and the supply of raw data. Furthermore, 
the manufacturer provided the R package “MouseDivGeno” (Yang, 2010) for subsequent 
analysis, together with its description, the MouseDivGeno Vignette (version 1.0.0). 
3.2.2  Genotyping using the MouseDivGeno R package 
A function called “simpleCNV”, which was comprised in the “MouseDivGeno” R package 
(Yang, 2010), was applied to reveal CNVs of the HAB/LAB samples in the Jax MDGA data, 
following the instructions of the MouseDivGeno Vignette. This function integrates 
normalized intensities from SNP probes and exons (IGPs) and uses the HiddenMarkov 
“HMM” R package to infer the most likely CNV states. The function always compares a 
reference with one sample. That is why both had to be defined, with the LAB sample 
serving as reference. In the output of the function all segments were listed that showed 
significantly more intensity, thus a copy number gain, or significantly less intensity, thus a 
copy number loss, in HAB vs. LAB animal. 
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3.3  Detection of CNVs and structural variants (SVs) by next-generation 
sequencing (NGS) 
3.3.1  DNA extraction 
First of all, six HAB and six LAB males, 29 weeks of age each, were carefully chosen from 
generation 40 and 41. As first selection criterion, animals had to show distinct line-
specific anxiety behavior on the EPM. Besides, they should belong to different 
generations and be the less related as possible, as the samples were supposed to be 
pooled for the sequencing process. Thus, CNVs that were specific to single individuals and 
those that remained not stable over generations could be recognized in the analysis of 
sequencing data and excluded from the final results. 
Here, the DNeasy blood & tissue kit (Qiagen, Düsseldorf, Germany) was used for DNA 
extraction. Directly after taking, the tail tips were stored at -80 °C. About one month later 
they were thawed to extract the DNA, following the manufacturer’s instructions. Hence, 
25 mg of tissue were gently shaken while incubated in 180 µl buffer ATL and 20 µl 
proteinase K for nearly 3 hours at 56 °C. After centrifugation for 3 min at 6,000 g, the 
supernatant was transferred to a new tube, mixed with 4 µl RNAse A and incubated 
another 2 min at room temperature. Next, 400 µl of pre-mixed 1:1-solution of buffer AL 
and 100% pure ethanol were added and all was loaded on the provided column. During a 
1-minute-centrifugation step at 6,000 g, the precipitated DNA was bound to the 
membrane of the column, where it could be washed with 500 µl buffer AW1 first, and 
500 µl buffer AW2 thereafter. In order to dry the DNA, the column was centrifuged at 
20,000 g for 3 min. As a last step, DNA was eluted in 200 µl buffer AE, centrifuged a last 
time at 6,000 g for 1 min. 
Finally, the concentration of DNA was measured on a NanoPhotometer and the quality of 
DNA was checked by loading 150 ng onto a 0.7%-agarose gel that run for 90 min at 80 V. 
Using ZipRuler Express DNA Ladder 2 as a standard marker, the DNA of all samples could 
be determined to be of high-molecular weight, with a length of about 20,000 bp. Until its 
use, the DNA was stored at 4 °C. 
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3.3.2  Performance of sequencing process 
The next-generation sequencing (NGS) was done in the facilities of Max Planck Institute of 
Psychiatry in Munich. The data were generated in two runs on the SOLiDTM 4 System 
(Applied Biosystems, Foster City, CA, USA).  
As previously mentioned, the DNA of six HAB and LAB males each was pooled after 
extraction. In advance, a quality check was performed by measuring the integrity, purity 
and concentration of all 12 samples. For the final pools 1 µg DNA of each animal was used 
to end up with a total amount of 6 µg HAB DNA and LAB DNA, respectively. 
With a 2 x 60 bp long mate-paired library (LMP library) the appropriate library type was 
chosen to detect CNVs and SVs. For its preparation, the DNA was sheared using the 
Covaris S2 System (Covaris, Woburn, MA, USA) to generate fragments of length 2,000 bp. 
All further steps followed the Applied Biosystems’ Mate-Paired Library Preparation guide 
(part # 4460958 Rev. A, revision date march 2011). Briefly, the DNA fragments were end-
repaired using End Polishing E1 and E2 enzymes before MP adaptors were ligated to, 
using T4 DNA ligase. The adaptors were missing a 5’ phosphate at the non-joining end, 
resulting in a nick on each strand when the DNA was circularized after purification with 
the Agencourt AMPure® XP Reagent. The circularization occurred through intramolecular 
hybridization at low concentrations, after removal of the blocking oligonucleotides that 
protected the 3’ overhangs of the MP Adaptors from self annealing, via heat 
denaturation. Before the DNA was purified using the Agencourt AMPure® XP Reagent 
again, uncircularized DNA was eliminated by Plasmid-SafeTM DNAse-treatment. Next, the 
nick was translated into the genomic DNA region using E.coli DNA polymerase I and the 
DNA was purified using the SOLiDTM Library Micro Column Purification Kit. Directly 
afterwards, 60 bp mate-paired tags were cleaved from the circularized template using 
first T7 exonuclease, that recognized the nicks and digested the unligated strand away 
from the tags to create a gap in the sequence that could then be recognized more easily 
by the S1 nuclease. Another Agencourt AMPure® XP Reagent-based purification step was 
followed by the adding of a dA tail to the S1-nuclease-treated DNA by A-Tailing Enzyme II 
that should increase the efficiency of the proximate ligation to P1-T and P2-T Adaptors 
using T4 DNA ligase. Before and after the ligation, the library was purified from side 
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products by binding streptaviding beads (Dynabeads® MyOneTM Streptavidin C1) to the 
biotin-labeled MP adaptors in the library molecules, and subsequent washing of the bead-
DNA complex. After a trial amplification to determine the optimal cycling number, 
resulting in 12 cycles for the HAB sample and 15 cycles for the LAB sample, the library was 
nick-translated and amplified using Library PCR Primers 1 and 2 with the Platinum® PCR 
Amplification Mix. The LMP library preparation was finished with the purification of DNA 
with the SOLiDTM Library Micro Column Purification Kit. The quality of library was checked 
on the Agilent 2100 Bioanalyzer (Agilent Technologies, Böblingen, Germany) followed by 
purification with Ampure beads to remove primer peaks and another quality check on the 
bioanalyzer. The quantification was done by qPCR using the SOLiD Library TaqMan 
Quantification kit (Cat. # A12127) following the manufacturer’s protocol. 
Before the LMP libraries could be sequenced they required to be clonally amplified on 
SOLiDTM P1 DNA Beads by emulsion PCR (ePCR). The bead preparation was conducted 
according to the manufacturer’s protocol. For both LMP libraries a 2 x E80 bead 
preparation scale was chosen, using an input of 1 pM library template each. The ePCR 
was followed by enrichment of the templated beads, which then were loaded onto slides. 
Each E80 preparation was loaded on one full slide. The sequencing was carried out in two 
runs with one HAB and one LAB library at a time. 
3.3.3  Data handling to detect CNVs and structural variants (SVs) 
Here, the following part is written in a straightforward manner. A more detailed 
description of data handling can be found in the supplementary data (report S1). 
3.3.3.1  Quality control and alignment 
The first step after data generation included the quality control (QC) of single reads. A 
mean quality value (QV) above 10.0 was considered to indicate sufficient quality. For the 
further analysis it should be kept in mind that a mate-paired library was used, as 
described above. Hence, every single read (60 bp in length) could be associated with its 
mate, another single read, which is known to appear at a distance of 2,000 bp in the 
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original genome. If only one mate of the pair passed the QC, both reads were not 
considered for the paired-end analysis of CNVs and SVs. 
In a second step all reads were aligned against a reference genome (based on UCSC 
genome browser mm9). Therefore, two different alignment programs, bowtie 
(version 0.12.7) and BWA aligner (version 0.5.7), were applied according to the following 
scheme. First, only read pairs that survived QC were aligned with bowtie. Second, those 
pairs that could not be aligned with bowtie were aligned with BWA. Finally, BWA was also 
applied on single reads that passed QC but whose mate did not. All resulted alignments 
(single reads) were post-processed in order to remove those reads that could be mapped 
at more than just one single position in the genome. 
3.3.3.2  CNV detection 
In order to detect CNVs, a “depth of coverage” analysis (DOC analysis), comparing the 
coverage between the HAB and LAB mouse lines, was performed using a custom Python 
program. In detail, that means that the whole reference genome was split into bins of 
200 bp length and all reads mapping into a single bin were counted (Figure III-6A). 
Theoretically, the paired end sequencing is not required to reveal CNVs. However, the 
additional pairing information encouraged the coverage estimation by counting also the 
bins in between the bins where the mates mapped and thus, more accurate results could 
be achieved (Figure III-6B). If two mates appeared to have an insert size much larger than 
2,000 bp (the z-score cutoff was calculated based on the first 200,000 reads) only the two 
bins of direct mapping were counted (Figure III-6A). 
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Figure III-6: Principle of bin counts. Reference genome (black horizontal lines) split into bins of 
200 bp length (black vertical lines). Two single reads of a mate-pair (orange lines), appearing at 
a distance of 2,000 bp in the sample genome (indicated by orange dashed line), were mapped 
against the genome. (A) Bin count of bins where reads could be aligned was increased (blue). (B) 
Additional increase in bin count of bins in between led to encouraged coverage. 
The subsequent statistical analysis was done bin- and chromosome-wise using Fisher’s 
Exact test, with a 2x2 contingency table per bin, containing the count of reads in the bin 
and the count of reads in the remaining bins of the chromosome, each for the HAB and 
the LAB sample. The resulting p-value was converted into a q-value using the Bonferroni-
Hochberg method. Since the test is a one-sided test, it had to be conducted twice to 
calculate q-values for the enrichment in HAB samples over LAB samples and vice versa. In 
a final step CNVs could be defined by finding “unusual” accumulations of specific 
q-values. That was done by requiring all –log10 of q-values within a window of 8 bins to 
exceed a initial finding threshold of 12. All bins right and left to those bins were still 
considered to be part of the CNV, as long as they exceeded an extension threshold of 10. 
The window size, initial finding threshold and extension threshold were defined based on 
carefully conducted pretests. 
3.3.3.3  SV detection 
With respect to the statistical model, the analyses to detect SVs did not differ to the one 
to define CNVs. Thus, the calculation of p-values from counts of aligned reads in 200 bp 
bins, the transformation of p-values into q-values, and the definition of accumulation 
differences between HAB and LAB samples was mainly done as described in 
chapter 3.3.3.2. Regarding the counting of the aligned reads in the bins, however, the SV 
analyses differ from each other and from the previously described one. 
For detecting large deletions within one mouse line, all “regularly” aligned mate-pairs 
were counted, as well as those that showed a significantly increased insert size, which 
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might indicate a deletion. Q-values were calculated as described above, except that the 
window size was increased to 12, the initial finding threshold to 50 and the extension 
threshold was decreased to 3, based on the fact that most of the bins would not comprise 
any mate-pairs with abnormal length of insert size. 
Based on the fact that the actual insert size was about 2,000 bp with a standard deviation 
of 850, in order to be significantly decreased, the aligned insert size was calculated to 
account for a maximum size of -400 bp, which is evidently not feasible. Thus, the analysis 
used for detection of large deletions couldn’t be applied for detecting large insertions. 
Therefore, followed up on the idea that the amount of aligned single reads, derived from 
mate-pairs with only one mate mapping to the reference genome (Figure III-7), should 
show a distinct elevation up- and downstream of the insertion, this type of SVs could be 
calculated assuming a window size of 7 bins, an initial finding threshold of 12 and an 
extension threshold of 3. 
 
Figure III-7: Principle of SV detection. Genome (black horizontal lines) split into bins of 200 bp 
(black vertical lines). If sample genome (left) implied insertion (bins colored in green) compared 
to reference genome (left), mate-pairs with one mate not mapping (indicated by green X) should 
be increased near insertion breakpoint. 
The analysis of inversions started with counting mates that mapped in the wrong 
direction. Theoretically, the single reads R3 and F3 of a mate-pair should both align to the 
reference genome on the forward or the reverse strand, respectively. Thus, if mates were 
found to map on different strands, that could be an indication for a present genomic 
inversion. The statistical analysis was conducted using a window size of 8 bins, an initial 
finding threshold of 40 and an extension threshold of 3. 
Finally, the wrong orientation of R3 and F3 reads was examined, which may be caused by 
complex SVs. To detect these genomic regions, those mate-pairs were counted, whose 
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R3 read could not be aligned upstream to the F3 read as expected, but the other way 
round. Based on these counts and a window size of 8 bins, an initial finding threshold 
of 30 and an extension threshold of 3 complex SVs could be detected. 
3.4  Influence of CNVs on gene expression 
3.4.1  Detection of differentially expressed genes in HAB/LAB mice by gene 
expression microarray analysis 
The raw data of genes differentially expressed between HAB and LAB mice in the 
basolateral (BLA) and central amygdala (CeA), the hypothalamic paraventricular nucleus 
(PVN), and the anterior part of cingulate cortex (Cg), respectively, were acquired by a 
former study on expression profile. In that study the RNA of eight HAB and eight LAB 
animals (generation 25) was tested separately on the MouseWG-6 v1.1 Expression 
BeadChip (Illumina, San Diego, CA, USA), which enabled to identify 46,000 individual gene 
transcripts (Czibere, 2008). Due to the fact that the former data analysis refers to 
information on probe position based on UCSC genome browser mm8, but the CNV data 
here refer to version mm9, and considering that in recent years new and better statistical 
approaches were developed to handle array data, a reappraisal of raw data was 
conducted. 
A detailed description of evaluating the differential expression data can be found in the 
supplementary data (report S2). In summary, raw data analysis was done using different 
functions in R, such as “vsn” (Huber et al., 2002) for data normalization. All data of probes 
found in all samples (46,657) were further filtered by three criteria. First, probes had to 
map to genes with EntrezGene-ID. Second, they had to be aligned uniquely to the 
genome with only two mismatches allowed. Third, only those genes with a detection 
p-value of less than 1x10-4 were selected. Based on these filtering conditions, the 
measured values of 12,171 probes were used for subsequent differential expression 
analysis, where the functions of the “Limma” R package (Smyth, 2005) were applied. In 
order to stabilize the statistical analysis (Smyth et al., 2005), significantly regulated genes 
were ranked using an empirical Bayes method (Smyth, 2004). Finally, statistical significant 
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expressed genes were determined based on a contrast analysis (for more detail see 
supplementary report S2). As final output of this analysis a list was created, including all 
12,171 probes with their respective p-value. Here, a p-value less than 0.05 indicated 
significant expression differences. 
3.4.2  Confirmation of candidate genes by quantitative real-time PCR (qPCR) 
3.4.2.1  Selection of candidate genes and primer design 
The candidate genes to be analyzed by qPCR were chosen based on the results of the 
expression microarray reappraisal (see chapter 3.4.1). The first selection criterion was a 
different expression between HAB and LAB mice in at least one of the four investigated 
brain regions. The eligible candidates were further analyzed for functional protein 
association networks formed by these candidates, using the STRING online software 
version 9.0 (see supplementary report S3). Finally, 12 genes were accepted that fulfilled 
both selection criteria. Then primers for qPCR were designed using the online tool 
Primer-Blast provided at the NCBI homepage. A list of these primers is shown in 
Table III-1. 
Table III-1: List of oligonucleotides used as primers for qPCR. The table is sorted by chromosome. 
Columns show (left to right): chromosome, gene represented by primer, primer orientation, primer 
sequence (direction 5’ to 3’), melting temperature and size of the resulting PCR product. 
Chr. Gene 
symbol 
Orientation Primer sequence 5'-->3' Tm [°C] Prod. size 
[bp] 
1 Rgs16 forward GGC TCA CCA CAT CTT TGA CG 59.2 110bp 
  reverse TGG TAG TGG CAG CTT GTA GG 59.39  
2 Ghrh forward CTC ATC CTC ACC AGT GGC TC 59.82 115bp 
  reverse ACA GCT GGC TCA GGA GTT TC 59.96  
7 Fgfr2 forward GGC AGT AAA TAC GGG CCT GA 59.82 84bp 
  reverse CAG CAC TTC TGC ATT GGA GC 60.46  
7 Prkcdbp forward CTG CAC GTC CTG CTC TTC A 60.01 85bp 
  reverse GGT CCT CCG GAC CCA AGA 60.28  
III Materials and Methods 
36 
Chr. Gene 
symbol 
Orientation Primer sequence 5'-->3' Tm [°C] Prod. size 
[bp] 
9 Glb1 forward GTT CTC CGG TCT TCT GAC CC 59.75 85bp 
  reverse AGA GCA GGG GCT TCA TCT TG 59.74  
11 Epn2 forward CTA GCC TCC CAC CCT AAT GG  58.94 130bp 
  reverse GCT CCT CTT CTC CGC TTG TC 60.46  
11 Pdk2 forward GAG ATG ACC CCG TCT CCA AC 59.82 120bp 
  reverse GGT TGG TGC TGC CAT CAA AG 60.04  
12 Rhoj forward ACG CCT TCC CAG AGG AAT AC 59.17 81bp 
  reverse GCA AGT GCT GCT TGC CTC 59.74  
17 Alk forward GGC AAG CCT GTG ATT TCC AC 59.76 128bp 
  reverse GAG TGG ACT TTG GGT CCA GC 60.61  
17 Glo1 forward GGA TTG CCG TTC CTG ATG TC 60.04 123 bp 
  reverse AGC CGT CAG GGT CTT GAA TG 58.98  
17 Slc30a6 forward TGG ACC CTT GGA TTT GGC TC 59.96 153bp 
  reverse CCG AAT CCA GTC GTC CTT GA 59.47  
19 Gnaq forward CAG GAG TGC TAC GAC AGA CG 60.18 82bp 
  reverse CGG CTA CAC GGT CCA AGT C 60.45  
 
3.4.2.2  RNA extraction 
Four different brain regions (BLA, CeA, PVN, Cg) were of interest for the qPCR analysis. 
The RNA was extracted of 11 HAB and 8 LAB males (generation 46), aged between 
7 and 10 weeks. The animals were killed by decapitation after being anesthetized with 
isoflurane. The brains were collected and directly frozen on dry ice, then stored at -20 °C 
until they were cut (rostral to caudal) into 200 µm thick slices by use of a cryostat 
(Microm HM560, Microm, Walldorf, Germany) and fixed on Superfrost microscope slides 
(Menzel, Braunschweig, Germany). The next step was carried out on dry-ice so that slides 
could not thaw completely. From the slides, the brain areas of interest were gained by 
micropuncture as described before by Palkovits (1973), using sample corers of 
0.5 mm (BLA, CeA) and 1.0 mm (Cg, PVN) in diameter (Fine Science Tools, Heidelberg, 
Germany). The appropriate slides were detected by help of the mouse brain atlas 
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(Paxinos and Franklin, 2001). Thus, slices corresponding to the bregma reference points 
-1.46 to -1.82 mm were used to punch the BLA, the reference points -1.22 to -1.58 mm 
(CeA), -0.58 to -0.94 mm (PVN), and 1.34 to -0.22 mm (Cg), respectively, were considered 
for punching the other brain regions. 
The RNA of each sample was extracted from the pooled punches of each brain region 
using the RNeasy Plus Micro Kit (Qiagen, Düsseldorf, Germany). Based on the kit’s 
protocol the sample was vortexed for 30 s with 350 µl buffer RLT plus and 5 µl carrier RNA 
working solution, the latter was prepared in advance as recommended. After transferring 
the sample to a gDNA Eliminator spin column and a 30-second-centrifugation at 8,000 g, 
the flow-through was mixed with 350 µl of 70% ethanol. Now the mix was centrifuged in 
a RNeasy MinElute spin column for 15 s at 8,000 g, mixed with 700 µl buffer RW 1, 
centrifuged under same conditions, subsequently mixed with 80 µl of 80% ethanol before 
centrifuged first for 2 min at 8,000 g and finally for 5 min at maximum speed and open lid. 
Then the RNA was eluted in 20 µl RNase-free water with an incubation time of 3 min at 
room temperature and spun down for 1 min at maximum speed. Before the RNA was 
stored at -20 °C until the day of cDNA synthesis, its concentration was measured on the 
Implen NanoPhotometer. 
3.4.2.3  cDNA synthesis 
Before the cDNA synthesis was performed, the RNA samples were adjusted to a 
concentration of about 50 ng/µl. The synthesis was then started with the preparation of a 
master mix as claimed in the protocol of the used High Capacity cDNA Reverse 
Transcriptase Kit (Applied Biosystems, Foster City, CA, USA). Thus, 10 µl master mix 
consisted of 2 µl RTbuffer, 0.8 µl dNTPs (100mM), 2 µl RT random primers, 1 µl 
MultiScribe Reverse Transcriptase and 4.2 µl nuclease-free water. The ice-cold master mix 
was then merged 1:1 with the sample RNA on a 96-well plate. For cDNA synthesis the 
thermocycler program was adjusted to the conditions listed in Table III-2.  
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Table III-2: Thermocycler program 
for cDNA synthesis. 
Temperature Time 
25 °C 10 min 
37 °C 120 min 
85 °C 5 min 
4 °C forever 
 
3.4.2.4  Performance of qPCR 
The qPCR was performed in a 384-well format, using the Roche LightCycler 480 (Roche 
Diagnostics Deutschland, Mannheim, Germany). Each sample was analyzed in duplicates 
using a 1:5 dilution of the original cDNA concentration (see chapter 3.4.2.3 for details on 
cDNA synthesis). In order to test the primer functionality, a standard curve was created 
for each primer pair, using 1:5, 1:25 and 1:125 dilutions of the original cDNA 
concentration of one HAB sample. Two housekeeper genes, beta-2 microglobulin (B2mg) 
and DNA polymerase II large subunit (Pol2b), were used for data normalization. 
In total, seven runs were required to test all candidate genes. Directly before the PCR was 
performed, each of the 384 wells was loaded with 2 µl cDNA (1:5) and 8 µl master mix, 
the latter consisting of 1 µl forward primer (10 µM), 1 µl reverse primer (10 µM), 
1 µl RNase free water and 3 µl of 2x SYBR Green MasterMix (Qiagen, Düsseldorf, 
Germany). The PCR ran under the conditions shown in Table III-3. Data analysis was 
performed using the absolute quantification fit points method, provided with the 
LightCycler software. The so created crossing points (Cp) were further analyzed by the 
∆∆CT-method (Livak and Schmittgen, 2001) to normalize the sample data to the 
housekeeper genes. Each sample’s fold regulation value was additionally normalized to 
the mean values of the HAB group, before expression differences between HAB and LAB 
animals were statistically analyzed by applying the Mann-Whitney U test (SPSS v16.0.1 
software). 
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Table III-3: Conditions of qPCR run. 
Temperature Time 
95 °C 5 min 
-------- Start loop (40x) -------- 
95 °C 10 s 
60 °C 30  s 
72 °C 10 s 
-------- End of loop -------- 
95 °C 5 s 
50 °C 10 s 
42°C 30 s 
 
3.4.3  Correlation of CNV data with expression data 
In a first step, the list of 12,171 microarray probes created during data analysis (see 
chapter 3.4.2) was adapted. Thus, all information but the ones about probe position, 
p-values and fold-change were removed. Afterwards, the probe positions were checked 
for mapping into any gene based on the Mouse Genome Informatics (MGI) database 
(referring to UCSC database version mm9) and the gene information was added to the 
list. The intention of this step was to ensure that the expression data could be compared 
to the CNV data without problems occurring caused by confusion about different genome 
databases consulted. Excluding all probes that could not be assigned to any of the 
chromosomes 1-19, X and Y, a table of 12,120 probes resulted. Next, a new list was 
generated, comprising all genes that appeared to be differentially expressed in at least 
one probe and one of the examined brain regions (BLA, CeA, Cg, PVN), combined with the 
information on how many probes mapped into these genes and how many of them 
showed a p-value less than 0.05. As final step, the genomic position of genes was aligned 
to the regions of CNVs defined by aCGH, JaxMDGA and NGS, respectively. Subsequently, 
an overlap count could be conducted and statistical analysis was performed. 
In a first approach the hypothesis that CNVs have an influence on protein coding gene 
expression was tested using a two-proportion z-test. The calculation was executed in R as 
described below: 
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n1 = amount of genes not showing significant expression difference 
n2 = amount of genes differentially expressed 
cnvDiff = amount of differentially expressed genes mapping in CNVs 
cnvNodiff = amount of genes not differentially expressed, mapping 
in CNVs 
      
         
  
 
      
       
  
 
      
                 
     
 
                    
 
  
 
 
  
  
   
         
  
 
                          
 
In a second approach, the question of whether the amount of gene copies (i.e. a copy 
number gain or loss) could influence the amount of gene expression (i.e. more or less 
expression) was examined. Initially, a CNV value and an expression value were assigned to 
every gene that was shown to be differentially expressed and that mapped into any CNV 
detected by aCGH, JaxMDGA or NGS, with a value of +1 for a copy number gain and more 
expression, respectively, and a value of -1 for the opposite conditions. In case the CNV 
data showed contradictory results, the gene appeared twice in the created list, once with 
a CNV value of +1 and once with a value of -1. A similar strategy was applied when 
assigning the expression values. If a gene was covered by several microarray probes and 
at least one of the probes showed more expression while the other(s) showed less, the 
gene was listed twice, once with an expression value of +1, once with a value of -1. For 
statistical analysis, the Pearson’s product-moment correlation was applied on the table of 
CNV and expression values, using the “cor.test” function of “stats” R package. The 
resulting p-values were corrected for multiple testing by bonferroni correction, using the 
“p.adjust” function in the just mentioned R package. The analysis was done for each of 
the four tested brain regions separately.  
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3.5  Influence of a single CNV comprising the glyoxalase 1 (Glo1) locus 
on anxiety-related behavior 
In order to test the influence of a single CNV on anxiety-related behavior, a selective 
breeding approach based on the HAB/LAB mouse lines was conducted. The decision to 
focus on the CNV comprising the Glo1 gene was made since Glo1 was shown before to be 
linked to anxiety and depression, not only in the HAB/LAB mouse model (Hambsch et al., 
2010; Kromer et al., 2005; Landgraf et al., 2007) but also in different human and animal 
studies (Hovatta et al., 2005; Tanna et al., 1989; Williams et al., 2009), although there was 
no consensus in these studies if the relationship is a positive or negative one. Thus, in the 
text below, the locus is referred to as Glo1 locus. However, it should be kept in mind that 
the locus not only comprised the Glo1 gene, but also Dnahc8 (dynein, axonemal, heavy 
chain 8) and parts of Glp1r (glucagon-like peptide 1 receptor). 
3.5.1  Breeding protocol 
The idea of the breeding approach was to end up with animals having the genetic 
background of HAB animals, with exception of the Glo1 locus and all its genetically linked 
loci, and further phenotype these animals to reveal a potential influence of that locus on 
behavior. The first generation arose from a HAB-LAB cross-breeding. The subsequent 
generations were selectively bred for the Glo1 locus by mating the individuals harboring 
the LAB-specific Glo1 locus with HAB animals. A detailed breeding scheme can be found in 
the supplementary data (report S4). 
In order to estimate the genomic similarity between HAB animals and the current 
generation, a similarity coefficient was evaluated. The calculation of that coefficient 
based on the probability of heredity of the Glo1 locus. An animal inherits 0.5 of its 
genome from its father and 0.5 from its mother. Thus, as animals of the first generation 
(G1) had a HAB mother and a LAB father, their similarity coefficient was 0.5. An animal of 
the next generation (G2) would inherit half of its genome from a HAB animal and the 
other half from an animal of G1. Since the similarity of the G1 genome to the original HAB 
genome is 0.5 and half of the genome is passed down to the offspring, the theoretic 
similarity to the HAB genome of the G1-originated half of the G2 genome is 0.25 
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(= 0.5 * 0.5). The similarity coefficient of G1 is therefore 0.75, the sum of 0.5 
(HAB-originated half of the G2 genome) and 0.25 (G1-originated half). The same principle 
was true for the subsequent generations, that is for generation 3 (G3), the similarity 
coefficient was a sum of 0.5 (HAB-originated) and 0.375 (G2-origianated; = 025 + ½*0.25). 
All similarity coefficients calculated up to the 10th generation are shown in Table III-4.The 
following formula could be applied to accelerate the calculation of the similarity 
coefficient x for a specific generation n: 
   
 
    
    
      
    
 
Table III-4: Similarity coefficients of Glo1 breeding approach. In 
the right column the similarity coefficient for the generation 
named in the left column is shown. The coefficient is an 
indicator for the resemblance with a HAB genome (with 1 as 
100% resemblance). 
Generation n Similarity coefficient xn 
1 0.5 
2 0.75 
3 0.875 
4 0.9375 
5 0.96875 
6 0.984375 
7 0.9921875 
8 0.99609375 
9 0.998046875 
10 0.999023438 
 
3.5.2  Genotyping of the animals 
The determination of the animals’ genotype was based on the knowledge of different 
copy number states for the Glo1 allele between HAB (one copy only) and LAB (more than 
one copy). Thus, a PCR analysis was performed using oligonucleotide primers targeting 
sequences around the CNV breakpoint. The binding positions of primers are depicted in 
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Figure III-8. A control primer pair was positioned in front of the potentially duplicated 
region to test the functionality of PCR, whereas the breakpoint primers embraced the 
CNV breakpoint, resulting in a PCR product of length 290 bp and 150 bp, respectively. 
Target primers only led to the generation of a specific product if a CNV was present, thus, 
a 150 bp product should only be seen in animals with the LAB locus. The primers were 
adapted from Williams et al. (2009) with their sequences shown in Table III-5. 
 
Figure III-8: Positions of genotyping primers. Black lines indicate the genomic region of 
chromosome 17, that embrace the CNV (blue lines). The target primers (red arrows) bind near 
to the CNV breakpoint, but outside of the Glo1 sequence (dark blue lines). PCR results only in a 
specific product of 150 bp in length (red line) if a duplication of the locus exists, which is the 
case in LAB, but not HAB animals. The control primers (green arrows) generate a product of 
290 bp length and were used to test functionality of PCR. CF = forward control primer, 
CR = reverse control primer, TF = forward target primer, TR = reverse target primer. 
Table III-5: Primers for targeting CNV breakpoint of Glo1 locus. 
Chr. Target Orientation Primer sequence  (5'  3') Tm [°C] Prod. size 
[bp] 
17 Breakpoint forward CTC TGC CCC AGA GAA CAG TC 64.0 150 
  reverse TGA TAG AGG CCA CAC AGC AG 64.1  
17 Control forward CAG TCG TCG ACA GTC ATC GT 64.1 290 
  reverse GAG CTG AAG GGA TCT GCA AC 63.9  
 
The genotyping was done using genomic DNA isolated from tail tips. Analogues to the 
protocol described in chapter 3.1.1 the DNA was extracted by use of the NucleoSpin® 
Tissue kit (Macherey Nagel, Düren). Subsequently, after measuring of DNA concentration, 
the PCR reaction mix was prepared with 4 µl DNA (25 ng/µl), 1 µl of each of the four 
primers (10 pmol/µl), 2 µl Taq buffer including KCl (Fermentas, St. Leon Rot, Germany), 
1.2 µl MgCl2 (25 mM) 0.4 µl dNTP mix (10 mM each), 7.4 µl distilled water and 1 µl Taq 
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DNA polymerase (1 U/µl). The PCR ran according to the conditions listed in and PCR 
products were screened for by gel electrophoreses using a 1.5% agarose gel. 
Table III-6: PCR conditions of Glo1 genotyping. 
Temperature Time 
95 °C 2 min 
-------- Start loop (35x) -------- 
95 °C 30 s 
60 °C 30 s 
72 °C 1 min 
-------- End of loop -------- 
72 °C 5 min 
8 °C forever 
3.5.3  Behavioral testing 
All 94 animals of the 6th generation were tested at the age of 8 weeks on the elevated 
plus-maze (EPM). One day later, they were tested in the open field (OF) and after one day 
of recovery in the tail suspension test (TST). The final test, the forced swim test (FST), was 
conducted another two days later. A detailed description of the test procedures can be 
found in chapters 2.1, 2.2, 2.3, and 2.5. 
3.5.4  Statistical analysis 
Since the idea of the Glo1 breeding approach was to reveal the influence of the CNV on 
phenotypes, the results of the behavioral tests were analyzed for genotype specific 
differences in behavior, applying the Mann-Whitney U test. Data acquired from males and 
females were examined separately. 
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4  Analysis of CNVs in CD-1 mice 
4.1  Testing of CD-1 mice in different behavioral experiments 
384 outbred CD-1 mouse males were phenotypically characterized in a series of five tests 
covering different aspects of anxiety. The aim of this project, called “CD-1 panel”, was to 
reveal the genetic contribution to anxiety-related behavior by examine later on the mice’s 
genotypes under different aspects. All mice were bred in the Charles River Laboratories 
(Sulzfeld, Germany) and delivered at the age of eight weeks in eight different batches 
each of 48 animals. Each batch of animals went through the identical test battery, as 
illustrated in Figure III-9. After a 4-day-habituation, half of the animals were tested on the 
elevated plus-maze (EPM) the other half in the open field (OF) and two days later vice 
versa. Another two days later all 48 animals were tested in the forced swim test (FST). 
Before the stress reactivity test (SRT) on day 12 and the tail suspension test (TST) on 
day 14 after arrival were performed, the animals could recover for four days. Subsequent 
to the last test all mice were anesthetized by inhalation of Isoflurane (Curamed Pharma, 
Karlsruhe, Germany) and then sacrificed by decapitation. For further studies, tail tips 
were taken and immediately frozen on dry ice before stored at -80 °C. 
 
Figure III-9: Test battery of CD-1 panel. Animals that performed the EPM test on day 4 
were tested in the OF on day 6 and vice versa. 
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4.2  Detection of CNVs in CD-1 mice 
4.2.1  JAX Mouse Diversity Genotyping Array (JaxMDGA) 
4.2.1.1  Performance of the array 
One way to detect CNVs in the phenotyped CD-1 mice was by use of the JAX Mouse 
Diversity Genotyping Array. The same array type was applied before to detect CNVs in 
HAB/LAB animals, though this time a 32-sample-format was chosen. More details on the 
array can be found in chapter 3.2.1. Again, tail tips were sent on dry ice to The Jackson 
Laboratory, where DNA extraction and subsequent processing was performed. Finally, the 
company provided the raw data for further analysis. 
In total 64 of the 384 phenotyped CD-1 animals (see chapter 4.1) were tested in two 
different approaches with 32 animals each. The mice’s behavior averaged over all 
performed tests provided the basis for choosing the 12 most anxious, 12 least anxious 
and 8 mean individuals to be analyzed in the first array approach (for details see Widner-
Andrä, 2011). The same selection strategy was pursued for the second approach, though 
not considering the animals already screened in the first approach.  
4.2.1.2  Computational analysis of Jax MDGA data 
The raw data provided by Jackson Laboratory were analyzed for each set of 32 animals 
separately. Analogues to the analysis of the HAB/LAB data, the “simple CNV” function of 
the “MouseDivGeno” R package was applied as described in chapter 3.2.2. That function 
required a reference sample to compare all other samples with. Since assigning only one 
sample to be the reference would lead to missing information on CNVs, the function was 
applied multiple times by looping over all samples to end up with comparisons of all 
sample pairs. The following R script section was written to loop over the samples: 
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files=list.files(pattern='.CEL',full.names=F) 
 
for(i in 1:length(files)){ 
 for(j in i+1:length(files)){ 
  if(j+1 <=32){ 
   result <- paste('Result_',as.character(files[i]),'_ggRef_', 
      as.character(files[j]),sep='') 
  
   simpleCNV(snpProbeInfo,snpInfo,snpReferenceDistribution, 
  invariantProbeInfo,invariantProbesetInfo, 
  invariantReferenceDistribution, 
       celFiles=files[i], 
  referenceCelFile=files[j], 
  summaryOutputFile=result) }}} 
 
The potential loss of information, if referring all samples to only one reference, is in 
consequence of the algorithm used by the “simple CNV” function. Briefly, the algorithm 
defines sets of array probes whose mean fluorescence values are considered to show 
significant differences between sample and reference. The first and last probes of such 
sets represent the breakpoints of the respective CNV. Theoretically it might happen that 
for a specific set of probes no significant difference could be found between samples and 
the reference, but if two samples would be compared to each other, the significance 
threshold might be passed, as exemplary depicted in Figure III-10.  
 
Figure III-10: Situation of potential information loss based on applied algorithm. 
Normalized fluorescence intensities of single probes from a reference sample (Ref, 
green), sample 1 (S1, red) and sample 2 (S2, blue) at a specific genome position are 
depicted as single dots. Comparisons of sample intensities to the reference intensities 
might not show significant differences, indicated by the orange crosses, and hence a 
potential CNV (orange lines) would be missed. A direct comparison of sample 1 with 
sample 2 intensities could pass the significance threshold (orange star). 
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The provided output of the “simple CNV” function was a list of CNVs with the mean value 
of the normalized fluorescence intensities of probes considered for CNV definition, and 
with information about chromosome, start and end point. After merging all output lists of 
all comparisons, duplicated elements were removed. However, there were still regions 
incorporated showing only slight shifts in breakpoints, thus, were very likely to represent 
just a single CNV. Therefore, those regions were outlined as one CNV only, with 
breakpoints as far away from each other as possible (Figure III-11).  
 
Figure III-11: Breakpoint definition for CD-1 CNVs. If results of different 
comparisons showed CNVs (orange lines) with huge overlap, the regions were 
outlined as a single CNV. Breakpoints for the newly defined CNV are indicated by 
green lines. Dashed lines depict former breakpoints. S1 = sample 1, S2 = sample 2, 
S3 = sample 3. 
As a consequence of the new breakpoint definition another problem occurred. Enlarging 
the size of the CNV meant also to increase the amount of array probes mapping into the 
CNV. Therefore, the mean normalized intensities of all relevant probes had to be 
recalculated, since the values were required for further analyses. As mentioned before, 
applying the “simple CNV” function only yielded a list of final results, but not the 
normalized intensities of any single probe. Thus, the “simple CNV” function had to be 
decrypted before subsequently the R code was rewritten to get the desired information. 
Since that new R script would fill several pages, it can be found in the supplementary data 
(report S5). Therein, all parts of the original function’s code that were rewritten were 
highlighted. 
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Shortly summarized, for each of the two array approaches the CNVs were revealed by 
comparing all 32 animals against each other and listed in two separate tables (one per 
approach). Each table comprised all CNVs that occurred in at least one pair of animals 
together with the information on chromosome, start and end point. For each animal and 
CNV the mean normalized intensities of the respective probe sets were calculated as the 
values were needed for further analysis on the correlation of CNVs and behavior. 
4.2.2  Multiplex Ligation-dependent Probe Amplification (MLPA) 
The Mulitplex Ligation-dependent Probe Amplification (MLPA), developed by 
MRC-Holland (Amsterdam, Netherlands) is a method to detect CNVs of multiple DNA 
sequences in a single multiplex PCR-based reaction. Fundamental for this method is that 
not the sample DNA is amplified during the PCR, but MLPA probes, each consisting of two 
oligonucleotides: the left probe oligonucleotide (LPO) and the right probe oligonucleotide 
(RPO). The LPO as well as the RPO consist of two parts, a primer binding sequence and a 
hybridizing sequence. In order to be ligated, both the LPO and the RPO have to bind to 
adjacent DNA target sequences via their hybridizing sequences, named the left and right 
hybridizing sequence (LHS and RHS), respectively. After ligation the probes are amplified 
exponentially by use of PCR primers specific for the forward primer binding sequence 
GGGTTCCCTAAGGGTTGGA, which forms the 5’ end of the LPO, and the reverse primer 
binding sequence TCTAGATTGGATCTTGCTGGCAC, which forms the 3’ end of the RPO. 
Here, differences in PCR product length could be obtained by designing hybridizing 
sequences of variable size, enabling the PCR products to be separated and quantified by 
capillary electrophoreses. 
4.2.2.1  Designing of synthetic MLPA probes 
In a first step, interesting target regions of the MLPA probes had to be defined. These 
regions were chosen based on preliminary data of the first JaxMDGA approach. CNVs that 
showed a correlation coefficient (correlation with time animals spent on the open arm) 
with a value belonging to the upper 20% of the frequency distribution, and whose 
genomic position overlapped with any CNV found by aCGH or JaxMDGA in HAB/LAB mice 
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were considered to be of interest. In a second step, three MLPA probes per region were 
designed for 11 CNVs, resulting in a total of 33 probes. 
Designing synthetic MLPA probes turned out to be a big challenge and was done by 
strictly following the recommendations in the “Designing synthetic MLPA probes” 
protocol (version 12) provided by MRC-Holland. In order to find candidate probes the 
genomic region of interest was retrieved from the UCSC genome browser, assembly 
NCBI37/mm9, and subsequently submitted to the freely available online tool for probe 
design MAPD (Zhi, 2010). The resulted list of potential probe sequences had to be further 
analyzed and checked for the required probe conditions. First, all LHS and RHS were 
tested for uniqueness using the BLAST tool provided at the Ensembl database (Flicek et 
al., 2011). Since probes were used in three different MLPA approaches, three sets of 
11 probes with each probe having a unique total length (LPO + RPO), had to be defined. 
The melting temperature for each probe was determined using the RaW program, 
provided and recommended by MRC-Holland, and had to be ≥ 71.0 °C for LHS/RHS of 
length 29 - 35 nt (nucleotides), ≥ 70.0 °C for 37 – 39 nt and ≥ 68 °C for 41 - 55 nt. Between 
probes, a total length difference of 4 nt was required. Furthermore, the GC-content 
should amount to ~50 %. Finally, for probe design it was taken into account that the 
5’ end of the LHS did not start with an adenine.  
All synthetic probes were ordered at Sigma-Aldrich (Taufkirchen, Germany), with all 
probes purified by HPLC and PAGE, respectively, and all RPOs 5’ phosphorylated. In 
Table III-7 all probes used in the experiment are listed, including information on the probe 
characteristics. Table III-8 shows information on the total probes’ genomic positions and 
also on the CNVs (based on final data) the probes mapped into. 
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Table III-7: Sequence information of MLPA probes. Here the sequences of LHS and RHS, respectively 
are listed as well as their size in nucleotides, their GC content in percent and their melting 
temperature, determined by use of RaW program. LHS and RHS together with the primer binding 
sequences form one MLPA probe.  
Probe 
No. 
Probe 
part 
Sequence 
Size 
[nt] 
GC 
[%] 
Tm [°C] 
1 LHS 
GGC TTT GTT AAA CTT GGC GTC TAC AGG TTG CTT TCC AGC  
CTA ACT AG 
 
47 47 81.48 
 
1 RHS 
GTT TTG CCG TGG TGA GGA AAT GAG GGT TTT AGA TGG 
GGA AGG GAA AG 
47 49 85.23 
2 LHS 
GAT GAT GGT TTC ACA GGT AGC AAT CAG GTG TGG CCC 
ATC ATA AAT CAT G 
49 45 83.69 
2 RHS 
AGC ACC TCC ATT GTG ACC AGA AGC CCC ATA TGC GGT TTG 
TTC CAG GTT G 
49 53 87.84 
 
3 LHS TAC TGA GGG GCC TGA AAC CTT ACA GCA ATA C 31 48 73.75 
 
3 RHS AAG AGC GAT CAC CAC CCC ATA CTA CAC ACA C 31 52 75.61 
4 LHS 
GTC ACA GTA ACA TTT CTC AGA AGT TAG CCC ACT GCC TTC 
CA 
41 46 79.95 
 
4 RHS 
GCT TTC AGT GTA GGA GAA GAG ATA TTC GAC ATC AGT 
GTG CC 
41 46 78.94 
5 LHS TTC CAA ATA GAC ACC CCT GCT TTG AAA GC 29 45 72.87 
5 RHS TCC CAC CTT AGT TGG CAG ATG GGA AGA TG 29 52 75.92 
6 LHS TGC AAA GGT AGG ATC CAT GTA TGT GCT CTG CAT 33 45 75.59 
 
6 RHS ACC ATA CTG CGG TTG TAC TGA CTC TCA TCT CCA 33 48 75.52 
7 LHS TTC GGT AAA GTG AGG ACT CCT TCT CAG AGC CAA AGA G 37 49 78.23 
7 RHS AAC GTT GCT AGG ACT GAA CGA TGT CAT CAA TAC CAC G 37 46 77.6 
8 LHS TCA CTT GGG CAG CTC CAT AGA ACA CAG TCC ATG CT 35 51 80.01 
 
8 RHS GAC GGG GGG CGG AGA TTT ATC TAA CTG GTG AAT GA 35 51 80.63 
9 LHS 
GGT CTA CTC TGG CTA ATT TGG TAA CAG ACC GTA GAT TGC 
CCT AGT 
45 47 79.6 
9 RHS 
AGA GAG TAC CTG CAA TAA TCC ATG CCT GAG AGA GTG 
GGG TGA GCA 
45 51 83.66 
10 LHS GTG ACT AGT CTT GCC GAG TTG CTC TTC TGC CTG TGA ATT 39 49 80.16 
 
10 RHS CTT GCT AAA GCA TGC CTA TGC AAC CCT TGG CTC TGC ATC 39 51 82.36 
11 LHS 
GGC AGA TGC AGA AAA AAG GGT AAC TAT CGG GGC TCC 
CTA CTT T 
43 49 82.1 
11 RHS 
TTT CTA AAC CCC CCT TTC CTA GTC TCT TAT GCC CCA CAA 
GTA G 
43 47 79.48 
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Probe 
No. 
Probe 
part 
Sequence 
Size 
[nt] 
GC 
[%] 
Tm [°C] 
12 LHS TAT CCA AGG TCA CGG TTC CAG AGG CCA TCT G 31 55 79.08 
 
12 RHS GTA CTT TGG GTC ATT GTC CTA CCG GGC TTG T 31 52 77.22 
13 LHS TAT CAA TTA CTG CGC TTG CGT GGG GAG GTC AAG TC 35 51 79.76 
13 RHS CAC AAC AGG GCT GAT GCG TGC TCT TCC GAT AAT TT 35 49 79.86 
 
14 LHS 
GCT CTT CAC AAA TAA TCC ATT CGG CTC AGA GAC TGT CGT 
AGA G 
43 47 80.08 
14 RHS 
AAG AAG TTG ATC ACG GGC CAC CTG C TC ACG TCT GCA 
CCG AAA 
43 53 86.35 
15 LHS TTC TCC TGT CGC TCT TCA AGC ACG AGT GT 29 52 75.61 
15 RHS AAC AGA GTG ATC GCA GAC AGG TGT GCA CT 29 52 75.25 
 
16 LHS 
GTC CCC ATA CTC AGG AAG TCT ACC CAC CCA CAT GAG CTA 
GA 
41 54 82.87 
16 RHS 
CTT TAA TGT TTT CAT GGG ACG CCT GGG AGG ACT GAG 
ATT TC 
41 46 81.09 
17 LHS GAA GAG GCA ATG ATT CCT TAT AGC CCC CCC CCA ATA AAA 39 46 80.31 
17 RHS GGG AGG CCC CTA AAG TGT CCC TAA GTC ATC ACC TAT CCT 39 54 81.99 
18 LHS 
GAC AGA GTT AAT GGG AGA GCG TTC TTC CCG CAT AA GCA 
CTT CTG T  
45 49 82.7 
18 RHS 
GGA CCG TGT AAC CAC AGA TTA CTC ATT ATG GCC AAA 
GAA GCC TCA 
45 47 82.15 
19 LHS TGT GTA TCT AGA GGG AAT GTT GGA GAG CAG TCA 33 45 74.06 
19 RHS GCT AGA AGC GCC AAG TAG GAA AAT CAG TCA GGT 33 48 76.13 
20 LHS 
GTT GCC TCT TGG TAC AGG GTT GGG AAA GGG AGC AGA 
TAT GTC TAA GA 
47 49 83.42 
20 RHS 
ACT GAT GAT CCA TCC TTC TCA GAC TTT ACT GGG TCC AAC 
TGA TAT CC 
47 45 80.47 
21 LHS TCT TGA GCA GTA GAG GCC CTA ATA TGA GAT GGA CAC T 37 46 75.83 
21 RHS AAA TAG AAT CAG GAC ATT CAG GGG ATT CAG GGG CTG T 37 46 78.5 
22 LHS 
GTG GGA GTC CTC TGG TTA CCA AGT CAA CCA AGC ACT ACT 
CAG AGA TCT A 
49 49 83.01 
22 RHS 
GAG CTG GCT GAC ACT ACA TGA CAC CCA AAA GCA GGA 
CAA TGT TAT ATG T 
49 45 82.22 
23 LHS TGC CTA GAG TTT ATG CTA TAG CCT AGG CTG CCT AAC C 37 49 75.7 
23 RHS CCA CCA GCA ACC ACT CAT GGC AGT CTT TCT GTT TTA G 37 49 79.98 
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Probe 
No. 
Probe 
part 
Sequence 
Size 
[nt] 
GC 
[%] 
Tm [°C] 
24 LHS 
GCA TGT GTG TGA GGG ATA AGA GTA GTG ACT GGC ATC 
ATT GG 
41 49 81.29 
24 RHS 
GCA CTT TCC CCC TTT TCA GAT GGA TCT GGA CAG AGC AGA 
AG 
41 51 83.43 
25 LHS 
GTT GAA CAT TGA GGT CCA GAT TTG GCA CCG TCT CCA GCA 
GAG T 
43 51 84.71 
25 RHS 
TTG GGG GTT CAG CTT TCT GGA CTA CAT TTT CTC CTC TTG 
GCA C 
43 49 82.65 
26 LHS TGT GAG GGT TGT TAG AGC AGA CGT AGC TCC AGG AA 35 51 78.81 
26 RHS GAA CAG CCA AGT CAG CCC TTC ATG AGC TCT GAA AT 35 49 79.14 
27 LHS 
GAA GAG AGC AGG CAT TCG TCA GCT ACT AAC TTG GGG 
TAG GTA TGT TAA G 
49 47 81.05 
27 RHS 
TGT CTG CAC CTC ATG TTA GCT TTA GGA AAA CCA GGA CTC 
AGT GAG CTA G 
49 47 81.83 
28 LHS TCT GCA GAG AGG AAG CAT GAT ACT TAC GTA GTG 33 45 72.52 
28 RHS ATG GAG ACA CTA CGT AGA GAT GGC ACT CCC GAC 33 55 77.83 
29 LHS 
GTC AGG GAC ACA CAG CAG TGG CAG GCC TCC ACA CTT 
ACT TTT TCG 
45 56 86.98 
29 RHS 
GTC CTG TAA CAA ACA CTC GGA AGA CAC CGT TGA AAG 
GAG GGA AAG 
45 49 83.31 
30 LHS TAG GGC AGG ATG ACA GAA ATG CTT GTT GCT T 31 45 74.73 
30 RHS AGC AAT GCA AAG CCC GTT GTC CTC ACA AAG G 31 52 78.88 
31 LHS TGC CTA GCT CCA CCT TCC TTC CAG TTT GC  29 55 77.16 
31 RHS TTC TCC ACC CTG ACC AGA TCA TCA GGC TC 29 55 77.28 
32 LHS GTG AAA GGC TAT CTC CAC ATT CTC CTG TAC TAG CTG CAA 39 46 77.88 
32 RHS 
ACT TGG ACC TGG TAG GGC AAC ACA TGT ATC AGG GCT 
GTG 
39 54 82.74 
33 LHS 
GAG AGC AGT GAT CAA CCA GGA CAC AAC AGC AGA GGA 
AGC CCA GAT CT 
47 53 86.42 
33 RHS 
GCC TGG AGT ATG GGT GAC AAT GAC AAC ATA CTT TCT TCT 
ACC TTC TG 
47 45 80.61 
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Table III-8: Genomic position of MLPA probes. The genomic position of combined LHS and RHS 
sequences (chromosome and basepair information) was determined by use of BLAST tool in Ensembl 
database. If the probe mapped into any gene sequence, the gene symbol is listed in column “in gene”. 
The fifth column shows the p-value of the final association of the behavior animals showed on the 
EPM (% time on the open arm) with the CNV detected in CD-1 mice by JaxMDGA (see chapter 4.3), to 
which the MLPA probe is targeted to. Columns 6-8 show the copy number status (HAB vs. LAB) of the 
HAB/LAB CNVs (detected by three different methods) the MLPA probe could be mapped to. 
Probe 
No. 
Chr 
 
Genomic 
Position 
(LHS+RHS) [bp] 
in    
gene 
p-value 
Asso.  
Status 
HAB/LAB 
aCGH 
Status 
HAB/LAB 
JaxMDGA 
Status 
HAB/LAB 
NGS 
1 2 
157,152,804 - 
157,152,897  
no 0.3297 loss loss - 
2 2 
157,153,700 - 
157,153,797  
no 0.3297 loss - - 
3 2 
157,153,831 - 
157,153,892  
no 0.3297 loss - - 
4 12 
 
68,608,045 - 
68,608,126  
no 0.2125 - loss loss 
5 12 
68,608,383 - 
68,608,411  
no 0.2125 - loss loss 
6 12 
68,610,071 - 
68,610,136  
no 0.2125 - loss - 
7 14 
9,483,225 - 
9,483,298  
no 0.0563 - gain - 
8 14 
 
9,481,584 - 
9,481,653  
no 0.0563 - gain - 
9 14 
9,480,633 - 
9,480,722  
no 0.0563 - gain - 
10 11 
120,875,255 - 
120,875,332  
no 0.0536 - gain - 
11 11 
120,880,146 - 
120,880,231  
no 0.0536 - gain - 
12 11 
 
120,883,311 - 
120,883,372  
no 0.0536 - gain - 
13 17 
30,743,662 - 
30,743,731  
Glo1 
(intron) 
0.4246 loss loss loss 
14 17 
30,870,646 - 
30,870,731  
no 0.4246 loss loss loss 
15 17 
30,895,305 - 
30,895,362  
Dnahc8 
(exon) 
0.4246 loss loss loss 
16 6 
 
101,281,458 - 
101,281,539  
no 0.4259 - - - 
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Probe 
No. 
Chr 
 
Genomic 
Position 
(LHS+RHS) [bp] 
in    
gene 
p-value 
Asso.  
Status 
HAB/LAB 
aCGH 
Status 
HAB/LAB 
JaxMDGA 
Status 
HAB/LAB 
NGS 
17 6 
101,285,391  - 
101,285,436  
no 0.4259 - gain gain 
18 6 
101,286,806 - 
101,286,895  
no 0.4259 - gain - 
19 1 
111,651,529 - 
111,651,594  
no 0.5699 loss - loss 
20 1 
 
111,662,394 - 
111,662,487  
no 0.5699 loss loss loss 
21 1 
111,663,531 - 
111,663,604  
no 0.5699 loss loss loss 
22 1 
155,368,537 - 
155,368,634  
no 0.3545 loss loss loss 
23 1 
155,364,562 - 
155,364,635  
no 0.3545 loss loss - 
24 1 
 
155,368,432 - 
155,368,513  
no 0.3545 loss loss loss 
25 5 
54,036,835 - 
54,036,920  
Rbpj 
(exon) 
0.3798 - gain - 
26 5 
54,041,592 - 
54,041,661  
Rbpj 
(exon) 
0.3798 - gain - 
27 5 
54,051,259 - 
54,051,356  
no 0.3798 - - - 
28 17 
 
13,267,096 - 
13,267,161  
no 0.0642 loss loss - 
29 17 
13,297,698 - 
13,297,787  
no 0.0642 loss - - 
30 17 
13,298,603 - 
13,298,664  
no 0.0642 loss - - 
31 6 
107,067,619 - 
107,067,676  
no 0.0955 - gain - 
32 6 
 
107,078,729 - 
107,078,806  
no 0.0955 - gain - 
33 6 
107,079,573 - 
107,079,666  
no 0.0955 - gain - 
 
III Materials and Methods 
56 
4.2.2.2  Performance of MLPA 
After their arrival, the MLPA probes were dissolved in TE buffer (10 mM Tris/HCl, 1 mM 
EDTA, pH 8.0) to obtain 10 µM stock solutions for ultramers (> 60 nt) and 100 µM ones for 
normal oligonucleotides (≤ 60 nt). The stock solutions were further diluted to 1 µM final 
solutions, which were stored at -20 °C until required for further processing. 
The DNA used to screen for CNVs by MLPA was extracted from tail tips of 54 CD-1 mouse 
males, previously tested in different behavioral tests (see chapter 4.1). Based on the 
percent time the animals spent on the open arm of the EPM, the 27 most anxious and 27 
least anxious ones were chosen. Additionally, one HAB and one LAB sample (both aged 
8 weeks, generation 46) were used as positive control and reference, respectively. The 
DNA extraction was done by use of the Wizard® Genomic DNA Purification Kit (Promega, 
Madisonm WI, USA), following the recommendations of the delivered protocol. Hence, 
about 0.5 cm tail tissue were digested over night at 55 °C in 17.5 µl proteinase K 
(20 mg/ml) and 600 µl previously prepared master mix of 3 ml EDTA (0.5 M, pH 8.0) and 
12.5 ml Nuclei Lysis Solution. The next day, 3 µl RNase Solution was added and incubated 
for 30 min at 43 °C and subsequently 5 min at room temperature. Then the sample was 
mixed with 200 µl Protein Precipitation Solution and vortexed for 20 s. After 5 min of 
incubation on ice, a 4-minute-centrifugation step was performed at 15,000 g. The 
supernatant was transferred into a new tube and mixed gently with 600 µl isopropanol. 
This time the sample was centrifuged for 2 min at 15,000 g and the supernatant was 
discarded. Another centrifugation step under the same conditions was performed after 
the addition of 600 µl ethanol (70 %). The supernatant was discarded and the DNA pellet 
was dried for 15 min at room temperature before it was dissolved at 65 °C for 1 hour in 
100 µl TE buffer. The DNA concentration was measured and 150 ng of each sample were 
checked for sufficient quality on a 1 % agarose gel. Finally, the samples were diluted with 
low-EDTA TE buffer (10 mM Tris/HCl, 0.5 mM EDTA, pH 8.0 – 8.5) to a final concentration 
of 20 ng/µl. 
The MLPA procedure was done in two approaches of 96-well format using the SALSA 
MLPA kit PM200-A1 Mouse reference (MRC-Holland), by following the given instructions. 
Thus, three sets of probes were prepared, called the synthetic basic probemix 1 – 3. For 
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each mixture 182.4 µl TE buffer were added to 0.8 µl of each of 11 different final 
solutions, premixed as described above. The first synthetic basic probemix contained the 
final solutions of MLPA probes 1 to 11, the second of probes 12 to 22 and the third of 
probes 23 to 33 (see Table III-7 and Table III-8). 
Just before the MLPA run was performed, 0.5 µl of the respective synthetic basic 
probemix, 1 µl PM200 probemix and 1.5 µl MLPA buffer (both provided in the kit) were 
combined for each sample tested to form the MLPA master mix. 3 µl of that mixture were 
added to 5 µl DNA (20 ng/µl) after a pre-incubation for 5 min at 98 °C and cooling down 
to 25 °C. The samples were heated to 95 °C for 1 min and then incubated over night at 
60 °C. The day after, before proceeding with the protocol, a ligase master mix for 
100 samples was prepared, including 2.5 ml distilled water, 300 µl Ligase buffer A, 300 µl 
Ligase buffer B and 100 µl Ligase-65. Then, the over-night-incubated samples were cooled 
down to 54 °C and 32 µl ligase master mix were added to each of it. The PCR program 
proceeded with 54 °C for 15 min, 98 °C for 5 min and 20 °C until the polymerase 
mastermix for 100 samples was prepared, consisting of 750 µl distilled water, 200 µl 
SALSA PCR primermix and 50 µl SALSA polymerase. Afterwards, 10 µl polymerase 
mastermix were added to each sample and PCR program was continued with 35 cycles of 
30 s at 95°C, 30 s at 60 °C and 60 s at 72 °C. Finally, after another 20 min at 72 °C, the PCR 
program finished achieving 15 °C and samples were stored at 4 °C until capillary 
electrophoresis was conducted. 
4.2.2.3  Performance of capillary electrophoresis 
The samples amplified in the MLPA PCR were diluted 1:50 and 1:100 with distilled water, 
before they were tested in two separate capillary electrophoresis runs. 1 µl of each 
sample was transferred to a 96-well sequencing plate and mixed with 12 µl 
electrophoresis master mix. The latter was prepared just before usage, consisting of 
1197.6 µl HiDi formamide and 2.4 µl GeneScan – 500 LIZ size standard (both delivered 
from Applied Biosystems) for samples diluted 1:50, and 1198.8 µl HiDi formamide and 
1.2 µl 500 LIZ standard for samples diluted 1:100. Subsequently, the plate was heated to 
95 °C for 3 min before it was stored on ice. The sequencing process was performed in the 
facilities of the institute of human genetics (Helmholtz Zentrum Munich, Germany) on an 
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Applied Biosystems Sequencer 3730. Read outs were provided as fsa-files and analyzed 
using the intermediate version 1.0.0.43 of the Coffalyser software, developed by 
MRC-Holland, strictly following the engineer’s instructions (Coffa and van den Berg, 
2011). 
4.3  Association of CNVs with behavior 
The CNVs detected by JaxMDGA in 64 phenotyped CD-1 mice (see chapter 4.2.1) were 
statistically analyzed for a potential association with anxiety-related behavior, using a 
generalized linear model, i.e. the “glm” function in R, considering the mean normalized 
intensities of the CNVs and the measurement values of different behavioral tests. The 
p-values were calculated by a likelyhood-ratio test as implemented in the “anova” 
function of the “stats” R package.  
The just described method was applied to the combined data sets of all 64 animals. The 
merging was done in analogy to the CNV detection described in chapter 4.2.1.2, that is, by 
defining overlapping CNVs as one with a size as large as possible, and calculating the 
mean normalized intensities of all newly defined CNVs. 
4.4  Cluster analysis of interesting genes using DAVID Bioinformatics 
Database 
After the association of CNVs with anxiety-related behavior, the list of CNVs that could be 
associated with the time animals spent on the open arm of the EPM was aligned with the 
table of all known mouse genes based on the MGI database (NCBI build m37). A 
functional cluster analysis was performed for all protein coding genes mapping into any of 
these CNVs. This was done by submitting the list of candidate genes to the DAVID 
bioinformatics database (version 6.7), a database for annotation, visualization, and 
integrated discovery. Following the protocol of Da Huang and colleagues 2009a, a 
functional annotation table was generated. Clusters with an enrichment score larger than 
1.3 were considered to show sets of genes having significant biological impact. 
The same functional annotation analysis was performed for all HAB/LAB candidate genes.
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IV  Results 
1  Position and impact of CNVs in HAB/LAB mice 
1.1  Position of CNVs detected by aCGH 
The comparison of the three different CGH arrays, performed with DNA extracted from 
tail tissue and brain of two different HAB and LAB mouse males, respectively, did not 
show prominent differences. However, for determination and breakpoint definition of 
CNVs, the data of all three arrays were considered, resulting in a total amount of 98 CNVs 
detected, with exactly half of them showing a copy number gain and loss in HAB mice, 
respectively. The list of CNVs including the genomic positions is shown in the 
supplementary table S1. 
The CNVs ranged in size from 9,947 bp to 7,484,010 bp with a mean of 992,497 bp and a 
median of 544,637 bp, covering about 3.7% (97,264,699 bp) of the genome. The minimal 
distance between the different CNVs was shown to be 10,560 bp, the maximal 
95,268,064 bp with a mean and a median of 20,361,585 bp and 7,251,905 bp, 
respectively. Out of 98 CNVs, 47 (= 48%) were smaller than 0.5 Mbp (megabasepairs), as 
shown in Figure IV-1. A more detailed frequency distribution of the CNVs with sizes less 
than 0.5 Mbp is depicted in Figure IV-2. 
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Figure IV-1: Frequency distribution of CNVs detected by aCGH in HAB vs. LAB mice, 
in size classes of 0.5 Mbp. The size classes shown are depicted in a range of 0.5 Mbp 
and are plotted against the number of CNVs in the respective size range. 
 
Figure IV-2: Detailed frequency distribution of CNVs < 0.5 Mbp, detected by aCGH 
in HAB vs. LAB mice. Size ranges of 50 kbp are plotted against the number of CNVs 
in the respective size range. 
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The detected CNVs are distributed all over the genome with most found on 
chromosome 7 (14 CNVs) and least on chromosome Y (1 CNV). Details on the 
chromosomal distribution of CNVs are shown in Figure IV-3 and Table IV-1. 
 
Figure IV-3: Chromosomal distribution of CNVs detected by aCGH in HAB vs. LAB mice. 
Chromosomes are shown on the x-axis. The y-axis depicts the frequency of CNVs in the 
respective chromosome. Most CNVs were detected on chromosome 7, least on 
chromosome Y. 
Table IV-1: Detailed information on aCGH-detected CNVs per chromosome. The first column shows 
the chromosome. The other columns comprise the following information (from left to right): number 
of CNVs, size of the CNVs summed up, median and mean size of the CNVs, and the size of the largest 
and smallest CNV, respectively. 
Chr 
No. of 
CNVs 
Sum 
[bp] 
Median 
[bp] 
Mean 
[bp] 
Max 
[bp] 
Min 
[bp] 
1 9 8,649,071 882,700 961,008 2,436,586 15,782 
2 7 6,172,682 541,689 881,812 2,686,812 21,312 
3 6 3,608,317 665,839 601,386 915,869 35,096 
4 2 3,277,833 1,638,917 1,638,917 2,263,464 1,014,369 
5 5 5,558,001 945,478 1,111,600 2,158,583 26,505 
6 2 1,226,380 613,190 613,190 1,090,185 136,195 
7 14 22,516,119 802,785 1,608,294 7,484,010 46,243 
8 5 4,927,061 1,142,405 985,412 2,344,409 17,576 
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Chr 
No. of 
CNVs 
Sum 
[bp] 
Median 
[bp] 
Mean 
[bp] 
Max 
[bp] 
Min 
[bp] 
9 4 2,068,300 497,304 517,075 1,033,682 40,010 
10 4 2,559,323 146,318 639,831 2,205,673 61,015 
11 3 6,074,087 1,710,166 2,024,696 4,302,267 61,654 
12 3 3,730,125 987,243 1,243,375 2,701,083 41,799 
13 3 4,266,014 688,709 1,422,005 3,446,373 130,932 
14 4 5,545,714 1,003,368 1,386,429 3,508,029 30,949 
15 2 5,209,248 2,604,624 2,604,624 3,608,029 1,601,219 
16 5 726,832 83,136 145,366 418,154 9,947 
17 8 5,291,902 440,133 661,488 1,990,959 19,017 
18 3 3,549,032 713,974 1,183,011 2,359,869 475,189 
19 2 1,030,394 515,197 515,197 934,750 95,644 
X 6 902,506 99,067 150,418 431,528 24,315 
Y 1 375,758 375,758 375,758 375,758 375,758 
 
1.2  Position of CNVs detected by JaxMDGA 
The analysis of JaxMDGA data revealed a total of 180 CNVs, all listed in supplementary 
table S2, with a mean and median size of 81,842 bp and 8,906 bp, and a maximum and 
minimum size of 7,383,756 bp and 2 bp, respectively. The variants covered about 0.55% 
(14,731,644 bp) of the genome and arose at a minimal and maximal distance of 1,482 bp 
and 106,573,464 bp, with a mean and a median of 10,857,870 bp and 3,733,285 bp, 
respectively. Following the original definition of CNVs, thus considering only those regions 
larger than 1 kbp, the minimum size shifted to 1,195 bp, while the mean and median size 
of the total of 137 CNVs was 107,431 bp and 15,427 bp, respectively. Most of the CNVs, 
namely 82.2%, or 76.6% if only considering regions > 1 kbp, were smaller than 50 kbp. 
Just 2 CNVs had a size larger than 0.5 Mbp. The majority of CNVs (118 or 83) showed a 
gain in the HAB animal, however, only 62 (or 54) showed a loss. The frequency 
distribution is illustrated in Figure IV-4, and more detailed for smaller CNVs in Figure IV-5. 
Figure IV-6 depicts only CNVs of size < 1 kbp. 
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Different to the CNVs detected by aCGH, here no copy number change was found on 
chromosome Y, whereas chromosome 7 was again shown to harbor most of the CNVs. 
Details on the frequency distribution over all chromosomes are shown in Figure IV-7 and 
Table IV-2. 
 
Figure IV-4: Frequency distribution of CNVs detected by JaxMDGA in HAB vs. LAB 
mice. The size classes are depicted on the xaxis and range from 50 kbp to 0.5 Mbp 
with a step size of 50 kbp. The y-axis shows the frequency of CNVs in the respective 
size class. 
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Figure IV-5: Detailed frequency distribution of CNVs < 50 kbp, detected by JaxMDGA 
in HAB vs. LAB mice. On the x-axis all bars but the first (1 kbp) depict a size range of 
5 kbp. The last bar refers to all CNVs > 50 kbp. On the y-axis the frequency of CNVs in 
the respective size class is shown. 
 
Figure IV-6: Frequency distribution of CNVs < 1 kbp, by JaxMDGA detected in HAB 
vs. LAB mice. On the x-axis the 43 CNVs of size < 1 kbp are depicted in size ranges of 
100 bp. All other CNVs (137) are combined and referred to in the last bar. The y-axis 
shows the frequency of CNVs in the respective size class. 
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Figure IV-7: Chromosomal distribution of CNVs detected by JaxMDGA in HAB vs. LAB 
mice. For each chromosome the number of detected CNVs is depicted. Grey columns 
refer to the full set of revealed CNVs (180). White columns show only data of variants 
larger than 1 kbp. 
Table IV-2: Detailed information on CNVs detected by JaxMDGA in HAB vs. LAB mice. For each 
chromosome (column 1) the median and mean size (columns 5 & 6) of all CNVs (number shown in 
column 3), as well as their maximum and minimum size (columns 7 & 8), are listed. The second column 
shows the set of CNVs to which the just mentioned parameters refer: “A” for the full set of 180 
detected CNVs and “B” for only those 137 CNVs larger than 1 kbp. 
Chr Set 
No. of 
CNVs 
Sum 
[bp] 
Median 
[bp] 
Mean 
[bp] 
Max 
[bp] 
Min 
[bp] 
1 A 11 294,171 7,448 26,743 106,453 2 
1 B 7 293,389 27,743 41,913 106,453 3,594 
2 A 9 59,780 706 6,642 33,825 97 
2 B 4 58,062 9,831 14,516 33,825 4,575 
3 A 7 522,573 7,641 74,653 479,350 483 
3 B 4 520,866 16,938 130,217 479,350 7,641 
4 A 9 1,791,498 15,427 199,055 1,116,514 333 
4 B 8 1,791,165 21,034 223,896 1,116,514 2,288 
5 A 8 501,157 11,531 62,645 286,323 52 
5 B 5 500,334 49,355 100,067 286,323 11,398 
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Chr Set 
No. of 
CNVs 
Sum 
[bp] 
Median 
[bp] 
Mean 
[bp] 
Max 
[bp] 
Min 
[bp] 
6 A 16 574,612 12,960 35,913 156,205 19 
6 B 12 573,518 28,712 47,793 156,205 3,224 
7 A 22 8,003,249 12,242 363,784 7,383,756 145 
7 B 19 8,002,512 13,324 421,185 7,383,756 1,381 
8 A 3 63,564 16,848 21,188 45,480 1,236 
8 B 3 63,564 16,848 21,188 45,480 1,236 
9 A 6 9,849 1,241 1,642 3,412 651 
9 B 3 7,546 2,617 2,515 3,412 1,517 
10 A 8 169,490 4,612 21,186 91,918 111 
10 B 6 169,191 7,262 28,199 91,918 1,391 
11 A 9 118,816 16,140 13,202 29,831 203 
11 B 8 118,613 16,566 14,827 29,831 1,195 
12 A 19 1,130,124 36,415 59,480 358,926 80 
12 B 18 1,130,044 38,416 62,780 358,926 2,097 
13 A 10 173,208 12,190 17,321 67,023 164 
13 B 7 171,628 25,909 24,518 67,023 1,696 
14 A 6 58,511 10,528 9,752 22,496 243 
14 B 4 57,823 14,063 14,456 22,496 7,201 
15 A 9 130,189 7,311 14,465 76,451 29 
15 B 6 129,652 12,543 21,609 76,451 1,700 
16 A 4 116,773 4,936 29,193 106,576 325 
16 B 3 116,448 5,919 38,816 106,576 3,953 
17 A 14 826,845 8,820 59,060 465,283 74 
17 B 11 826,538 9,628 75,140 465,283 1,661 
18 A 5 108,886 13,141 21,777 59,779 6,131 
18 B 5 108,886 13,141 21,777 59,779 6,131 
19 A 3 27,592 1,308 9,197 26,255 29 
19 B 2 27,563 13,782 13,782 26,255 1,308 
X A 2 50,757 25,379 25,379 33,025 17,732 
X B 2 50,757 25,379 25,379 33,025 17,732 
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1.3  Position of CNVs and structural variants (SVs) detected by NGS 
A total of 5,851 CNVs was detected by NGS (supplementary table S3), with 3,489 regions 
showing a loss and 2,362 a gain of copy number in HAB mice. The CNVs ranged in size 
from 1,400 bp to 421,400 bp with a mean and a median of 4,654 bp and 2,400 bp, 
respectively, covering about 1.03% (27,233,200 bp) of the genome. The smallest distance 
between two variants was shown to be 200 bp, the largest 47,829,800 bp, with a mean 
and a median of 420,251 bp and 49,200 bp, respectively. Only 43 CNVs (0.73 %) were 
larger than 50 kbp, 4,862 (83.10 %) were even smaller than 5 kbp. The frequency 
distribution of all CNVs is shown in Figure IV-8 with size classes of 50 kbp. Figure IV-9 and 
Figure IV-10 illustrate the frequency distributions of CNVs smaller than 50 kbp and 5 kbp, 
with a step size of 5 kbp and 500 bp, respectively. 
The CNVs are distributed all over the genome. In concordance to the other detection 
methods, most were found on chromosome 7 (646 CNVs) and least on chromosome Y 
(5 CNVs). Details on the chromosomal distribution of CNVs are shown in Figure IV-11 and 
Table IV-3. 
 
Figure IV-8: Frequency distribution of CNVs detected by NGS in HAB vs. LAB mice, in 
size classes of 50 kbp. The size classes are plotted against the number of CNVs in the 
respective range, with a step size of 50 kbp. 
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Figure IV-9: Detailed frequency distribution of CNVs < 50 kbp, detected by NGS in HAB 
vs. LAB mice. CNVs of size < 50 kbp are depicted in size ranges of 5 kbp. The last bar 
refers to all CNVs larger than 50 kbp. 
 
Figure IV-10: Detailed frequency distribution of CNVs < 5 kpb, detected by NGS in HAB 
vs. LAB mice. CNVs of size < 5 kbp are depicted in size ranges of 500 bp on the x-axis. 
The last bar represents all CNVs larger than 5 kbp. The frequency of CNVs in the 
respective size class is shown on the y-axis. 
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Figure IV-11: Frequency distribution of CNVs detected by NGS in HAB vs. LAB mice 
over all chromosomes. Most CNVs were found on chromosome 7, least on 
chromosome Y, with the frequencies plotted against the chromosomes. 
Table IV-3: Detailed information on CNVs detected by NGS in HAB vs. LAB mice. The first column 
shows the chromosome. The other columns comprise the following information (from left to right): 
number of CNVs, size of the CNVs summed up, median and mean size of the CNVs, and the size of 
largest and smallest CNV, respectively. 
Chr 
No. of  
CNVs 
Sum 
[bp] 
Median 
[bp] 
Mean 
[bp] 
Max 
[bp] 
Min 
[bp] 
1 540 1,969,200 2,400 3,647 69,200 1,400 
2 427 1,296,400 2,400 3,036 49,800 1,400 
3 312 1,133,200 2,400 3,632 49,400 1,400 
4 278 2,599,600 3,000 9,351 166,200 1,400 
5 310 2,207,000 2,800 7,119 180,200 1,400 
6 381 1,482,600 2,400 3,891 147,800 1,400 
7 646 4,986,000 3,600 7,718 142,800 1,400 
8 207 603,200 2,200 2,914 18,400 1,400 
9 166 486,400 2,200 2,930 34,000 1,400 
10 232 990,400 2,600 4,269 76,000 1,400 
11 196 751,600 2,300 3,835 73,200 1,400 
12 417 2,369,200 2,800 5,682 101,800 1,400 
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Chr 
No. of  
CNVs 
Sum 
[bp] 
Median 
[bp] 
Mean 
[bp] 
Max 
[bp] 
Min 
[bp] 
13 283 843,000 2,400 2,979 14,400 1,400 
14 311 939,800 2,400 3,022 22,200 1,400 
15 287 824,000 2,400 2,871 9,600 1,400 
16 157 493,000 2,400 3,140 28,400 1,400 
17 374 2,267,200 2,600 6,062 421,400 1,400 
18 180 469,600 2,200 2,609 8,200 1,400 
19 105 284,600 2,200 2,710 8,800 1,400 
X 37 225,400 3,800 6,092 55,200 1,600 
Y 5 11,800 2,200 2,360 3,800 1,600 
 
Besides the CNVs, 8,035 large deletions were detected in HAB and 7,208 in LAB mice, of 
which 6,451 were found to overlap at least partially between the two mouse lines. About 
80% of the deletions did show an overlap of more than 80% (see figure 1.2 of 
supplementary report S1). There were 1,621 deletions only detected in HAB and 782 only 
in LAB. A list of all deletions can be found in the supplementary table S4. Furthermore, 
236 SVs causing wrong mate order were found in HAB, 190 in LAB, with 140 overlapping 
between the lines. All SVs of that kind are listed in supplementary table S5. In addition to 
that, 81 insertions and 169 inversions were revealed in HAB, 36 and 118, respectively in 
LAB. Thereof, 82 inversions were unique in HAB and 31 in LAB. 33 of the insertions were 
overlapping between both lines. The respective data are outlined in supplementary 
table S6 (insertions) and table S7 (inversions). 
1.4  Comparison of CNVs detected by aCGH, JaxMDGA and NGS 
When comparing CNV data acquired by aCGH, JaxMDGA and NGS, a total of 4.8 Mbp 
were found to overlap between the data sets. This equates to approximately 5 %, 33 % 
and 18 % of the total length of CNVs detected by aCGH, JaxMDGA and NGS, respectively. 
Several CNVs did overlap, at least partially, in all three methods. Details on the 
comparison are shown in Table IV-4. Since it is possible that CNVs detected by one 
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method overlapped with just a single CNV defined by another method, the number of 
CNVs is shown with respect to just one detection method, e.g., 33 aCGH-CNVs overlapped 
with CNVs defined by both other methods. The positions of overlapping CNVs are 
outlined in detail in supplementary table S8 and depicted in Figure IV-12 to Figure IV-16. 
Some of the regions were shown to overlap in nearly full length between the different 
data sets, while others outlined the same region but were defined as one or multiple 
CNVs by different methods. Since, due to limitations in resolution, that effect might be 
difficult to recognize when displaying the full length of the chromosomes, parts of 
chromosome 17 were enlarged exemplarily (Figure IV-17). The first of the enlarged 
regions depicts the CNV with the Glo1 locus, further investigated by the breeding 
approach described in chapter 1.6. 
Table IV-4: Comparison of CNVs detected in HAB vs. LAB mice by three different methods. Upper 
part: numbers of respective CNVs. Part below: sizes of respective CNVs in basepairs. Line “overlap both 
others” shows the number of CNVs defined by the respective detection method that overlap with any 
other CNV detected by the other two methods. 
 
aCGH JaxMDGA NGS 
 
No. of CNVs 98 180 5,851  
Overlap aCGH (No. CNVs) - 76 1,821  
Overlap JaxMDGA (No. CNVs) 42 - 293  
Overlap NGS  (No. CNVs) 97 86 -  
Overlap both others (No. CNVs) 33 53 220  
   
 
 
Total size of CNVs [bp] 97,264,699 14,731,644 27,233,200  
Mean size of CNVs [bp] 992,497 81,842 4,654  
Median size of CNVs [bp] 544,637 8,906 2,400  
Overlap in all methods [bp] 4,824,789  
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Figure IV-12 (A) – (D): Genomic positions of CNVs on chromosomes 1 – 4, detected in HAB vs. LAB 
mice. The chromosomes are indicated by grey lines. CNVs are shown in different colors depending on 
their detection method with red for NGS, dark red for JaxMDGA and orange for aCGH. Start points of 
CNVs are marked by dots and lines are drawn till the end points. Due to limitations in resolution small 
CNVs might appear as dots only. Lines and dots drawn above the chromosome indicate a copy number 
gain in HAB mice, while those below depict a copy number loss. 
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Figure IV-13 (A) – (D): Genomic positions of CNVs on chromosomes 5 – 8, detected in HAB vs. LAB 
mice. The chromosomes are indicated by grey lines. CNVs are shown in different colors depending on 
their detection method with red for NGS, dark red for JaxMDGA and orange for aCGH. Start points of 
CNVs are marked by dots and lines are drawn till the end points. Due to limitations in resolution small 
CNVs might appear as dots only. Lines and dots drawn above the chromosome indicate a copy number 
gain in HAB mice, while those below depict a copy number loss. 
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Figure IV-14 (A) – (D): Genomic positions of CNVs on chromosomes 9 – 12, detected in HAB vs. LAB 
mice. The chromosomes are indicated by grey lines. CNVs are shown in different colors depending on 
their detection method with red for NGS, dark red for JaxMDGA and orange for aCGH. Start points of 
CNVs are marked by dots and lines are drawn till the end points. Due to limitations in resolution small 
CNVs might appear as dots only. Lines and dots drawn above the chromosome indicate a copy number 
gain in HAB mice, while those below depict a copy number loss. 
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Figure IV-15 (A) – (D): Genomic positions of CNVs on chromosomes 13 – 16, detected in HAB vs. LAB 
mice. The chromosomes are indicated by grey lines. CNVs are shown in different colors depending on 
their detection method with red for NGS, dark red for JaxMDGA and orange for aCGH. Start points of 
CNVs are marked by dots and lines are drawn till the end points. Due to limitations in resolution small 
CNVs might appear as dots only. Lines and dots drawn above the chromosome indicate a copy number 
gain in HAB mice, while those below depict a copy number loss. 
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Figure IV-16 (A) – (D): Genomic positions of CNVs on chromosomes 18, 19, X & Y, detected in HAB vs. 
LAB mice. The chromosomes are indicated by grey lines. CNVs are shown in different colors depending 
on their detection method with red for NGS, dark red for JaxMDGA and orange for aCGH. Start points 
of CNVs are marked by dots and lines are drawn till the end points. Due to limitations in resolution 
small CNVs might appear as dots only. Lines and dots drawn above the chromosome indicate a copy 
number gain in HAB mice, while those below depict a copy number loss. 
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Figure IV-17: Genomic position of CNVs on chromosome 17, detected in HAB vs. LAB mice. The 
chromosome is indicated by a grey line. CNVs are shown in different colors depending on their 
detection method with red for NGS, dark red for JaxMDGA and orange for aCGH. Start points of CNVs 
are marked by dots and lines are drawn till the end points. Due to limitations in resolution small CNVs 
might appear as dots only. Lines and dots drawn above the chromosome indicate a copy number gain 
in HAB mice, while those below depict a copy number loss. Parts of the full-length chromosome (A) are 
enlarged below, highlighted by a dark and light blue square. Enlarged pictures show (B) a CNV 
including the Glo1 locus with breakpoints defined similarly by all detection methods and (C) a region 
defined as single and multiple CNV(s), respectively with unequal breakpoints.  
1.5  Expression versus CNV data 
1.5.1  Differentially expressed genes detected by expression microarray 
Out of 12,171 probes that passed the filtering process, the reappraisal of the expression 
microarray data showed 291 in the CeA, 117 in the BLA, 297 in the PVN and 254 in the Cg, 
respectively, to be differentially expressed between HAB and LAB mice. These probes 
represented a total of 8,981 protein coding genes, with 374 differentially expressed in at 
least one of the tested brain regions, of which 256 were detected in the CeA, 100 in the 
BLA, 260 in the PVN and 222 in the Cg. All 374 genes are listed in supplementary table S9, 
including information on how many probes representing them were found to feature 
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differences in expression levels, thus a p-value less than 0.05, and in which regions that 
difference occurred. Table IV-5 shows the p-values and the relative fold-change for all 
array probes of the 12 genes validated by qPCR. 
Table IV-5: Expression differences of genes analyzed later on in qPCR, detected by expression 
microarray. A p-value less than 0.05 shows significant expression difference between HAB and LAB 
mice (written in bold letters), a p-value not indicating significance but being less than 0.1 indicates a 
trend (italic and bold letters). A negative fold-change indicates less, a positive more expression in HAB 
mice. If multiple probes target a gene, the result of each probe is shown separately in a distinct line. 
The genes that were targeted by more than one probe are marked by the probe number written in 
brackets behind the gene symbol. 
Gene 
symbol 
CeA 
pVal 
CeA 
foldCh 
BLA 
pVal 
BLA 
foldCh 
PVN 
pVal 
PVN 
foldCh 
Cg 
pVal 
Cg 
foldCh 
Alk 0.0048 -1.5218 0.9999 -1.2246 0.0065 -1.5067 1.0000 -1.1637 
Epn2 (1) 1.0000 -1.0384 0.9999 1.0045 1.0000 1.0141 1.0000 1.0742 
Epn2 (2) 0.6024 1.2571 0.9999 1.0822 1.0000 1.1726 1.0000 1.1457 
Epn2 (3) 0.0494 1.7020 0.9999 1.2465 0.4560 1.4442 0.0027 2.0011 
Epn2 (4) 1.0000 1.1404 0.9999 -1.0456 1.0000 1.0006 1.0000 1.0308 
Epn2 (5) 1.0000 1.0689 0.9999 1.0131 1.0000 -1.0117 1.0000 1.0390 
Fgfr2 1.0000 1.0801 0.9999 1.2349 1.0000 1.1086 1.0000 1.0080 
Ghrh 0.0000 -2.3654 0.9999 -1.1687 0.0000 -9.8041 1.0000 1.0287 
Glb1 (1) 0.9186 -1.1698 0.9999 -1.1616 0.0012 -1.5986 1.0000 -1.1765 
Glb1 (2) 1.0000 1.0972 0.9999 -1.0182 1.0000 1.0730 1.0000 1.1376 
Glo1 0.0011 -2.7181 0.0792 -2.2790 0.0007 -2.8015 0.0017 -2.6572 
Gnaq (1) 0.0000 4.6921 0.0006 3.2946 0.0000 3.2645 0.0000 5.6461 
Gnaq (2) 0.7608 1.2314 0.9999 1.0533 1.0000 -1.0328 1.0000 1.0024 
Gnaq (3) 1.0000 -1.0290 0.9999 1.0662 1.0000 -1.0082 1.0000 -1.0542 
Pdk2 0.0001 -1.9379 0.0480 -1.6630 0.0000 -2.1816 0.0231 -1.5839 
Prkcdbp 0.1844 -1.4126 0.9999 -1.1686 0.0157 -1.6087 1.0000 -1.0019 
Rgs16 1.0000 1.1484 0.9999 1.2215 1.0000 1.0822 0.0267 -1.6101 
Rhoj 1.0000 -1.0978 0.9999 -1.0952 0.0249 -1.3600 1.0000 -1.0691 
Slc30a6 (1) 1.0000 1.0182 0.9999 -1.2367 1.0000 -1.1919 1.0000 -1.1070 
Slc30a6 (2) 0.0000 2.1748 0.0019 1.8883 0.0000 2.7410 0.0000 1.9532 
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1.5.2  Confirmation of differentially expressed genes by qPCR 
For three of the twelve genes tested in qPCR, Fgfr2, Ghrh and Prkcdbp, no reliable results 
could be obtained by qPCR. Therefore, these genes were excluded from the statistical 
analysis. The qPCR results of the remaining nine genes are listed in Table IV-6. Comparing 
that list with Table IV-5 showed that most of the microarray results could be confirmed, 
as indicated by a (*) following the p-value in Table IV-6. 
Table IV-6: Expression differences of genes successfully tested in qPCR. The first part shows relative 
expression rate with standard error (SEM) and p-value (calculated by Mann-Whitney-U test) for CeA 
and BLA, the second part for PVN and Cg. A p-value < 0.05 (bold letters) indicates a significant 
difference between HAB and LAB gene expression, a p-value < 0.1 (bold and italic letters) indicates a 
trend. * = confirmed microarray result; (*) = confirmed result of at least one microarray probe; 
*T = eventually confirmed microarray result, with one of the methods showing a trend. 
Gene 
symbol 
CeA 
relEx HAB 
+- SEM 
CeA 
relEx LAB 
+- SEM 
CeA 
pVal 
 BLA 
relEx HAB 
+- SEM 
BLA 
relEx LAB 
+- SEM 
BLA 
pVal 
Alk 1.0 ± 0.09 0.91 ± 0.08 0.6203  1.0 ± 0.12 1.24 ± 0.17 0.3637* 
Epn2 1.0 ± 0.07 0.72 ± 0.08 0.0132(*)  1.0 ± 0.06 0.88 ± 0.03 0.1864* 
Glb1 1.0 ± 0.27 0.89 ± 0.12 0.4574*  1.0 ± 0.14 1.78 ± 0.22 0.0064 
Glo1 1.0 ± 0.06 2.79 ± 0.20 0.0003*  1.0 ± 0.06 3.07 ± 0.22 0.0003*T 
Gnaq 1.0 ± 0.08 0.95 ± 0.14 0.409(*)  1.0 ± 0.08 1.12 ± 0.22 0.8688(*) 
Pdk2 1.0 ± 0.09 0.78 ± 0.03 0.0318  1.0 ± 0.12 0.93 ± 0.12 0.6203 
Rgs16 1.0 ± 0.16 0.84 ± 0.15 0.409*  1.0 ± 0.09 0.85 ± 0.15 0.1864* 
Rhoj 1.0 ± 0.10 1.18 ± 0.09 0.1604*  1.0 ± 0.09 1.31 ± 0.14 0.0475 
Slc30a6 1.0 ± 0.18 0.64 ± 0.06 0.0575(*T)  1.0 ± 0.12 1.16 ± 0.10 0.2831(*) 
 PVN 
relEx HAB 
+- SEM 
PVN 
relEx LAB 
+- SEM 
PVN 
pVal 
 Cg 
relEx HAB 
+- SEM 
Cg 
relEx LAB 
+- SEM 
Cg 
pVal 
Alk 1.0 ± 0.14 1.66 ± 0.81 0.7412  1.0 ± 0.10 1.31 ± 0.09 0.0132 
Epn2 1.0 ± 0.07 0.89 ± 0.20 0.1604*  1.0 ± 0.12 0.92 ± 0.07 0.8590(*) 
Glb1 1.0 ± 0.07 1.94 ± 0.42 0.0166(*)  1.0 ± 0.11 1.23 ± 0.14 0.1167* 
Glo1 1.0 ± 0.11 3.25 ± 0.36 0.0003*  1.0 ± 0.15 2.65 ± 0.25 0.0004* 
Gnaq 1.0 ± 0.21 1.51 ± 0.27 0.1167(*)  1.0 ± 0.16 0.45 ± 0.04 0.0022(*) 
Pdk2 1.0 ± 0.09 1.87 ± 1.04 0.5089  1.0 ± 0.17 0.91 ± 0.10 0.8688 
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Gene 
symbol 
CeA 
relEx HAB 
+- SEM 
CeA 
relEx LAB 
+- SEM 
CeA 
pVal 
 BLA 
relEx HAB 
+- SEM 
BLA 
relEx LAB 
+- SEM 
BLA 
pVal 
Rgs16 1.0 ± 0.12 1.08 ± 0.36 0.3218*  1.0 ± 0.09 0.85 ± 0.12 0.1604 
Rhoj 1.0 ± 0.11 1.74 ± 0.61 0.039*  1.0 ± 0.13 0.90 ± 0.13 0.2477* 
Slc30a6 1.0 ± 0.27 1.27 ± 0.54 0.6797(*)  1.0 ± 0.19 0.95 ± 0.10 0.8688(*) 
 
1.5.3  Correlation of differentially expressed genes with CNV data 
In total 8,981 protein coding genes were tested for expression differences in the 
microarray-based approach, of which 532 were located in regions where a CNV was 
shown either by aCGH, JaxMDGA or NGS (for details on CNV positions see chapter 1). The 
counting of genes that were differentially or equally expressed between HAB and LAB and 
those that fell into regions where a CNV was shown resulted in the numbers outlined in 
Table IV-7. Applying a two-proportion z-test on the data revealed a significant influence of 
CNVs on expression in all the tested brain regions, with a p-value of 1.17 x 10-69 for the 
comparison of the CNV data with the expression data including all genes that showed 
differences in at least one brain region. Considering each brain region separately resulted 
in p-values of 4.17 x 10-49 (CeA), 5.28 x 10-40 (BLA), 1.76 x 10-64 (PVN) and 3.33 x 10-54 (Cg). 
PVN PVNPVN Cg Cg Cg 
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Table IV-7: Count of genes that are differentially expressed between HAB and 
LAB mice and overlap with CNVs. The first column shows the respective brain 
region, the second column the count of genes that were found to be differentially 
expressed and the last column the number of genes that were not only found to 
show differences in expression level but also overlap with any CNV. 
Brain region 
Genes diff. 
expressed 
Genes diff. ex. 
& in CNV 
At least one 374 101 
CeA 256 70 
BLA 100 37 
PVN 260 79 
Cg 222 67 
 
Applying the Pearson’s product-moment correlation, a positive correlation between gene 
expression and the CNV status (i.e. a gain or loss in HAB vs. LAB animals) was shown for 
all four brain regions. Except for the BLA, the p-values did all reach significance, thus a 
value less than 0.05, before of the application of Bonferroni correction. Afterwards, 
however, the significance threshold was not reached any more. The respective values are 
listed in Table IV-8. 
Table IV-8: Result of the correlation of CNVs with expression. Each brain is 
outlined in a separate line. Significant p-values (< 0.05) are marked with an asterisk 
(*). In the third column the nominal p-values are shown, in the last column the 
Bonferroni corrected p-values. A positive value in the second column indicates a 
positive correlation of copy number with expression. 
Brain region Correlation p-value 
p-value 
corrected 
CeA 0.311 0.0021* 0.1998 
BLA 0.208 0.1432 1.0000 
PVN 0.309 0.0012* 0.1246 
Cg 0.536 0.0057* 0.2831 
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1.6  Influence of the Glo1 CNV on behavior 
In order to test the influence of a single CNV that included the Glo1 locus, the Glo1 
breeding approach was performed, mating animals showing the LAB-specific locus with 
HAB mice. Animals of the 6th generation were tested in different behavioral tests, the 
EPM, the OF, the TST and the FST. After determination of the phenotype, the animals 
were genotyped for the Glo1 locus by PCR and subsequent gel electrophoresis. On the 
gel, a band indicating an existing product length of 150 bp (Figure IV-18) could only be 
seen, if more than one copy of the genomic region was present, thus exclusively in 
animals having the LAB-specific genotype. Out of 94 mice tested, 26 females and 30 males 
were identified to have that genotype, while 20 females and 18 males were shown to 
have the HAB-specific locus. 
 
Figure IV-18: Picture of a gel showing both HAB- and 
LAB-specific genotypes. The control band of size 290 bp 
is indicated by a green arrow, the LAB-specific band 
(150 bp) by a red one. Marker: ZipRuler Express DNA 
Ladder 1. 
The behavior of the animals was subsequently analyzed with respect to the genotype by 
discriminating a variety of behavioral parameters. The most important parameter was the 
time the mice spent on the open arm of the EPM (Figure IV-19A), since that is the key 
parameter of the original HAB/LAB breeding. For that behavioral aspect, no significant 
difference could be observed, neither when comparing all animals having the 
HAB-specific Glo1 locus (“hab” animals) with all having the LAB-specific one (“lab” 
animals; p = 0.939), nor when these groups were analyzed for females (p = 0.877) and 
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males (p = 0.932) separately. The same was true for all parameters of other behavioral 
experiments analyzed, like the key parameters total distance animals travelled in the OF 
(pall = 0.638, pfemales = 0.223, pmales = 0.717), the time animals spent floating in the FST 
(pall = 0.338, pfemales = 0.278, pmales = 0.835) and the time animals were immobile during 
the TST (pall = 0.864, pfemales = 0.629, pmales = 0.896), as depicted in Figure IV-19B-D. 
 A) B) 
   
 C) D) 
   
Figure IV-19: Results of behavioral testing in animals of the 6th Glo1 breeding generation. Groups of 
“hab” and “lab” animals were compared to each other, gender-dependent and independent. No 
significant difference (p < 0.05) could be shown in any of the test parameters, neither in the time 
animals spent on the open arm of the EPM (A), in the total distance animals travelled in the OF (B), in 
the time animals floated during FST (C), nor in the time animals were immobile in the TST (D). Data of 
“hab” animals are shown in red (females N=26, males N = 30), data of “lab” in blue (females N = 20, 
males N = 18). Whiskers include values within a maximum of 1.5 interquartile range (IQR). Outliers 
(values not within 1.5 IQR) are indicated by dots. 
 
IV Results 
84 
2  Position and impact of CNVs in CD-1 mice 
2.1  CNVs examined by MLPA 
The measurement values of 33 probes targeting 11 CNVs previously detected in CD-1 
mice by JaxMDGA were analyzed using the Coffalyser software. For all samples a warning 
was shown that DNA concentration in the MLPA run was too low. However, the results 
for all probes (1:100-dilution of MLPA probes) are outlined in supplementary table S10. 
The results of the 1:50-dilution were not shown, as they seemed less reliable than the 
measurement values of the 1:100-dilution. The data were further analyzed probe-wise for 
differences between the two groups of each 27 animals showing least and most 
anxiety-related behavior on the EPM (percent time on the open arm), respectively, by 
applying the Mann-Whitney-U test. Only one probe (no. 15) showed a significant 
difference between the two groups (p = 0.039) and two other (no. 21 and 14) a trend 
(p = 0.077 and 0.086). In Table IV-9, the result for the HAB sample is compared to the CNV 
status detected by aCGH, JaxMDGA and NGS. 
Table IV-9: Comparison of the CNV status of 33 different loci determined by MLPA with the CNV 
status detected by aCGH, JaxMDGA and NGS in a HAB sample. The first column shows the MLPA 
probe number, the second the MLPA result. In the other columns the status of each CNV, detected by 
the respective method, in which the MLPA probe can be mapped, is listed. A minus (-) indicates that 
no CNV was detected. Probes mapping into different CNVs are separated by black lines. 
MLPA 
Probe no. 
MLPA  
(CNV status 
in HAB) 
aCGH 
(CNV status 
in HAB) 
JaxMDGA 
(CNV status 
in HAB) 
NGS 
(CNV status 
 in HAB) 
1 - loss loss - 
2 - loss - - 
3 - loss - - 
4 loss - loss loss 
5 loss - loss loss 
6 - - gain - 
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MLPA 
Probe no. 
MLPA  
(CNV status 
in HAB) 
aCGH 
(CNV status 
in HAB) 
JaxMDGA 
(CNV status 
in HAB) 
NGS 
(CNV status 
 in HAB) 
7 - - gain - 
8 - - gain - 
9 - - gain - 
10 - - gain - 
11 - - gain - 
12 gain - gain - 
13 loss loss loss loss 
14 loss loss loss loss 
15 loss loss loss loss 
16 - - - - 
17 loss - gain gain 
18 gain - gain - 
19 - loss - loss 
20 loss loss loss loss 
21 loss loss loss loss 
22 gain loss loss loss 
23 loss loss loss - 
24 - loss loss loss 
25 - - gain - 
26 - - gain - 
27 - - - - 
28 loss loss loss - 
29 - loss - - 
30 - loss - - 
31 - - gain - 
32 - - gain - 
33 - - gain - 
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2.2  Behavior of CD-1 mice screened for CNVs by JaxMDGA 
In the “CD-1 panel” 384 mice were phenotyped. Here, only selective behavioral data of 
the 64 mice tested for CNVs by JaxMDGA are shown. For the full data set and a more 
detailed analysis see Widner-Andrä (2011). The animals to be examined on the JaxMDGA 
were chosen based on their phenotypes averaged over all behavioral tests, with 16 
animals showing intermediate and each 24 high and low anxiety-related behavior, 
respectively. However, that clear distinction could not be drawn with regard to single 
behavioral parameters (Figure IV-20). As mentioned above, with the percent time the 
animals spent on the open arm of the EPM, the distance they travelled in the OF, the time 
they floated in the FST, the Cort increase after the SRT and the time they spent immobile 
in the TST, only the key parameters of behavioral data are shown, since they were used 
for further analysis. 
 
Figure IV-20: Behavior of 64 CD-1 mice screened for CNVs by JaxMDGA. On the x-axis 
the key parameters of five different behavioral tests are shown. Each dot represents 
the respective measurement value of a single animal, with the height drawn on the y-
axes. EPM and OF data refer to the left y-axis, FST, SRT and TST to the right. Black lines 
indicate the respective mean values of all animals. 
2.3  Position of CNVs detected in CD-1 mice by JaxMDGA 
For CNV detection in the raw data of the JaxMDGA, the probe measurement values of a 
sample animal has to be compared to those of a reference animal. Since it was not useful 
to determine one animal to serve as reference sample (as described in chapter III-4.2.1.2), 
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all 32 animals per array were compared to each other by running multiple sample-
reference combinations. Afterwards the data of the two arrays were merged. Thus, 764 
regions were shown to differ in copy number in at least one pair of the 64 animals 
screened for CNVs. All the detected CNVs are listed in supplementary table S11 and their 
genomic position is depicted in Figure IV-21. 
 
Figure IV-21: Genomic positions of CNVs detected in 64 CD-1 mice by JaxMDGA. Chromosomes are 
indicated by grey lines with the basepairs shown on the x-axis and the chromosomes on the yaxis. 
Start points of CNVs are marked by dots and lines are drawn till the end points. Due to limitations in 
resolution small CNVs might appear as dots only. 
Most of the CNVs (61%) ranged in size between 1 kbp and 50 kbp, 18.6% (622) were 
smaller than 1 kbp, with a mean size of 77,249 bp and a median of 14,377 bp. The 
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frequency distribution of all CNVs is shown in Figure IV-22. The distribution of regions 
smaller than 50 kbp is outlined in more detail in Figure IV-23, the distribution of those 
smaller than 1 kbp in Figure IV-24. Considering only the 622 CNVs whose size exceeded 
1 kbp, the smallest region was shown to have 1,003 bp and the largest 7,568,999 bp, with 
a mean of 94,796 bp and a median of 20,322 bp. Most of the CNVs were found on 
chromosome 2 and chromosome 6, considering all regions or only those larger than 
1 kbp, respectively, whereas none could be revealed on chromosome Y. Details on the 
frequency distribution of CNVs over all chromosomes are shown in Figure IV-25 and 
Table IV-10. 
 
Figure IV-22: Frequency distribution of CNVs detected in 64 CD-1 mice by JaxMDGA. 
The size classes are plotted against the number of CNVs in the respective range, with a 
step size of 50 kbp. 
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Figure IV-23: Detailed frequency distribution of CNVs < 50 kbp detected in CD-1 mice. All bars but the 
first (1 kbp) comprise a size range of 5 kbp, indicated on the x-axis. The last bar includes all CNVs 
> 50 kbp. The number of CNVs in the respective size range is shown on the y-axis. 
 
Figure IV-24: Frequency distribution of CNVs < 1 kbp detected in 64 CD-1 mice by 
JaxMDGA. 142 CNVs of size < 1 kbp are depicted in size ranges of 100 bp, indicated on 
the x-axis. All other CNVs (622) are referred to in the last column. The number of CNVs in 
the respective size range is shown on the y-axis. 
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Figure IV-25: Chromosomal distribution of CNVs detected in 64 CD-1 mice. For each 
chromosome (x-axis) the number of detected CNVs (y-axis) is depicted. Grey columns refer 
to the full set of revealed CNVs (764). White columns show only data of variants larger 
than 1 kbp (622). 
Table IV-10: Detailed information on CNVs detected in 64 CD-1 mice by JaxMDGA. For each 
chromosome (column 1) the median and mean size (columns 5 & 6) of all CNVs (quantity shown in 
column 3), as well as their maximum and minimum size (columns 7 & 8), are listed. The second column 
shows the set of CNVs to which the just mentioned parameters refer: “A” for the full set of 764 
detected CNVs and “B” for only those 622 CNVs larger than 1 kbp. 
Chr Set 
No. of 
CNVs 
Sum 
[bp] 
Median 
[bp] 
Mean 
[bp] 
Max 
[bp] 
Min 
[bp] 
1 A 54 3,320,987 15,407 61,500 946,665 13 
1 B 43 3,317,251 24,755 77,145 946,665 2,653 
2 A 65 5,036,683 13,644 77,487 2,916,531 10 
2 B 51 5,030,235 18,828 98,632 2,916,531 1,030 
3 A 58 2,627,902 8,842 45,309 479,349 12 
3 B 46 2,623,363 17,297 57,030 479,349 1,225 
4 A 30 3,853,017 4,337 128,434 1,619,401 137 
4 B 20 3,848,386 17,915 192,419 1,619,401 1,280 
5 A 56 4,946,924 17,423 88,338 2,100,801 8 
5 B 45 4,942,885 25,792 109,842 2,100,801 1,025 
IV Results 
91 
Chr Set 
No. of 
CNVs 
Sum 
[bp] 
Median 
[bp] 
Mean 
[bp] 
Max 
[bp] 
Min 
[bp] 
6 A 62 2,791,483 17,489 45,024 376,782 1 
6 B 55 2,788,702 21,494 50,704 376,782 1,033 
7 A 56 14,929,513 22,530 266,598 7,568,999 182 
7 B 50 14,927,087 30,770 298,542 7,568,999 1,112 
8 A 26 946,602 16,442 36,408 158,972 4 
8 B 24 946,215 18,676 39,426 158,972 1,132 
9 A 16 519,584 9,233 32,474 276,328 391 
9 B 13 518,145 15,310 39,857 276,328 1,516 
10 A 32 1,160,360 11,465 36,261 324,148 76 
10 B 24 1,158,370 24,581 48,265 324,148 1,003 
11 A 30 544,634 10,062 18,154 95,599 7 
11 B 22 541,694 16,444 24,622 95,599 1,599 
12 A 49 3,188,781 20,603 65,077 386,118 25 
12 B 45 3,187,642 26,299 70,836 386,118 1,174 
13 A 44 2,371,123 12,736 53,889 1,434,939 82 
13 B 39 2,367,750 17,070 60,712 1,434,939 1,071 
14 A 47 7,879,612 13,385 167,651 4,470,511 60 
14 B 39 7,876,836 15,576 201,970 4,470,511 1,599 
15 A 34 1,101,538 20,574 32,398 271,706 28 
15 B 29 1,099,434 29,596 37,912 271,706 1,948 
16 A 11 201,041 6,651 18,276 76,999 1 
16 B 7 200,766 16,163 28,681 76,999 4,084 
17 A 44 2,375,102 9,181 53,980 653,222 34 
17 B 32 2,370,932 19,713 74,092 653,222 1,119 
18 A 20 298,590 7,860 14,930 82,183 63 
18 B 16 296,422 13,752 18,526 82,183 1,171 
19 A 26 759,115 14,055 29,197 187,300 77 
19 B 19 755,669 18,287 39,772 187,300 1,307 
X A 4 165,544 38,952 41,386 87,242 398 
X B 3 165,146 70,035 55,049 87,242 7,869 
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2.4  CNVs associated with behavior 
Each of the 764 CNVs detected by JaxMDGA was associated with different behavioral 
parameters using a generalized linear model. The resulting p-values are outlined in 
supplementary tables S12 to S16. Below, the result for the key parameter of each 
behavioral test is summarized.  
For the most important key parameter, the time animals spent on the open arm of the 
EPM, 55 CNVs were shown to be significantly associated (p < 0.05) with nominal p-values 
between 0.0005 and 0.0489. Another 35 CNVs showed a trend with values between 
0.0503 and 0.0993. However, significances got lost after applying Bonferroni correction. 
Therefore, only nominal significances were considered for further analysis. In Table IV-11 
all CNVs having a significant nominal p-value are outlined. Exemplarily for a significant 
p-value, a trend and none significance, three different CNVs associated with the time 
animals spent on the open arm of the EPM are depicted in Figure IV-26. There, the 
behavioral data of all 64 animals are plotted against the mean normalized intensities of all 
JaxMDGA probes in the respective CNV as an indicator for different copy numbers. 
Table IV-11: List of CNVs detected in 64 CD-1 mice that were significantly associated with the time 
animals spent on the open arm of the EPM. Significance (p < 0.05) was only reached with regard to 
nominal p-value. 
RegNo Chr Start End Size 
No. of 
probes 
in CNV 
nominal 
p-value 
p-value 
corrected 
9 1 52,348,330 52,357,761 9,431 3 0.0173 13.2277 
14 1 72,198,891 72,210,724 11,833 11 0.0048 3.6427 
52 1 183,060,113 183,072,518 12,405 24 0.0351 26.8540 
65 2 46,736,100 46,736,483 383 3 0.0457 34.9074 
106 2 147,572,128 147,572,911 783 5 0.0265 20.2351 
110 2 152,838,130 152,838,140 10 3 0.0447 34.1463 
113 2 158,641,258 158,643,203 1,945 5 0.0139 10.6138 
115 2 159,730,233 159,749,061 18,828 7 0.0297 22.7034 
123 3 15,340,258 15,819,607 479,349 47 0.0109 8.3530 
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RegNo Chr Start End Size 
No. of 
probes 
in CNV 
nominal 
p-value 
p-value 
corrected 
134 3 52,324,222 52,329,358 5,136 6 0.0131 9.9925 
137 3 75,378,209 75,414,973 36,764 15 0.0481 36.7160 
163 3 116,043,731 116,044,155 424 2 0.0457 34.9099 
165 3 116,765,381 116,765,393 12 3 0.0049 3.7257 
177 3 143,512,892 143,520,968 8,076 4 0.0144 10.9773 
179 4 6,095,005 6,095,833 828 2 0.0364 27.7772 
199 4 111,745,396 112,286,229 540,833 112 0.0338 25.8107 
200 4 112,348,832 113,968,233 1,619,401 160 0.0203 15.5093 
237 5 59,737,484 59,830,718 93,234 21 0.0331 25.3247 
245 5 79,306,300 79,320,284 13,984 5 0.0151 11.5637 
253 5 105,034,912 105,359,320 324,408 61 0.0236 18.0645 
254 5 105,511,760 105,511,768 8 3 0.0281 21.4800 
263 5 148,493,203 148,495,504 2,301 12 0.0368 28.1326 
265 6 8,041,854 8,049,012 7,158 12 0.0359 27.4472 
267 6 23,304,438 23,304,526 88 2 0.0351 26.8289 
302 6 107,165,345 107,215,744 50,399 14 0.0401 30.6273 
311 6 137,984,036 137,984,036 1 1 0.0024 1.8134 
312 6 138,231,553 138,237,439 5,886 11 0.0221 16.9189 
313 6 138,345,026 138,345,242 216 3 0.0056 4.2408 
317 6 139,939,182 139,950,758 11,576 9 0.0303 23.1715 
397 8 79,438,032 79,453,386 15,354 17 0.0088 6.6910 
401 8 80,806,213 80,834,051 27,838 15 0.0414 31.6039 
408 9 17,303,897 17,358,876 54,979 15 0.0374 28.5508 
442 10 72,164,250 72,231,618 67,368 11 0.0093 7.1281 
443 10 73,046,724 73,090,099 43,375 9 0.0286 21.8730 
463 11 33,359,372 33,375,067 15,695 4 0.0261 19.9380 
483 11 116,602,360 116,630,414 28,054 33 0.0089 6.8325 
486 12 11,545,659 11,610,212 64,553 13 0.0391 29.8354 
497 12 57,140,406 57,157,776 17,370 11 0.0039 3.0090 
498 12 57,366,059 57,387,621 21,562 8 0.0005 0.3516 
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RegNo Chr Start End Size 
No. of 
probes 
in CNV 
nominal 
p-value 
p-value 
corrected 
508 12 77,397,670 77,403,999 6,329 18 0.0489 37.3403 
516 12 100,077,912 100,080,008 2,096 7 0.0013 1.0050 
517 12 100,214,407 100,217,042 2,635 6 0.0034 2.5618 
518 12 102,582,454 102,828,642 246,188 96 0.0440 33.5929 
519 12 110,355,216 110,412,139 56,923 8 0.0456 34.8510 
561 13 73,546,675 73,574,553 27,878 11 0.0461 35.2310 
600 14 63,715,836 63,731,412 15,576 7 0.0317 24.1878 
607 14 78,207,014 78,207,745 731 3 0.0208 15.9274 
625 14 122,006,064 122,006,350 286 6 0.0375 28.6396 
636 15 29,502,036 29,545,764 43,728 18 0.0072 5.5338 
673 17 6,255,961 6,909,183 653,222 59 0.0012 0.8981 
695 17 45,324,397 45,349,233 24,836 10 0.0026 2.0003 
701 17 53,145,663 53,184,954 39,291 15 0.0464 35.4150 
731 18 74,681,698 74,696,062 14,364 9 0.0098 7.5124 
732 18 74,750,012 74,750,945 933 4 0.0114 8.6793 
733 18 75,257,879 75,261,870 3,991 6 0.0426 32.5340 
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Figure IV-26: Association of copy number with behavior. Each dot represents a single animal (N=64). 
On the x-axes the time animals spent on the open arm is plotted. The y-axes show the mean 
normalized intensities of JaxMDGA probes in the respective CNV, representing the relative copy 
number. (A) CNV no. 498 is shown as example for a region significantly associated with behavior 
(nominal p = 0.0005). Regression line: y = 0.0091x + 9.4389. (B) CNV no. 164 is depicted as example for 
a region with a trend in the association p-value (nominal p = 0.0509). Regression line: y = 0.0061x + 
10.201. (C) CNV no. 453 is shown as example for a region not significantly associated with behavior 
(nominal p = 0.9969). Regression line: y = 0.0008x + 9.6225. 
For the key parameter of the TST, the time animals were immobile, the nominal p-values 
reflected a trend in 43 CNVs and were significant in 25 CNVs, ranging from 0.0019 to 
0.0496. The time animals floated in the FST was significantly associated with 69 CNVs 
(nominal p-values between 0.0003 and 0.0492) and associated with a trend in 40 CNVs. 
35 CNVs could be significantly associated with the total distance the animals travelled in 
the OF with a minimum nominal p-value of 0.0023 and a maximum of 0.0494. Here, 28 
CNVs had nominal p-values less than 0.1 but greater than 0.05. Finally, for the SRT 
parameter “Cort increase” the association was shown to be nominal significant for 44 
CNVs with nominal p-values ranging from 0.0014 to 0.0497. For 51 CNVs a trend could be 
shown. 
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3  Candidate genes of anxiety-related behavior 
3.1  Candidate genes in HAB/LAB mice 
In total, 73 of 98 CNVs detected by aCGH, 101 of 180 CNVs detected by JaxMDGA and 
1,581 of 5,851 CNVs detected by NGS were shown to include at least one protein coding 
gene. Since CNVs were revealed as a potential influencing factor on gene expression in 
HAB/LAB mice (see chapter 1.5.3), all protein coding genes in regions where CNVs were 
detected are candidate genes that potentially influence the phenotypic expression of 
anxiety-related behavior. Out of 998 (aCGH), 145 (JaxMDGA) and 1,085 (NGS) genes, 
respectively, 68 were found to be the most promising candidates as they appeared in all 
three data sets obtained by the different CNV detection methods. The latter ones are 
listed in Table IV-12, the others in supplementary tables S17 to S19. 
Of special interest are those genes that did not only lay in regions where CNVs were 
detected in HAB/LAB, but also overlapped CNVs of CD-1 mice found to be associated with 
the time animals spent on the open arm of the EPM (see chapter 2.4). These 15 genes are 
outlined in Table IV-13. 
Table IV-12: Protein coding genes in CNVs detected by aCGH, JaxMDGA and NGS in 
HAB/LAB mice. The table shows all 68 genes found in data of all three detection methods, 
sorted by genomic position. 
Gene symbol MGI ID Chr Gene start Gene end 
Hmcn1 2685047 1 152,409,654 152,840,565 
Npl 1921341 1 155,350,146 155,396,844 
Sirpb1a 2444824 3 15,371,819 15,426,504 
Sirpb1b 3779828 3 15,495,754 15,575,065 
Sirpb1c 3807521 3 15,695,145 15,748,528 
Skint4 2444425 4 111,744,621 111,840,681 
Skint3 3045331 4 111,904,850 111,973,073 
Skint9 3045341 4 112,058,574 112,106,590 
Skint6 3649262 4 112,908,844 112,959,568 
Skint5 3650151 4 113,613,249 113,672,102 
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Gene symbol MGI ID Chr Gene start Gene end 
Skint11 2685415 4 113,835,989 113,917,633 
Gm3259 3781437 5 95,734,834 95,772,936 
Gm7963 3643214 5 95,854,546 95,857,656 
D5Ertd577e 1261918 5 95,885,825 95,914,583 
C230055K05Rik 2441896 5 105,242,188 105,288,830 
Vmn1r72 2182256 7 12,254,948 12,255,868 
Gm6605 3644762 7 39,231,315 39,237,190 
Gm5591 3648692 7 39,303,158 39,313,212 
Gm4454 3782638 7 39,351,859 39,356,187 
Gm1988 3780157 7 46,425,170 46,435,208 
Gm6124 3779556 7 46,474,468 46,480,344 
Gm16387 3646111 7 46,511,994 46,519,904 
Gm6833 3645553 7 46,562,898 46,572,951 
Dub2a 3051372 7 110,398,251 110,401,019 
Olfr597 3030431 7 110,468,915 110,469,874 
Olfr635 3030469 7 111,127,690 111,128,655 
Trim34-1 2137359 7 111,392,973 111,489,207 
Trim5 3646853 7 111,411,900 111,436,608 
Gm15134 3805550 7 111,448,744 111,485,423 
Trim12-2 4821183 7 111,487,268 111,501,876 
Olfr486 3030320 7 115,315,312 115,316,256 
Olfr487 3030321 7 115,355,097 115,356,041 
Tex24 1921539 8 28,454,866 28,459,659 
E030030I06Rik 2442914 10 21,833,938 21,868,629 
Raet1c 109431 10 21,878,375 22,093,945 
H60b 3649078 10 21,993,152 22,008,655 
Raet1d 1861032 10 22,082,077 22,093,945 
Iltifb 2151139 10 117,726,685 117,732,094 
Gm10480 3642435 12 18,223,364 18,224,634 
Gm9590 3779999 12 18,394,561 18,413,667 
5730507C01Rik 1917882 12 18,521,544 18,540,997 
Gm16948 4439872 12 114,849,395 114,849,828 
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Gene symbol MGI ID Chr Gene start Gene end 
Gm16999 4439923 12 115,272,016 115,272,487 
Gm16697 4439621 12 115,821,780 115,822,213 
Gm16746 4439670 12 117,100,078 117,100,511 
Gm16812 4439736 12 117,106,984 117,107,413 
Pde4d 99555 13 109,240,142 110,743,669 
Cdh12 109503 15 21,041,207 21,519,288 
Tcp10b 98542 17 13,253,977 13,275,092 
Gm10512 3642173 17 13,397,908 13,399,077 
Smok2a 1351487 17 13,414,054 13,420,524 
Smok2b 3037705 17 13,421,718 13,430,055 
Gm9880 3711246 17 13,547,438 13,569,717 
Btbd9 1916625 17 30,357,046 30,667,310 
Gm9874 3642006 17 30,622,456 30,622,908 
Glo1 95742 17 30,729,806 30,749,539 
1700097N02Rik 1914772 17 30,759,394 30,762,030 
Dnahc8 107714 17 30,763,936 31,012,209 
Gm9937 3642051 17 31,011,751 31,012,146 
Glp1r 99571 17 31,038,812 31,073,455 
H2-T22 95956 17 36,175,352 36,179,692 
H2-T9 95965 17 36,175,352 36,179,692 
Gm6034 3646212 17 36,179,906 36,195,590 
H2-T10 95942 17 36,254,035 36,258,389 
Gm10500 3641966 17 36,258,775 36,265,692 
Gm10499 3702919 17 36,278,703 36,282,868 
Mid1 1100537 X 166,123,131 166,428,730 
G530011O06Rik 3603513 X 166,412,975 166,416,849 
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Table IV-13: Protein coding genes in CNVs detected in HAB/LAB and CD-1 mice. Genes 
listed here were shown to be in regions where CNVs were detected in HAB/LAB mice by 
three different methods. The genes were also found to lay in CNVs detected in CD-1 mice 
that were associated with the time animals spent on the open arm of the EPM, with nominal 
p-values indicating significance or a trend. (* = nominal p-value < 0.05; ° = nominal 
p-value < 0.1. 
Gene symbol MGI ID Chr Gene start Gene end 
Sirpb1a* 2444824 3 15,371,819 15,426,504 
Sirpb1b* 3779828 3 15,495,754 15,575,065 
Sirpb1c* 3807521 3 15,695,145 15,748,528 
Skint4* 2444425 4 111,744,621 111,840,681 
Skint3* 3045331 4 111,904,850 111,973,073 
Skint9* 3045341 4 112,058,574 112,106,590 
Skint6* 3649262 4 112,908,844 112,959,568 
Skint5* 3650151 4 113,613,249 113,672,102 
Skint11* 2685415 4 113,835,989 113,917,633 
C230055K05Rik* 2441896 5 105,242,188 105,288,830 
Tcp10b° 98542 17 13,253,977 13,275,092 
Gm10512° 3642173 17 13,397,908 13,399,077 
Smok2a° 1351487 17 13,414,054 13,420,524 
Smok2b° 3037705 17 13,421,718 13,430,055 
Gm9880° 3711246 17 13,547,438 13,569,717 
 
3.2  Candidate genes in CD-1 mice 
All protein coding genes that were in regions where CNVs associated with any behavioral 
parameter were revealed are of potential interest for further studies. Here, the focus is 
on the genes in CNVs that were significantly associated (i.e. nominal p < 0.05) with the 
time animals spent on the open arm of the EPM (see chapter 2.4). These 53 genes are 
listed in Table IV-14. Considering all 764 CNVs, a total amount of 911 protein coding 
genes was found to overlap with 389 of them. These genes are outlined in supplementary 
table S20. 
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Table IV-14: Protein coding genes in CNVs detected by JaxMDGA in 64 CD-1 mice. The symbols, 
MGI IDs and genomic positions of the genes are shown. The last column includes the number of 
the respective CNV the gene is overlapping with (for details on CNV position see chapter 2.3). If 
more than one CNV number is mentioned, the gene comprises a genomic region with multiple 
CNVs. 
Gene symbol MGI ID Chr Gene start Gene end CNV no. 
Mreg 2151839 1 72,206,020 72,258,881 14 
Nvl 1914709 1 183,023,554 183,074,288 52 
Pdrg1 1915809 2 152,834,626 152,841,163 110 
Dhx35 1918965 2 158,620,543 158,683,950 113 
Sirpb1a 2444824 3 15,371,819 15,426,504 123 
Sirpb1b 3779828 3 15,495,754 15,575,065 123 
Sirpb1c 3807521 3 15,695,145 15,748,528 123 
Serpini1 1194506 3 75,361,469 75,447,417 137 
Cdc14a 2442676 3 115,975,471 116,126,950 163 
Skint4 2444425 4 111,744,621 111,840,681 199 
Skint3 3045331 4 111,904,850 111,973,073 199 
Skint9 3045341 4 112,058,574 112,106,590 199 
Skint2 3649629 4 112,286,202 112,320,445 199 
Skint10 2685416 4 112,383,752 112,447,471 200 
Skint6 3649262 4 112,908,844 112,959,568 200 
Skint5 3650151 4 113,613,249 113,672,102 200 
Skint11 2685415 4 113,835,989 113,917,633 200 
C230055K05Rik 2441896 5 105,242,188 105,288,830 253 
Gbp9 3605620 5 105,508,317 105,539,297 254 
Flt1 95558 5 148,373,180 148,537,587 263 
Col28a1 2685312 6 7,947,808 8,142,617 265 
Cadps2 2443963 6 23,212,773 23,789,420 267 
Slc15a5 3607714 6 137,932,107 138,021,717 311 
Lmo3 102810 6 138,311,439 138,530,489 313 
Plcz1 2150308 6 139,938,197 139,989,978 316 
Nr3c2 99459 8 79,423,341 79,768,911 397 
Ttc29 1920551 8 80,737,196 80,918,225 401 
Pcdh15 1891428 10 72,562,090 74,112,482 443 
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Gene symbol MGI ID Chr Gene start Gene end CNV no. 
Ranbp17 1929706 11 33,111,795 33,413,746 463 
Gm11735 3713525 11 116,599,248 116,611,242 483 
BC018473 3039625 11 116,613,481 116,620,687 483 
St6galnac1 1341826 11 116,626,339 116,636,821 483 
Mthfd1 1342005 12 77,356,395 77,420,789 508 
Eml5 2442513 12 100,024,814 100,139,694 516 
Ttc8 1923510 12 100,158,784 100,221,448 517 
Catsperb 2443988 12 102,642,892 102,864,160 518 
Dock9 106321 14 121,941,261 122,097,639 625 
Tmem181a 1924356 17 6,270,475 6,305,783 673 
Gm2792 3780960 17 6,407,216 6,410,679 673 
Dynlt1b 98643 17 6,429,260 6,435,444 673 
Gm2802 3780971 17 6,491,318 6,493,657 673 
Gm2808 3780977 17 6,506,579 6,582,263 673 
Dynlt1f 3780996 17 6,600,835 6,609,656 673 
Dynlt1c 3807476 17 6,646,959 6,655,064 673 
Gm2833 3781005 17 6,658,217 6,679,001 673 
Gm2827 3780999 17 6,661,442 6,672,834 673 
Gm2839 3781011 17 6,753,404 6,803,325 673 
Dynlt1d 3781039 17 6,797,760 6,818,159 673 
Dynlt1e 3781053 17 6,851,795 6,860,617 673 
Gm2867 3781044 17 6,874,264 6,878,036 673 
Sytl3 1933367 17 6,877,808 6,942,391 673 
Myo5b 106598 18 74,600,590 74,931,147 731, 732 
Dym 1918480 18 75,178,426 75,446,620 733 
 
3.3  Identified clusters in the candidate genes 
The list of 15 candidate genes, defined in HAB/LAB mice by comparing the CNV data of 
three different detection methods with the above mentioned candidate genes of the 
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CD-1 mice, was submitted to the DAVID Bioinformatics Database 
(http://david.abcc.ncifcrf.gov) for functional annotation clustering. Thus, two significant 
cluster could be identified that could be linked to the immune system and to signal 
transduction, respectively. The genes involved in these clusters are outlined in 
Table IV-15. 
Table IV-15: Identified clusters in 15 candidate genes of anxiety-related behavior in HAB/LAB mice. 
Genes were determined comparing their genomic position with the position of CNVs detected in 
HAB/LAB mice by three different methods and afterwards with the position of CNVs in CD-1 mice 
associated with anxiety-related behavior. Clusters were detected using the functional annotation tool 
of the DAVID Bioinformatics Database. Genes are sorted in alphabetical order. 
Cluster 
Enrichment 
score 
No. of genes in 
cluster 
Symbols of genes in cluster 
„Immune 
system“ 
2.21 10 
Sirpb1a, Sirpb1c, Skint3, 
Skint4, Skint5, Skint6, Skint9, 
Skint11, Tcp10b, 
Tcp10c (= Gm9880) 
„Signal 
transduction“ 
1.56 4 
Smok2a, Smok2b, 
Tcp10b, Tcp10c (= Gm9880) 
 
The same analysis was performed for the 53 candidate genes that were shown to overlap 
with CNVs associated with anxiety-related behavior in CD-1 mice (see chapter 3.2). Here 
again, two significantly enriched gene clusters with enrichment scores > 1.3 were 
identified (Table IV-16). The first cluster was named “Signal transduction“, since the 3 
genes embraced in that cluster are all involved in processes mediating signaling. The 
second significantly enriched cluster comprises 26 genes, which can be connected to the 
immune system. 
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Table IV-16: Identified clusters in 53 candidate genes of anxiety-related behavior in CD-1 mice. 
Genes were determined comparing their genomic position with the position of CNVs in CD-1 mice 
associated with anxiety-related behavior. Clusters were detected using the functional annotation tool 
of the DAVID Bioinformatics Database. Genes are sorted in alphabetical order. 
Cluster 
Enrichment 
score 
No. of genes in 
cluster 
Symbols of genes in cluster 
„Signal 
transduction“ 
2.09 3 Dock9, Ranbp17, Sytl3 
„Immune 
system“ 
1.95 26 
Cadps2, Catsperb, Col28a1, 
Dock9, Flt1, Gm11735, Mreg, 
Nr3c2, Pcdh15, Ranbp17, 
Serpini1, Sirpb1a, Sirpb1c, 
Skint10, Skint11, Skint2, 
Skint3, Skint4, Skint5, Skint6, 
Skint9, Slc15a5, St6galnac1, 
Sytl3, Tmem181a, Ttc8 
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V  Discussion 
1  The detection of CNVs 
Multiple methods have been developed recently to detect CNVs either in a genome-wide 
approach or at specific loci. But still, the CNV detection remains a challenging task since 
the results depend not only on the method used but also on the algorithm applied on the 
data and no “gold standard” algorithm has been established so far (Alkan et al., 2011; 
Pinto et al., 2011; van de Wiel et al., 2010; Warden et al., 2011; Zhang et al., 2011). That 
is why in the current study three different methods, two probe-based high-density 
genotyping arrays (aCGH, JaxMDGA) and one whole-genome sequencing approach (NGS), 
were used to detect CNVs in the HAB/LAB mouse model to overcome the limitations of a 
single approach and thus increase the reliability of the data. In total, four different 
methods to reveal CNVs in the genome of HAB/LAB or CD-1 mice have been employed. As 
previously mentioned, aCGH, JaxMDGA and NGS were used for screening the genome of 
HAB/LAB mice, while JaxMDGA was used to examine the genome of CD-1 mice as well. 
Additionally, another test screening specific loci (MLPA) was performed. One LAB and one 
HAB animal were also tested in that approach to serve as reference and positive control 
samples, respectively. 
1.1  CNVs in the HAB/LAB mouse model 
For CNV detection by means of aCGH, the DNA was purified from two HAB and LAB mice 
each. It was extracted from tail tips of all four individuals, as well as from brain tissue of 
just one HAB and LAB mouse, respectively. Thus, three independent data sets were 
generated. The results of the different data sets, i.e. the probes’ log2 ratios of 
measurement values from the HAB against the LAB samples, were compared to each 
other. A very high level of concordance was observed in the data gathered from tail tissue 
of both HAB/LAB mouse pairs, indicating that the animals of one mouse line did not show 
differences in their genome with respect to CNVs. Since the mouse lines were bred for 
over 40 generations and thus, feature a high inbreeding factor, this outcome was not 
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surprising and confirms a high degree of genetic homogeneity among the individuals of 
one line. The DNA extracted from different tissues did also not display diverging variation, 
which was again expected since copy number dependency on tissue was described before 
only for mitochondrial (Fuke et al., 2011), but not genomic DNA. However, since DNA of 
only two animal pairs and two tissues were compared, further studies should be 
conducted to clearly show the extent of variation between the individuals of a single 
breeding line. 
As mentioned above, the definition of CNV breakpoints strongly depends on the 
algorithm applied. There are multiple algorithms available for analyzing aCGH data 
(Benelli et al., 2010; Cahan et al., 2008; Picard et al., 2005; van de Wiel et al., 2010), each 
having advantages and disadvantages. In order to simplify the processing, Peter Park and 
others (Lai et al., 2008) developed the CGHweb online tool to analyze aCGH raw data with 
multiple algorithms simultaneously. However, in this study it was refrained from applying 
several algorithms since CNVs were confirmed by two additional techniques. Thus, just 
the segMNT algorithm was applied on the aCGH data, recommended and performed by 
NimbleGen, the array-providing company. 
In total, 98 CNVs have been detected in HAB/LAB mice by means of aCGH, covering about 
3.7% of the genome, with 52% of the CNVs being larger than 500 kbp, about 32% differing 
in size between 50 and 500 kbp and none being smaller than 5 kbp. It is difficult to 
estimate the reliability of these findings, since only a few studies were published 
comparing CNVs in different mouse lines based on aCGH data. These studies mainly 
detected CNVs between different mouse strains and there the occurrence of variants is 
supposed to be enlarged compared to those found in two individuals of distinct lines that 
were bred based on the same mouse strain like HAB/LAB (Cutler et al., 2007; Graubert et 
al., 2007). Besides, in the published literature there is not always a clear distinction drawn 
between segmental duplications and CNVs, which makes comparisons more difficult. 
However, the size range of detected CNVs from some thousands to several mega 
basepairs was similar in all studies using aCGH (Cutler et al., 2007; Graubert et al., 2007; 
Henrichsen et al., 2009a; Henrichsen et al., 2009b), and is thus in concordance with the 
size range of CNVs found in HAB/LAB mice. 
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The second detection method, JaxMDGA, resembled the first in also being a high-density 
genotyping array. However, it provided a greater coverage than the first array. Analogues 
to the aCGH analysis, multiple algorithms were available for the processing of raw data 
(Banerjee et al., 2011; Teo et al., 2011; van de Wiel et al., 2010; Wang et al., 2007; 
Winchester and Ragoussis, 2012; Zhang et al., 2011). However, the application of those 
was desisted, since here again, the validation should occur by the implementation of the 
other detection methods, aCGH and NGS. Thus, the CNV data were generated just by 
means of one algorithm, which was included in the R package provided by the Jackson 
Laboratory (Yang, 2010).  
In contrast to the results of the aCGH assay, the analysis of JaxMDGA data revealed in 
total more variable regions (180) but none of them was shown to be on the 
Y chromosome. Missing CNVs on the Y  chromosome might be explained by the fact that 
only the first 16.6% of that chromosome were covered by probes of the JaxMDGA chip, 
since for the rest of the chromosome no “chippable” probes according to stringent 
selection criteria could be defined and thus added to the chip by the supplier (Yang et al., 
2009). Consequently, if CNVs would occur in the remaining 83.4% of the chromosome 
they would not be detected. The size of all CNVs summed up comprised just about 0.6% 
of the genome as the single regions were smaller than those found by aCGH, with only 
about 1% exceeding 500 kbp, nearly 17% ranging in size between 50 and 500 kbp and 40% 
being smaller than 5 kbp. It remains to be clarified, which of the data reflect the real 
situation in the animals more effective. According to a current study of Pinto and 
colleagues (Pinto et al., 2011) the results of the JaxMDGA analysis should yield more 
accurate data, not only because of the increased resolution due to the higher number of 
probes on the chip, but also since a better individual probe performance was shown. 
However, these are not the only aspects to be considered, since the choice of the 
computational method could also strongly influence the outcome (Pinto et al., 2011). 
Since all array probes were designed based on the C57BL/6J mouse strain it could happen 
that for a specific region of the CD-1 mouse strain-based HAB/LAB genome the binding 
probability of distinct probes is reduced due to changes in the nucleotide sequence. 
Depending of the algorithm applied on the raw data, this reduced probe binding might be 
wrongly detected as a change in copy number or not. Additionally, since different probes 
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were used in aCGH and JaxMDGA, the binding probability might be reduced in probes of 
just one of the two arrays. In consequence, an evaluation of the two created data sets 
remains difficult. Hence a third experiment, the NGS, was performed to encircle the 
position of CNVs in the HAB/LAB mouse genome. 
Even though NGS has a great potential and is clearly the most sophisticated 
whole-genome sequencing approach existing to date, the thereby generated data do not 
answer the claim for completeness. Besides the unavoidable technical-induced variance 
that exists for each experimental setup, problems might have been occurred during the 
alignment of the single reads derived from HAB/LAB mice (having the genomic 
background of the CD-1 mouse strain) against the reference genome, which is the 
commonly used genome of the C57BL/6J mouse strain. Thus, DNA segments not existing 
in the reference genome could get lost since the respective reads could not be aligned. 
For sequences with slight differences to the reference genome, specific reads might not 
have passed the alignment threshold and therefore the coverage at some positions could 
be reduced and with it the reliability of the data at the respective position. Furthermore, 
the performance of a complex computational analysis was necessary to gather the final 
CNV positions, in which several variables, such as the bin size or the number of allowed 
mismatches had to be estimated. Although the calculation was done to best knowledge, 
false positive or negative findings are likely to occur also in the CNV data generated by 
NGS. 
A total of 5,851 CNVs were detected by means of NGS. Their mean size was much smaller 
than the one of variants detected by other methods. About 83% of the variable regions 
were shown to be smaller than 5 kbp, while 0.7% ranged in size between 50 and 500 kbp 
and none exceeded 500 kbp. Nonetheless, in considering the total size, they covered 
about 1.03% of the whole genome, which is in between the coverage of JaxMDGA- (0.6%) 
and aCGH-defined CNVs (3.7%). 
Considering the pitfalls of all performed assays, it seems likely that the real number and 
size of the CNVs indeed existing in HAB and LAB mice is somewhere in between the ones 
discovered. One way to define the real breakpoints of the variants could be to estimate 
their exact position by means of qPCR and follow-up PCR as it was done for the Glo1 locus 
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by Williams and colleagues (Williams et al., 2009), and finally use Sanger sequencing to 
uncover the sequence of the region. However, if data gathered from three different 
detection methods point to the same region to vary, this region might already be 
accepted as a present CNV. 
The sum of all basepairs overlapping between CNVs defined by the three applied 
detection methods exceeded 4.8 Mbp. This reflects about 0.18% of the whole genome 
and thus a relatively large part of it. For comparison only, HAB/LAB mice were estimated 
to harbor about 800,000 SNPs, which reflects nearly 0.03% of the genome (Ludwig 
Czibere, personal communication). Considering their relatively large extent alone, it 
seems likely that they affect the expression of several genes, directly by gene dosage 
alteration or indirectly (see chapter II-6) and thus contribute to the distinct phenotypes of 
HAB and LAB mice. 
1.2  CNVs in CD-1 mice 
The detection of CNVs in 64 CD-1 mice by JaxMDGA appeared to be more challenging 
than the examination in HAB/LAB mice using the same method, since a completely new 
determination approach had to be proposed to discover the variants as discussed below. 
In contrast to the detection of SNP data, where each probe provides an absolute signal 
indicating the presence or absence of a specific basepair, the probe signals for CNV 
detection need to be set in relation to a reference. To date, there is no commonly 
available algorithm that would be easily applicable on the raw data of a flexible number 
of array runs, to analyze the data with respect to each other. Therefore, the same 
function (“simpleCNV”) used before to detect HAB/LAB mouse CNVs had to be 
implemented (Yang, 2010). This led to the first problem, the definition of the reference 
sample, since in contrast to the study of HAB/LAB mouse DNA, multiple animals of 
variable phenotypes had to be examined. If just one of the animals had been chosen to 
serve as reference sample, information on variable positions between two separate 
animals might have gotten lost, as explained in more detail in chapter III-4.2.1.2 
(Figure III-10). For this reason, the raw data of each animal were separately compared to 
the raw data of each other animal tested in the approach. The outcome of that multiple 
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application of the “simple CNV” function was a list of all regions assumed to harbor CNVs 
in any of the tested pairs. In the next step, overlapping regions were defined as one, with 
breakpoints as far away from each other as possible (Figure III-11). That “strategy of the 
largest size” was chosen since, in case of one pair of animals showing a CNV of 
remarkable smaller size at the specific locus than all the other pair-wise comparisons, the 
opposite strategy would not only clearly underestimate the extent of the CNV but also 
could in worst case (e.g., if the region would comprise just a few probes) lead to an 
increased false-positive rate, obtained by the subsequent calculation. Of course, similar 
problems might occur by using the strategy applied, but in this particular case the 
subsequent calculation would lead to an increased false-negative rate, which can be 
accepted since it increases the reliability of the detected CNVs. After the new breakpoint 
definition the recalculation of the respective intensity values as a measurement 
parameter of the copy number had to be performed. These intensities were required for 
the successive association of CNVs with the animals’ behavior. 
Using the procedure described above, 764 CNVs were detected, of which about 2% 
exceeded 500 kbp, around 18% were in a size range of 50 to 500 kbp and 34% appeared 
to be smaller than 5 kbp. The size distribution is in concordance to the one found in 
HAB/LAB mice by the same method (i.e. JaxMDGA), and hence does not differ from the 
expectation. Here, the CNVs covered about 5.2% of the genome. Even though that is 
10-fold more than the same method revealed in HAB/LAB mice, it seems to be acceptable 
since not only two inbred but 64 outbred animals were compared and not all of the CNVs 
were found in each sample-reference pair. Here again, no variants were detected on the 
Y chromosome, which could be explained as above, that is, by the fact that the JaxMDGA 
probes cover only the first part of the chromosome. 
MLPA, a second method to screen for CNVs associated with behavior in CD-1 mice was 
used with the intention of confirming the findings of the JaxMDGA approach for specific 
regions. Unfortunately, the probes for the MLPA experiment had to be designed based on 
preliminary data, but the final CNV data determined by JaxMDGA differed remarkably. As 
a consequence, none of the regions reviewed by MLPA showed significant association 
with anxiety-related behavior according to the final JaxMDGA data. However, 12 of 33 
MLPA probes mapped to CNVs showing a trend in the nominal association p-values. In 
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order to test the reliability of measurement values of MLPA probes with respect to the 
JaxMDGA data (HAB/LAB) a HAB sample was included in the analysis. Thereby, the results 
of 18 probes could be confirmed. However, as long as the definite breakpoints of the 
HAB/LAB mouse CNVs are not verified, this cannot be an absolute confirmation of 
reliability, since data gathered from aCGH and NGS might show different results. Besides, 
it needs to be considered that there is a bias in the detection of CNVs between different 
CD-1 mice since measurements of a single individual had to be analyzed with respect to 
the reference sample, which was a LAB animal. Therefore, existing differences between 
CD-1 animals might be masked. However, the findings of the JaxMDGA (CD-1) approach 
could be confirmed by 19 of 33 probes targeting 11 CNVs. The analysis of three probes 
(no. 14, 15 and 21) did hint towards an association of the respective CNV with the 
animals’ behavior on the EPM. Since animals used for MLPA were different from those 
tested in JaxMDGA and they showed more extreme behavior, these regions indeed could 
be of interest for further analyses, even though they were not occurring in the 
JaxMDGA-detected CNVs associated with behavior. But, as long as the functionality of the 
probes is not approved and since the analysis software warned of less DNA amount used 
in the MLPA PCR run, the MLPA results need to be considered with caution. 
2  The contribution of CNVs to phenotypic variation 
A study published some years ago concluded that common CNVs that can be typed on 
existing platforms are unlikely to have a major role in the genetic basis of human diseases 
(Wellcome Trust Case Control Consortium, 2010). However, this conclusion has to be 
considered with caution since it was drawn from a genome-wide association study. 
Although GWAS are commonly used as a powerful tool to examine the genetics of 
complex traits, Lee and colleagues claimed that their design is better poised to detect 
common variants of common diseases (Lee et al., 2012). Hence, the genetic architecture 
of complex diseases and phenotypes that consists of multiple rare variants of modest 
effect, seems to be difficult to detect by GWAS (Lee et al., 2012; McClellan et al., 2007). 
Therefore, CNVs should not be neglected as contributors to complex phenotypes like 
anxiety (Gamazon et al., 2011). 
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There are multiple molecular mechanisms conceivable to explain how CNVs and other SVs 
might contribute to respective phenotypes and diseases. Some of the effects are more 
evident than others, like the change of gene dosage by the alteration of copy number 
(Lupski et al., 1992), while others are of more complex nature. CNVs might also convey 
the effects even when they do not harbor any coding region, for instance by the 
duplication or deletion of regulatory elements. Enhancers and repressors were shown to 
act as cis-regulatory domains even though they extend long distances outside the gene 
(Kleinjan and van Heyningen, 2005) and hence CNVs could regulate the transcription of 
genes far outside their breakpoints. Furthermore, CNVs could also mediate their effects 
by physically impairing the access of the genes to the transcription machinery or by 
influencing transvection (Henrichsen et al., 2009a; Stankiewicz and Lupski, 2010; Wu and 
Morris, 1999). In this study, the focus is on the influence of CNVs on the expression of 
genes located inside the variant regions. Further studies are supposed to examine the 
remaining effects mentioned above. 
2.1  The influence of CNVs on expression levels in HAB/LAB mice 
About 25% of all autosomal genes were shown to overlap with CNVs in mice (Henrichsen 
et al., 2009b) and therefore a considerable contribution of this type of variation on the 
gene products, i.e. the expression level, is to be expected. Effects of CNVs on expression 
levels have previously been reported with a positive correlation in some cases and a 
negative in others (Cahan et al., 2009; Stranger et al., 2007; Williams et al., 2009). As a 
first step to test for the impact of CNVs on gene expression in HAB/LAB mice, a 
reappraisal of a previously conducted expression microarray experiment (Czibere, 2008; 
Czibere et al., 2011) was performed. The expression differences between HAB and LAB 
animals were newly generated as better computational approaches have been developed 
since the array was analyzed for the first time. Moreover, for better comparability, the 
data sets of expression values and CNVs should refer to the most actual version of the 
mouse genome, which was UCSC mm9 in terms of CNVs, while formerly generated 
expression data referred to version mm8 and thus had to be updated. In total, 374 
protein coding genes were found to be significantly differentially expressed in at least one 
of the four tested brain regions. Of those genes, 12 were carefully chosen to be validated 
V Discussion 
113 
by qPCR based on two selection criteria. First, they had to feature different expression 
levels as indicated by microarray results and second, they should be part of a functional 
protein association network, shown by means of the STRING online software. Most of the 
qPCR results confirmed the expression differences detected by means of the expression 
microarray (see Table IV-6), thereby emphasizing the reliability of the data created by the 
array. The reasons for potential problems occurring during the microarray performance, 
the qPCR process and the probe design leading to contradictory outcome of the two 
methods are manifold and are not discussed here, since the focus of this study is on the 
functional impact of CNVs and a discourse about limitations of methods to detect 
expression differences would go beyond the scope of this dissertation. These topics have 
already been in the focus of multiple studies and were discussed in recent publications 
(Roberts, 2008; Vagner et al., 2013). 
The correlation procedure of CNVs with the expression profile in HAB/LAB mice was done 
in two separate steps. First, the influence of CNVs on expression was tested by the 
application of a two-proportion z-test. For all analyzed brain regions (CeA, BLA, Cg, PVN) it 
was demonstrated that a significant amount of genes showing expression differences 
were hosted in regions of genomic variance, with p-values up to 1.76 x 10-64. Thus, the 
evidence of CNVs being able to regulate the expression of genes located inside their 
breakpoints was adduced. The second step focused on the question if an elevated copy 
number entailed an increase, and a decreased copy number a decline in expression levels, 
respectively. For CeA, Cg and PVN, but not for BLA a significant positive correlation was 
shown with respect to the nominal p-values (Pearson’s product-moment correlation). In 
contrast, the Bonferroni corrected p-values were not significant for any of the four brain 
regions. This outcome is in concordance with a previous study showing only a weakly 
significant correlation between gene dosage and relative expression levels (Henrichsen et 
al., 2009b) and could be explained by the CNVs’ modes of action themselves (as outlined 
in chapter II-6), for instance by a negative feedback loop. Besides, several environmental 
and genetic factors like SNPs, epigenetic factors and others are known to influence gene 
expression and thereby might interfere with the effects mediated by CNVs. 
Even though the most simple conclusion, namely that more gene copies reflect more 
gene expression and vice versa, cannot be drawn, the convincing p-values of the applied 
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z-test make clear that CNVs have to be considered as a serious influencing factor of gene 
expression and hence phenotypic variations. Therefore, it seems worthwhile to focus on 
CNVs and their influence on phenotypic behavior in further studies of the HAB/LAB 
mouse model. 
2.2  A breeding approach to examine the impact of a single CNV 
comprising the Glo1 locus on anxiety-related behavior 
The idea of the breeding approach was to breed animals having the full genetic 
background of HAB mice, with exception of one locus harboring a LAB-specific CNV. The 
advantage of a breeding approach over biotechnological methods is the conservation of 
potential genetic linkage of the CNV. To go for the CNV comprising the Glo1 and the 
Dnahc8 locus was decided since Glo1 was shown before to be linked to anxiety and 
depression (Hovatta et al., 2005; Tanna et al., 1989; Williams et al., 2009) and was 
previously detected as a candidate gene in the HAB/LAB mouse model (Hambsch et al., 
2010; Kromer et al., 2005; Landgraf et al., 2007). The HAB- and LAB-specific loci could be 
easily discriminated by means of a PCR analysis using primers targeting the breakpoints of 
the CNV that induced a specific product only if more than one copy of the locus was 
present, which was just the case for the LAB-specific locus. 
Animals of the sixth breeding generation, having a calculated similarity coefficient to HAB 
mice of about 0.98, were considered to have sufficient HAB-specific genetic background 
to develop the high-anxious phenotype, and therefore to examine potential effects of the 
CNV. If the CNV would contribute remarkably to the phenotype, the animals harboring 
the LAB-specific locus were expected to behave less anxious than those with the 
HAB-specific locus. In none of the analyzed parameters of the four performed behavioral 
tests (EPM, OF, FST, TST) a significant difference could be found, indicating that the 
examined CNV alone is not causing a modification of anxiety-related behavior. But that 
does not mean that the duplicated region has no effect at all. Following the idea of the 
formerly described Two Hit Model (Canales and Walz, 2011; Girirajan and Eichler, 2010; 
Girirajan et al., 2010) it might be that the CNV (“first hit”) does only influence the 
phenotype if a “second hit” occurs, for instance another CNV or any other genetic factor. 
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Furthermore, it has to be considered that the phenotyped animals, that were shown to 
harbor the LAB-specific CNV, were heterozygous for that locus, since half of their genome 
was inherited from a HAB individual. Therefore, it remains possible that the effect 
mediated by the LAB-specific allele is masked by the HAB-specific one. Hence, in a follow 
up study, the animals of the next generation should be bred by intercrossing mice from 
the 6th generation to generate individuals homozygous for the CNV locus (HAB- or 
LAB-specific), which should subsequently be analyzed for differences in their behavioral 
patterns. 
The breeding approach could not only reveal a potential influence of the examined CNV, 
it could additionally be used to test if the phenotype of the HAB mouse line can be 
sustained, even though intercrossed with the LAB line in one generation. For that 
purpose, the time animals spent on the open arms of the EPM (the behavioral parameter 
the HAB/LAB mouse lines are bred based on) was compared between animals harboring 
the HAB-specific and LAB-specific locus, respectively. The behavior of animals with the 
most HAB-like genetic background (i.e. mice with the HAB-specific locus) was observed to 
be in the same range as the behavior of HAB mice, which usually spend about 10 to 20 
seconds on the open arms (Figure IV-19A and Figure II-1). Thus, the approach emphasizes 
the stability of the lineage specific phenotype of HAB animals. 
2.3  The effect of CNVs on anxiety-related behavior in CD-1 mice 
By means of the JaxMDGA 764 CNVs could be detected in 64 CD-1 mice, as discussed in 
chapter 1.2. The aim of the subsequent analysis was to find those CNVs that affect the 
anxiety-related behavior in these mice. For this purpose, the variable regions were 
correlated with different behavioral parameters. But before that correlation could be 
performed, the problem of defining the respective copy number status, i.e. the amount of 
copies of a single CNV in all animals with respect to each other, had to be solved. Thus, as 
first step, the “simple CNV” function of the “MouseDivGeno” R package was modified to 
achieve the normalized intensities of each JaxMDGA probe (outlined in supplementary 
report S5). Then all intensity values of the probes falling into a newly defined CNV were 
averaged. The resulting mean intensity values were used as measurement variable of the 
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relative copy number of the respective region. Finally, these values were associated with 
multiple behavioral parameters in a statistical approach using a generalized linear model. 
The most important parameter was the time the animals spent on the open arm of the 
EPM, for which a total of 55 CNVs were shown to be significantly associated with when 
only considering the nominal p-value (nominal p-value < 0.05). Other 35 CNVs still 
exhibited a trend in the nominal p-value (p < 0.1). The key parameter of the EPM was 
termed as more important than that of other behavioral tests since the HAB/LAB 
breeding is based on, enabling a comparison of CNVs found to be associated in CD-1 mice 
to those detected in HAB/LAB mice. Nevertheless, other tests were performed and 
statistically analyzed, in order to complete the picture and provide the basis for further 
studies. Here only the results for the respective key parameters showing nominal p-values 
that reach significance (p < 0.05) are mentioned, with 25 CNVs for the time immobile in 
the TST, 69 CNVs for the floating time in the FST, 35 CNVs for the distance travelled in the 
OF, and 44 CNVs for the Cort increase in the SRT. However, all significances got lost after 
the application of Bonferroni correction. But does that mean that the effect of CNVs on 
anxiety-related behavior is negligible? 
The answer is a clear “no”. Considering the full spectrum of literature available, there 
should be no doubt that anxiety is induced by complex molecular mechanisms that in turn 
are influenced by multiple genetic and environmental factors. It was postulated before 
that the heritability of complex traits is not likely due to some single genes but to multiple 
genes of small effect size (Plomin et al., 2009). Thus, specific genes and genetic factors in 
and of itself might be less strongly associated with complex traits and diseases than 
particular patterns of genetic variation and environmental interaction (Rucker et al., 
2011). Not including at least parts of the patterns when analyzing the influence of a single 
factor to complex behavior might easily lead to p-values not reaching significance, which 
does not necessarily signify that the single factor per se is irrelevant. Therefore, future 
studies should focus on the revelation of the variation patterns. In concordance to this 
claim, the authors of a current review postulated that “the implication of CNV on [human] 
health will have to wait several large-scale correlation studies not only with one CNV but 
also with permutations and combinations of various likely [genetic and environmental] 
variations” (Almal and Padh, 2012). To date, more complex calculations of associations 
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including all or at least most of the possible influencing factors are not feasible since the 
number of these factors pushes the physical limits of calculable capacity. Recently, 
computational methods were developed mapping phenotypes not just to single loci in the 
genome but to pairs of genetic loci, thereby systematically searching for epistatic 
interactions (Kam-Thong et al., 2012; 2011). Even though these methods are heading in 
the right direction, it will take several years until more complex patterns than just two 
interacting factors can be calculated in a cost- and time-effective manner. By then, 
research is constrained to the available methods and should aim for collecting as many 
information on influencing factors of complex traits as possible. In consequence, the goal 
of the here performed association study was to detect the CNVs that are most likely to 
contribute to the phenotype and not to prove their contribution per se. Therefore, even 
though significances of p-values got lost after correction, the CNVs with a significant 
nominal p-value could be accepted as interesting candidates affecting anxiety-related 
behavior. The fact that CNVs can indeed contribute to phenotypic variation was 
previously shown by others (e.g., Malhotra and Sebat, 2012) as well as in the current 
study of CNVs in the HAB/LAB mouse model as described above (chapter 2.1). 
3  Candidate genes of anxiety-related behavior 
3.1  Candidate genes in the HAB/LAB mouse model 
CNVs were shown to alter gene expression in HAB/LAB mice, as discussed above 
(chapter 2.1). At least to some extent this effect is mediated by changes in copy number 
of the protein coding genes themselves. Therefore, the CNVs defined by three different 
detection methods were checked for harboring genes, using a list of all known mouse 
genes referring to NCBI build m37. For the 98 CNVs revealed by aCGH 998 genes were 
found to map into. Even though more CNVs were detected by JaxMDGA, fewer genes 
(145) overlapped these regions, which is in concordance with the fact that the total size 
of the CNVs was smaller as well (~ 27 Mbp against ~ 97 Mbp). The total size of the 
variants detected by NGS (~ 15 Mbp) was more similar to the one revealed by JaxMDGA, 
however the number of genes found in these CNVs resembled with 1,085 the amount of 
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genes overlapping the aCGH-detected CNVs. Even though it is likely that the size of the 
variants is overestimated by aCGH and maybe underestimated by NGS, the true situation 
of genomic variation is difficult to assess and therewith the definition of candidate genes. 
However, if genes mapped into regions where CNVs were revealed by all three methods, 
they were considered to be reliable candidates of influencing the behavior in HAB/LAB 
mice. That condition was fulfilled by 68 genes. 
Besides the limitations in detection methods, another factor has to be considered when 
defining candidate genes. Due to a population bottleneck effect that potentially occurred 
by choosing a restricted proportion of the CD-1 mouse population as basis for the 
HAB/LAB mouse model and by the subsequent inbreeding protocol, some of the genetic 
variants emerging between the HAB and LAB mouse lines might have been established by 
chance and do not contribute to the phenotypical expression. Therefore, the 
68 candidate genes were compared to the genes that mapped into CNVs of 64 CD-1 mice 
showing a significant association with the time the animals spent on the open arms of the 
EPM. In doing so, the list of candidate genes was further narrowed down to 15 genes. 
These 15 candidate genes were analyzed for functional annotation my means of the 
software tool provided at the DAVID Bioinformatics Database (da Huang et al., 2009a; 
2009b). 
The resulting two clusters were related to the immune system and to signal transduction, 
respectively. It is not a new finding that the immune system can be linked to anxiety and 
depression (Leonard and Song, 1996; Stein, 1989). For example, it is known that there 
exists a relationship between anxiety/depression and organ or stem cell transplantation, 
which could, at least partially, be explained by the immunosuppressive medication the 
patients get (Cukor et al., 2008; Tecchio et al., 2012). Furthermore, it was observed that 
patients with anxiety disorder had a reduced count in CD8+ T cells (T suppressor cytotoxic 
lymphocytes), cells that contribute to the immune response by recognizing antigen 
presenting cells via binding of the Class I MHC (major histocompatibility complex) 
molecule by the cells’ T cell receptor (Atanackovic et al., 2004; Van Laethem et al., 2012). 
In Wistar rats a genetically determined relationship was suggested to exist between low 
activity of the immune response and a high level of active anxiety (Loskutova et al., 2007). 
Nautiyal and colleagues found an elevated anxiety-like behavior in mast cell deficient 
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mice, thereby providing evidence for the behavioral importance of neuroimmune links 
(Nautiyal et al., 2008). Although there are plenty more findings on the correlation of 
anxiety and/or depression and the immune system than the just mentioned, the 
underlying molecular processes are of a complex nature and not understood yet. Thus the 
question of the involvement of the candidate genes forming the here defined immune 
system-related cluster is not easy to answer. The function of the respective genes is 
described below. However, further studies need to be performed to enlighten the genes’ 
contribution to the anxiety phenotype and the respective role the CNVs might play. 
Concerning the second cluster, a connection to an anxiety mouse model was easily 
conceivable, at least at first glance, as signal transduction is clearly needed for the 
expression of any phenotypical behavior. However, checking the genes forming the 
cluster, one could notice that they are all linked to male fertility. Considering that there 
was no difference in the fertility of HAB and LAB males observed so far, this fact was a bit 
puzzling. Hence, a closer look at the characteristic of the respective genes was taken and 
is outlined below. Briefly summarized, the genes belong to two families, both detected by 
examinations on fertility (Hammer et al., 1989; Herrmann et al., 1999). Their exact 
function still remains ambiguous. However, their proximity to the major 
histocompatibility complex (MHC), a cell surface molecule involved in the immune 
response that is encoded by a large gene family, as well as their structure of protein 
kinase domains (Ma et al., 2002; Redkar et al., 2000) led to the assumption that the genes 
might be involved in important, not fertility-related molecular processes that could 
contribute to the immune response or manipulate behavioral expression. That hypothesis 
lacks proof, though. Subsequent studies should be performed to enlighten the 
contribution of these genes to the HAB/LAB phenotyes. 
Sirpb1a and Sirpb1c 
The signal-regulatory protein beta 1A (Sirpb1a), also called Sirpb1 or Sirpβ1, and the 
signal-regulatory protein beta 1C (Sirpb1c) are genes whose human equivalents belong to 
the so called “SIRP family”, a gene family, which was detected in 1997 with at least 
15 members all encoding proteins involved in the regulation of signals defining different 
physiological and pathological processes (Kharitonenkov et al., 1997). The SIRP family 
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belongs to the immunoglobulin (Ig) superfamily since its members possess an Ig-like 
domain. This domain was shown to be involved in cell-surface recognition and binding 
functions and appears not only in immunoglobulins but also in non-immunoglobulins. 
Even though most proteins with Ig-folds were found to play a role in the adaptive 
immune system, the abundance of the domain type reflect their usefulness in protein 
interactions in many cell types (Barclay, 2003; Bork et al., 1994; Williams and Barclay, 
1988). Although most of the studies hint to an involvement of the SIRP family members in 
the immune system it might be that it executes other functions as well, possibly through 
the activation of the MAPK pathway (Barclay and Brown, 2006; Hayashi et al., 2004). This 
pathway is known to play a role in important cellular processes like cell differentiation 
and survival, growth control and cellular adaptation to chemical and physical stress 
(Chang and Karin, 2001; Cobb, 1999; Orton et al., 2005; Widmann et al., 1999). 
Additionally, the MAPK pathway was linked to anxiety and depression before (Di 
Benedetto et al., 2009; Jurek et al., 2012; Wefers et al., 2012), thus, further studies on the 
connection of Sirp genes and the MAPK pathway seem promising to take the research on 
uncovering the molecular processes of anxiety a step forward. 
Skint 
Not much is known about the members of the Skint (selection and upkeep of 
intraepithelial T cells) gene family yet, whereat Skint1 is still the best examined. Ten intact 
paralogous genes to Skint1 (Skint2 – Skint11) were found in mice that all show expression 
in the thymus and/or the skin (Boyden et al., 2008). To date, no detailed information on 
the Skint family members defined as candidate genes in HAB/LAB mice (Skint3, Skint4, 
Skint5, Skint6, Skint9 and Skint11) is available. However, Skint1 was shown to be involved 
in the determination of functional programs of the murine T cell development (Barbee et 
al., 2011; Havran and Jameson, 2010; Turchinovich and Hayday, 2011). Hence, it was 
considered to define a critical axis of communication between thymic stroma and γδ T cell 
progenitors (Hayday, 2009). The γδ T cells are the prototype of “unconventional” 
T lymphocytes and were shown to recognize “stress antigens” like the Rae-1 (RAE1 RNA 
export 1 homolog) gene product that was linked to skin carcinoma, and thus initiate a 
lymphoid stress-surveillance response (Girardi et al., 2001; Hayday, 2000, 2009). 
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Considering that a response to stress must be rapid, the precursor frequency of T cells to 
be suitable for stress surveillance should be high, which could be indirectly achieved by 
the mediation of Skint1. Unfortunately there are no data available for the Skint family 
members detected in HAB/LAB mice. Besides, there is no indication that the lymphoid 
stress surveillance affects anxiety or depression, although it was supposed to be involved 
in tumor immunology, inflammation, allergy, autoimmunity and infectious disease 
(Hayday, 2009). However, the involvement of “stress antigens” and a surveillance 
mechanism including Skint genes in the phenotypical expression of anxiety is conceivable 
and might open a field for further investigations. 
Furthermore, the Skint genes are, like the Sirpb genes, members of the immunoglobulin 
superfamily (Boyden et al., 2008). Therefore, these genes possess an Ig-like domain 
through which they could act on protein interactions in many cell types (Barclay, 2003; 
Bork et al., 1994; Williams and Barclay, 1988) and, thus, might have yet undetected 
functions, related or non-related to the immune system, that could somehow influence 
the behavioral phenotype. 
Tcp10 and Smok2 
The Tcp10 (t-complex protein 10) genes map to the so called t-complex, a proximal part 
of the mouse chromosome 17 that spans about 15-20 cM and reflects a contiguous region 
of the MHC, an important contributor of the immune system. The t-complex is known to 
appear naturally in closely related variants, also referred to as t-haplotypes. These 
variants are held together as unified entities by four neighbouring inversions (Hammer et 
al., 1989; Redkar et al., 2000). The functions of the genes located in the t-complex are 
largely unknown, although some of the genes were linked to male fertility (Harrison et al., 
1998; Huw et al., 1995; Ma et al., 2002; Mazarakis et al., 1991; Olds-Clarke and Johnson, 
1993). It has been suggested that multiple genes within the t-complex contribute to male 
sterility by altering the sperm function, including motility, capacitation (a process of 
interaction with the oocyte) and binding to the zona pellucida (a glycoprotein membrane 
surrounding the oocyte) (Redkar et al., 2000). Although not shown before, it might be 
that genes involved in the just mentioned mechanisms could also contribute to other 
molecular processes that require cell-cell interactions and thus alter e.g., the immune 
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response or any other phenotypical expression like anxiety-related behavior. Of course, 
that hypothesis is highly speculative and needs to be pursued by further experiments. 
One element of the t-complex is the so called t-complex responder (Tcr) locus that 
influences the transmission ratio distortion (TRD). The TRD is the phenomenon that male 
mice heterozygous for a complete t-haplotype (t/+) preferentially transmit the 
t-haplotype chromosome to their progeny. However, the precise location of the 
responder region is not evident. A member of the Tcp10 gene family, Tcp10b, was initially 
proposed as a candidate for Tcr (Bullard and Schimenti, 1991; Davies and Willison, 1991; 
Pilder et al., 1992; Schimenti et al., 1988) but was later on rejected due to the results of 
further examination (Ewulonu et al., 1996). In another study large parts of the region 
supposed to contain the Tcr were isolated and appeared in in vitro experiments to be an 
odd serine/threonine protein kinase, created from a rearrangement of a gene designated 
as Smok (sperm motility kinase) with its neighboring gene Rsk3 (ribosome S6 kinase). In 
the same study Smok was shown to represent a new gene family. Thus, Tcr was supposed 
to represent a mutant form of the Smok gene family and was therefore abbreviated by 
the symbol SmokTcr. Another two family members were suggested to form a subfamily, 
termed Smok2, since different to the other genes, their open reading frame was extended 
(Herrmann et al., 1999; Redkar et al., 2000). Even though no further data are available, 
the Smok2 proteins contain conserved residues of the serine/threonine protein kinase 
consensus sequence (Herrmann et al., 1999) and thus a highly speculative hypothesis 
could be that Smok2 participates in signal transduction or other important cellular 
processes through the phosphorylation of distinct proteins. 
3.2  Candidate genes in CD-1 mice 
As described in chapter II-6, CNVs might influence behavioral phenotypes by the 
alteration of gene expression in multiple ways. One possibility is by directly changing the 
amount of specific genes per se. Thus, genes mapping into regions of detected CNVs were 
considered to be of primary interest and these candidate genes were not only revealed in 
HAB/LAB mice, as discussed in chapter 3.1, but also in CD-1 mice. Of the 764 CNVs 
detected by JaxMDGA in 64 CD-1 mice only a part could be associated to anxiety-related 
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behavior, measured by different parameters in several behavioral tests. Thus, 55 CNVs 
were associated with the percentage of time the animals spent on the open arm of the 
EPM. These CNVs were chosen to provide the basis for further analysis as HAB/LAB mice 
were bred for that behavioral parameter and therefore, the resulting genes were 
comparable to the HAB/LAB derived candidates. In total, 53 genes were found to map 
into the genomic regions of these CNVs and they were subsequently studied to identify 
functional clusters, using the functional annotation tool provided at the DAVID 
Bioinformatics database (da Huang et al., 2009a; 2009b). 
The same two types of clusters that were found in HAB/LAB animals were also defined 
here, i.e. one cluster that could be linked to the immune system and another one 
comprising genes that were shown to be involved in signal transduction. Many of the 
genes found to form the immune system cluster were also defined as candidate genes in 
HAB/LAB mice. A detailed description of these genes and the discussion about the 
relationship between the immune system and anxiety/depression could be found above 
(chapter 3.1). 
Although designated equally, the signal transduction cluster was formed by three genes 
different to the ones building the equivalent cluster in HAB/LAB animals. Below, the 
characteristics of these genes are just mentioned briefly to give an idea on how they 
might influence signal transduction and thereby the behavior. A deeper insight into their 
molecular mechanisms requires extensive investigations and is thus subjected to 
advanced studies. 
One of the genes, Ranbp17 (RAN binding protein 17), was described to belong to the 
importin β superfamily, having a high sequence similarity to the importin β-related 
transport receptors, which are important mediators of the transport between nucleus 
and cytoplasm (Kutay et al., 2000; Lee et al., 2010). The role of Ranbp17 in nuclear 
transport though remains to be reported. Interestingly, the transcript(s) expression of 
Ranbp17 has been described to be testis-enriched in mouse tissue samples (Koch et al., 
2000; Lee et al., 2010). That is striking, since the candidate genes of the analogues cluster 
in HAB/LAB mice could be linked to male fertility as well. Although it might be a 
coincidence, genes being involved in the alteration of fertility that also play a role in other 
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molecular processes altering the behavior, could indeed be a driving factor of anxiety 
evolution and further studies should focus on that topic. 
The second gene of the signal transduction cluster, Dock9 (dedicator of cytokinesis 9), 
which is also part of the immune system cluster, was shown to activate Cdc42, a Rho 
family small GTPase. That family is known to regulate multiple molecular processes like 
cell migration, cell cycle progression, gene expression, innate immunity, and bacterial and 
viral infections (Kwofie and Skowronski, 2008). Therefore, multiple ways on how the gene 
might be involved in signal transduction and thereby manipulate anxiety-related behavior 
are conceivable and might be the topic of future examinations. 
Another gene also appearing in both clusters is Sytl3 (synaptotagmin-like 3). Its product, a 
peripheral membrane protein, might be involved in vesicular trafficking (Fukuda and 
Mikoshiba, 2001; Kuroda et al., 2002). Although it was not shown to be associated with 
any lentivirus infection in mammals so far, it could interact with Rab27a, a member of the 
Ras oncogene family, reported to be required for enveloped virus assembly of human 
cytomegalovirus (Fraile-Ramos et al., 2010; White et al., 2012). Furthermore, Rab27a was 
reported to regulate phagocytosis and to be involved in exosome synthesis (Ostrowski et 
al., 2010; White et al., 2012; Yokoyama et al., 2011). Thus Sytl3 could indirectly exert 
influence on those processes and thereby on behavioral patterns. 
4  Conclusion 
Despite newly developed detection methods, the generation of reliable genetic data, as 
basis for subsequent investigations on genetic variation influencing behavioral 
phenotypes, remains a huge challenge in current research. This is not only because each 
of the available techniques is biased in some way, but also due to the dependency of 
results from the applied computational method for processing the raw data. In this study, 
employing three of the most advanced techniques, a comprehensive catalogue of CNVs in 
the HAB/LAB mouse model was successfully generated. 
Based on this catalogue, it could be demonstrated that CNVs contribute to the expression 
pattern of protein coding genes mapping into the variant regions. By the correlation of 
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CNVs with anxiety-related behavior in CD-1 mice, further genes of interest were 
discovered, thereby verifying some of the candidate genes found in HAB/LAB mice. These 
confirmed candidate genes could be linked to the immune system and to signal 
transduction by use of a functional annotation clustering method. Hence, this thesis 
provides not only a comprehensive catalogue of CNVs in HAB/LAB mice but also a first 
insight into the functionality of CNVs with respect to anxiety-related behavior, and 
therefore forms an important basis for the conductance of advanced studies. 
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VI  Perspectives 
This study focused on the detection of CNVs, but also examined their influence on gene 
expression and behavior, thereby providing a profound basis for advanced examinations. 
Multiple follow-up studies are conceivable and the prioritized are described below. 
First, CNV data could be checked against information on SNPs in HAB/LAB mice. Although 
associated with behavior before, the role of SNPs, especially for the ones provoking a 
silent mutation, is not yet clear. One hypothesis might be that SNPs pave the way for the 
formation of CNVs and other structural variants when occurring at so called “hotspots”, 
genomic regions of high sequence similarity leading to misalignments and thus 
rearrangements of the genome (Gu et al., 2008). A potential finding of an accumulation of 
SNPs near CNV breakpoints could support that hypothesis. In this context the 
examination of mitochondrial DNA (mtDNA) would be of interest, too, since this type of 
DNA could vary in copy number depending of the tissue examined (Fuke et al., 2011). 
Thus, the detection of an enlarged occurrence of both SNPs and CNVs in the mtDNA of a 
specific tissue but no SNPs and no CNVs in another tissue of the same animals, would 
provide further evidence for SNPs being a precursor of CNV formation. 
Furthermore, knowing the exact CNV breakpoints of HAB/LAB mice could ease the 
detection of these variants in animals of future generations. Besides, it could help to 
indicate, which of the applied techniques and algorithms for CNV detection performed 
best and thus give a hint on the reliability of variances detected in the 64 CD-1 mice by 
JaxMDGA. The most important, but not easiest thing to do could be to encircle the exact 
breakpoints of the CNVs using a PCR-based strategy, that is by designing qPCR primers 
mapping in the proximity of the assumed breakpoint thereby narrowing down the region 
to a size that could be targeted by PCR primers. A similar strategy was applied by Williams 
and colleagues to verify the CNV harboring the Glo1 locus (Williams et al., 2009). 
Subsequently performed Sanger sequencing could finally reveal the exact breakpoints. 
This strategy sounds easy to follow, however, successful primer design could be a time 
consuming task and, though a single run might not be expensive, the sum of all costs 
could quickly reach financial limits. Thus, it is recommended to focus on those CNVs that 
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seem to be of major interest, either because they are likely to be involved in the 
expression alteration of genes found to be of interest by other studies, or because they 
are likely to interact with other genetic factors like SNPs or epigenetic factors, thereby 
influencing the mice’s anxiety-related behavior. 
Further work could also focus on the detection of new candidate genes. In the here 
performed study only the protein coding genes overlapping regions of suggested CNVs 
were listed as candidate genes. Other types of genetic features like (non-) coding RNA 
genes or known transcription factor binding sites could be added. Additionally, since 
cis-acting regulators were found to act over a distance of several megabases (Kalari et al., 
2010; Lettice et al., 2002; Nobrega et al., 2003), all protein coding genes and other 
genetic feature types occurring at a defined distance from the CNV breakpoints could be 
of interest and included in the list. 
Finally, a continuation of the so called “Glo1 breeding approach” could be performed. 
Although no difference in the anxiety-related behavior of animals with a HAB genetic 
background harboring the LAB-specific Glo1 CNV compared to those animals harboring 
the HAB-specific locus was shown in this study, it should be considered that the tested 
animals were heterozygous for that locus. It might be that behavioral changes would 
occur when the mice were homozygous for the respective CNV. Thus, a cross-breeding 
approach of the next generation of animals could result in the required homozygous 
animals and the performance of behavioral test might reveal a less anxious phenotype. 
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VIII  Supplementary data 
All supplementary data can be found on the enclosed DVD. Here, the whole content of 
the DVD, including short descriptions of the data, is listed. 
Report S1: Analysis of structural variants in HAB/LAB mice based on NGS data. This 
preliminary report was written by André Altmann (former member of RG Binder, MPI 
of Psychiatry) who was in charge of data processing, as the NGS was done in 
collaboration with RG Binder.  
Report S2: Analysis of expression microarray data. A detailed description of expression 
microarray data analysis to detect differentially expressed genes between HAB and 
LAB mice. 
Report S3: STRING analysis of candidate genes. All genes found to be differentially 
expressed in at least one of the brain regions BLA, CeA, Cg and PVN via expression 
microarray were checked for building of networks. Here the results of the analysis 
using STRING online software v9.0 are shown. 
Report S4: Breeding scheme of Glo1-selective breeding approach. A family tree of all 
animals that were mated is shown. For each animal the number and generation is 
shown. 
Report S5: Rewritten version of the Simple CNV function. The modified “simpleCNV” 
function of the R package “MouseDivGeno”, used to analyze data of the JaxMDGA 
approach screening for CNVs in CD-1 mice. All parts that were rewritten are 
highlighted in this report. The notes not belonging to the R code itself were marked 
by symbol (#). 
Table S1: CNVs detected by aCGH. All 98 CNVs detected by aCGH are listed including 
information on the genomic position. 
Table S2: CNVs detected by JaxMDGA. All 180 CNVs detected by JaxMDGA are listed 
including information on the genomic position. 
Table S3: CNVs detected by NGS. All 5,851 CNVs detected by NGS are listed including 
information on the genomic position. 
Table S4: Deletions detected by NGS. All deletions detected by NGS either in HAB or LAB 
mice are listed including information on the genomic position. 
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Table S5: Sequences of wrong orientation detected by NGS. All regions detected by NGS 
are listed, where the R3 read was aligned downstream to the F3 read during analysis, 
indicating a complex structural variant. 
Table S6: Insertions detected by NGS. All insertions detected by NGS either in HAB or LAB 
mice are listed including information on their genomic position. 
Table S7: Inversions detected by NGS. All inversions detected by NGS either in HAB or 
LAB mice are listed including information on the genomic position. 
Table S8: Comparison of CNVs detected by three different methods. List of all CNVs 
detected by aCGH, JaxMDGA and NGS in HAB/LAB with overlapping CNVs written in 
one line. 
Table S9: Genes differentially expressed between HAB and LAB mice. Genomic positions 
of genes found to be differentially expressed in HAB and LAB mice by expression 
microarray. 
Table S10: Result of MLPA analysis. For all 33 probes targeting 11 potential CNVs in 54 
CD-1 mice and one HAB mouse the copy number status in respect to a LAB sample is 
shown. 
Table S11: CNVs detected in CD-1 mice by JaxMDGA. CNVs listed were revealed in at 
least one pair of the 64 animals screened. 
Table S12 Association of CNVs, detected in CD-1 mice, with behavior on the EPM. For 
five different parameters of the EPM test the nominal p-value and the p-value after 
Bonferroni correction are shown. 
Table S13 Association of CNVs, detected in CD-1 mice, with behavior in the TST. For 
three different parameters of the TST the nominal p-value and the p-value after 
Bonferroni correction are shown. 
Table S14 Association of CNVs, detected in CD-1 mice, with behavior in the FST. For 
seven different parameters of the FST the nominal p-value and the p-value after 
Bonferroni correction are shown. 
Table S15 Association of CNVs, detected in CD-1 mice, with behavior in the OF. For seven 
different parameters of the OF the nominal p-value and the p-value after Bonferroni 
correction are shown. 
Table S16 Association of CNVs, detected in CD-1 mice, with Cort concentrations in SRT. 
For three different Cort concentrations the nominal p-value and the p-value after 
Bonferroni correction are shown. 
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Table S17 Protein coding genes in CNVs detected by aCGH in HAB/LAB mice. List of all 
protein coding genes of which the genomic position overlapped with any CNV 
detected in HAB/LAB by aCGH. 
Table S18 Protein coding genes in CNVs detected by JaxMDGA in HAB/LAB mice. List of 
all protein coding genes of which the genomic position overlapped with any CNV 
detected in HAB/LAB by JaxMDGA. 
Table S19 Protein coding genes in CNVs detected by NGS in HAB/LAB mice. List of all 
protein coding genes of which the genomic position overlapped with any CNV 
detected in HAB/LAB by NGS. 
Table S20 Protein coding genes in CNVs detected by JaxMDGA in 64 CD-1 mice. Genes 
overlapping with any of the detected CNVs are shown, not considering if an 
association with behavioral data was found. 
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